Unnamed: 0,title,date,stock,sentiment
878676.0,"Shares of several healthcare companies are trading higher on continued optimism amid the reopening of the economy, which would increase consumer spending and economic activity.",2020-06-08 11:41:00-04:00,MYL,positive
878677.0,Interim Results Of U.K. Trial Of Hydroxychloroquine Show No Evidence Of Benefit In Hospitalized COVID-19 Patients,2020-06-05 09:41:00-04:00,MYL,positive
878678.0,"Mylan and Lupin Receive European Marketing Authorization For Nepexto, Biosimilar Etanercept",2020-06-04 08:07:00-04:00,MYL,neutral
878679.0,"Hydroxychloroquine No Better Than Placebo In Preventing Infection With The Conroavirus, University Of Minnesota Study Shows",2020-06-03 15:26:00-04:00,MYL,positive
878680.0,"BZ NOTE: The New England Journal Of Medicine Is Set To Release A Highly-Anticipated Study On The Effects Of Hydroxychloroquine At 5 p.m. Today; Watching Shares Of Mylan, Teva As Early Results Of The Study Have Been Published By Dow Jones",2020-06-03 15:06:00-04:00,MYL,positive
878681.0,"Shares Of Mylan, Teva Ticking Lower As Dow Jones Reports 'Antimalaria Drug Didn't Protect Against Covid-19 In Latest Large Study'",2020-06-03 15:03:00-04:00,MYL,negative
878682.0,'Antimalaria Drug Didn't Protect Against Covid-19 In Latest Large Study',2020-06-03 15:02:00-04:00,MYL,negative
878683.0,'WHO says hydroxychloroquine coronavirus trials to resume' -AFP Tweet,2020-06-03 12:14:00-04:00,MYL,neutral
878684.0,Revance And Mylan To Advance Development Program For Biosimilar To BOTOX; $30M Milestone Payable To Revance From Mylan,2020-06-01 08:34:00-04:00,MYL,neutral
878685.0,Mylan's Pakistan Partner AGP to Sell Remdesivir to Treat Covid-19 Within Two Months,2020-05-31 09:25:00-04:00,MYL,positive
878686.0,Mylan Invalidates Sanofi's Lantus® SoloSTAR® Device Patents In IPR Proceedings,2020-05-29 15:25:00-04:00,MYL,neutral
878687.0,"WHO Halts Use of Hydroxychloroquine,, Chloroquine in Solidarity Trials for Covid-19 Due to Concerns; Says Remain Useful for Malaria",2020-05-25 12:43:00-04:00,MYL,positive
878688.0,President Trump Says He's No Longer Taking Hydroxychloroquine,2020-05-25 12:41:00-04:00,MYL,negative
878689.0,"In The Midst Of Pandemic, Traders Pin Their Hopes On These Healthcare ETFs",2020-05-19 09:38:00-04:00,MYL,positive
878690.0,Shares of several healthcare companies are trading higher in sympathy with the overall market as optimism around a coronavirus vaccine increased following news from Moderna.,2020-05-18 10:23:00-04:00,MYL,positive
878691.0,'#COVID19 No data disclosed for #remdesivir #hydroxychroloquine in the DISCOVERY trial in France.' -Tweet From Andy Biotech. BZ NOTE: Content In Tweet From ~2 Hours Ago,2020-05-14 12:11:00-04:00,MYL,neutral
878692.0,"UBS Maintains Neutral on Mylan, Raises Price Target to $17",2020-05-13 09:32:00-04:00,MYL,neutral
878693.0,"The Daily Biotech Pulse: Gilead Signs Manufacturing Deal For Remdesivir, Bristol-Myers Gets Refuse-To-File Letter",2020-05-13 07:40:00-04:00,MYL,neutral
878694.0,"Mylan shares are trading higher after the company announced an agreement with Gilead, under which Mylan will have rights to distribute remdesivir in 127 countries. Gilead's remdesivir is being evaluated as a potential coronavirus treatment.",2020-05-13 06:37:00-04:00,MYL,positive
878695.0,"UPDATE: Under The Terms Of The License Agreement Signed With Gilead, Mylan Has Rights To Manufacture And Distribute Remdesivir In 127 Low- And Middle-Income Countries, Including India.",2020-05-12 16:19:00-04:00,MYL,positive
878696.0,Mylan To Supply Investigational Antiviral Remdesivir For The Potential Treatment Of Coronavirus/COVID-19,2020-05-12 16:17:00-04:00,MYL,neutral
878697.0,"'Gilead strikes licensing agreements w 5 cos (Cipla Ltd., Ferozsons Laboratories, Hetero Labs Ltd., Jubilant Lifesciences and Mylan) to manufacture remdesivir in 127 countries, royalty-free until WHO declares end of global public health emergency' -Tweet",2020-05-12 14:22:00-04:00,MYL,positive
878698.0,Mylan Shares Fall To Session Low As CEO Interviews On CNBC,2020-05-11 15:22:00-04:00,MYL,neutral
878699.0,"From Mylan Earnings Conference Call: About Half Of Active Ingredients Are Sourced From India, China",2020-05-11 11:01:00-04:00,MYL,positive
878700.0,Mylan Sees FY20 Sales $11.50B-$12.50B vs $11.74B Est.,2020-05-11 08:17:00-04:00,MYL,neutral
878701.0,"Mylan Q1 EPS $0.040 Does Not Compare To $0.860 Estimate, Sales $2.620B Miss $2.650B Estimate",2020-05-11 08:16:00-04:00,MYL,negative
878702.0,"Earnings Scheduled For May 11, 2020",2020-05-11 04:19:00-04:00,MYL,neutral
878703.0,"The Week Ahead In Biotech: Virtual Conference Presentations, Clovis PDUFA Date In The Spotlight",2020-05-10 15:40:00-04:00,MYL,neutral
878704.0,"Wells Fargo Maintains Equal-Weight on Mylan, Lowers Price Target to $18",2020-04-30 11:49:00-04:00,MYL,positive
878705.0,Pfizer CEO Says No Change In Commitment To Merger Of Upjohn Unit With Mylan,2020-04-28 10:21:00-04:00,MYL,positive
878706.0,"Mylan And Biocon Launch Fulphila, Biosimilar Pegfilgrastim, In Canada",2020-04-28 07:20:00-04:00,MYL,neutral
878707.0,Mylan Option Alert: Jan 15 $15 Puts at the Bid: 2300 @ $2.661 vs 12606 OI; Earnings 5/5 Before Open [est] Ref=$15.49,2020-04-23 13:06:00-04:00,MYL,positive
878708.0,"Mylan Shares Tick Higher, Still Down 0.9% For Session, But Off Intraday Low; Hearing EU Conditional Approval Was Given For Off-Patent Deal With Pfizer",2020-04-22 12:38:00-04:00,MYL,positive
878709.0,Mylan Names Robert Coury Chair,2020-04-15 17:03:00-04:00,MYL,neutral
878710.0,"Piper Sandler Maintains Neutral on Mylan, Lowers Price Target to $17",2020-04-15 08:48:00-04:00,MYL,negative
878711.0,Shares of several healthcare companies are trading higher amid overall market strength after the US Federal Reserve announced a further $2.3 trillion in financing programs to support the economy. Other potential positive sector catalysts include demand for therapies and medical supplies amid the coronavirus pandemic and US Senator Sanders exiting the Presidential race.,2020-04-09 09:58:00-04:00,MYL,positive
878712.0,"UPDATE: Mylan Highlights Is Donating Product To WHO To Support Investigation Of Potential Coronavirus Treatments, Notes Co. Is Only Co. Providing Hydroxychloroquine Sulfate Tablets, 1 Of 3 Cos. Supply Lopinavir/Ritonavir Tablets For WHO's SOLIDARITY Trial",2020-04-08 13:46:00-04:00,MYL,positive
878713.0,"Mylan Offers Updates On Efforts To Help Coronavirus Outbreak: Continues To Collaborate With Pharmacies, Wholesalers, Gov'ts, Has Begun Shipping Added Product To Wholesalers, Mentions Co.'s Hydroxychloroquine Sulfate Tablets",2020-04-08 13:45:00-04:00,MYL,positive
878714.0,U.S. Emergency Management Official Says Working to Push Out Millions of Doses of Hydroxychloroquine,2020-04-05 19:31:00-04:00,MYL,negative
878715.0,Trump Says Will Ask Doctors if he Should Take Anti-malarial Drug to Treat Coronavirus,2020-04-04 17:20:00-04:00,MYL,positive
878716.0,Trump Says 29M Doses of Anti-malarial Drugs Will Be Put in Strategic National Stockpile for Coronavirus Patients,2020-04-04 16:59:00-04:00,MYL,neutral
878717.0,"Morgan Stanley Maintains Equal-Weight on Mylan, Lowers Price Target to $18",2020-04-02 09:24:00-04:00,MYL,negative
878718.0,"Shares of several healthcare companies are trading lower, selling off from this week's strength. While the US stimulus package boosted economic optimism, demand concerns still exist amid the coronavirus outbreak.",2020-03-27 10:58:00-04:00,MYL,positive
878719.0,"Mylan, Lupin Reports Positive CHMP Opinion For Nepexto",2020-03-27 09:31:00-04:00,MYL,positive
878720.0,"Shares of several healthcare companies are trading lower, selling off from this week's strength. While the US stimulus legislation has boosted economic optimism, demand concerns still exist amid the coronavirus outbreak.",2020-03-27 09:22:00-04:00,MYL,positive
878721.0,"RBC Capital Maintains Outperform on Mylan, Lowers Price Target to $26",2020-03-27 07:28:00-04:00,MYL,negative
878722.0,"The Daily Biotech Pulse: FDA Nod For Bristol-Myers Squibb, Xencor Licenses Tech To Vir For COVID-19 Treatment, Delay In Pfizer's Upjohn-Mylan Merger",2020-03-26 08:23:00-04:00,MYL,negative
878723.0,"Mylan, Pfizer Report Delay Of Deal Closing For Mylan, Upjohn Deal, Closing Now Expected H2'20",2020-03-26 07:05:00-04:00,MYL,negative
878724.0,Mylan Voluntarily Waived Exclusive Rights In US To Distribute Its Generic Version Of Kaletra Antiretroviral 100mg/25mg And 200mg/50mg Tablets,2020-03-25 13:38:00-04:00,MYL,positive
878725.0,"Chloroquine, Hydroxychloroquine And Coronavirus: What You Should Know",2020-03-24 17:16:00-04:00,MYL,neutral
878726.0,FDA Says In A Letter To Pfizer And Mylan Detailed How Epipen Devices May Activate Prematurely If Blue Safety Release Is Removed Using A Sideways Force,2020-03-24 13:49:00-04:00,MYL,positive
878727.0,70 Stocks Moving In Friday's Mid-Day Session,2020-03-20 12:02:00-04:00,MYL,neutral
878728.0,Shares of several healthcare companies are trading higher as the market rebounds from coronavirus-related selloffs.,2020-03-20 09:43:00-04:00,MYL,positive
878729.0,"The Daily Biotech Pulse: Mylan Ramps Up Manufacturing Of Potential COVID-19 Drug, Lexicon Stops Study Early, Masimo To Buy German Ventilation Company",2020-03-20 07:44:00-04:00,MYL,negative
878730.0,31 Stocks Moving in Friday's Pre-Market Session,2020-03-20 07:26:00-04:00,MYL,neutral
878731.0,Mylan Ramps Up U.S. Manufacturing Of Hydroxychloroquine Sulfate Tablets To Meet Potential Coronavirus Patient Needs; Expects To Be In A Position To Begin Supplying Hydroxychloroquine Sulfate Tablets By Mid April,2020-03-19 15:28:00-04:00,MYL,neutral
878732.0,"The Daily Biotech Pulse: Setback For DBV In Peanut Allergy Patch Review, Roche Starts Coronavirus Test Shipment, Regeneron Aims For 'Cocktail' COVID-19 Treatment",2020-03-17 08:48:00-04:00,MYL,neutral
878733.0,Shares of several healthcare companies are trading lower in sympathy with the overall market on continued downward momentum caused by the coronavirus. The virus has had a negative impact on the global economy.,2020-03-16 09:40:00-04:00,MYL,negative
878734.0,"The Daily Biotech Pulse: Roche Obtains FDA Emergency Use Authorization For COVID-19 Test, Chembio Appoints New CEO, Inovio Slumps On Earnings",2020-03-13 07:52:00-04:00,MYL,negative
878735.0,Stocks That Hit 52-Week Lows On Thursday,2020-03-12 12:10:00-04:00,MYL,negative
878736.0,Mylan Wins District Court Decision Against Sanofi's Lantus SoloSTAR Patent,2020-03-10 13:00:00-04:00,MYL,positive
878737.0,"The Daily Biotech Pulse: Mesoblast To Test Candidate On Coronavirus Symptoms, Proxy Battle Ahead For Rockwell Medical, Glaukos to Join S&P SmallCap 600 Index",2020-03-10 09:19:00-04:00,MYL,negative
878738.0,Mylan shares are trading lower despite the company's Biologics Lice application was accepted by the FDA. NOTE: The overall market is trading lower amid a steep decline in the price of oil after OPEC members failed to meet a production agreement.,2020-03-09 08:57:00-04:00,MYL,negative
878739.0,Mylan's Biologics Lice Application Accepted by the FDA,2020-03-09 08:07:00-04:00,MYL,positive
878740.0,Stocks That Hit 52-Week Lows On Friday,2020-03-06 11:22:00-05:00,MYL,negative
878741.0,"The Daily Biotech Pulse: Breakthrough Device Designation For Neuronetics, AbbVie Receives European Label Expansion, AstraZeneca Flunks Late-Stage Study",2020-03-06 08:49:00-05:00,MYL,negative
878742.0,"The Daily Biotech Pulse: Trevana Pain Drug Resubmission Accepted For Review, Can-Fite To Explore Treatment For COVID-19",2020-03-05 08:05:00-05:00,MYL,negative
878743.0,Stocks That Hit 52-Week Lows On Wednesday,2020-03-04 11:12:00-05:00,MYL,negative
878744.0,Shares of several drugmakers and healthcare companies are trading higher following US Super Tuesday results in which Joe Biden won the highest number of delegates. Biden's more 'moderate' healthcare policies have been seen as more favorable for the sector.,2020-03-04 07:48:00-05:00,MYL,positive
878745.0,"The Daily Biotech Pulse: Takeda Jumps Into The COVID-19 Fray, Exact Sciences Buys Cancer Diagnostics Companies",2020-03-04 07:37:00-05:00,MYL,negative
878746.0,Stocks That Hit 52-Week Lows On Friday,2020-02-28 10:16:00-05:00,MYL,negative
878747.0,"Mylan Shares Halted On Circuit Breaker, Rebounded From Session Low, Stock Still Down 3.6% For Session",2020-02-28 09:44:00-05:00,MYL,neutral
878748.0,Shares of several healthcare companies are trading lower as the global coronavirus spread continues to cause equities across sectors to sell off amid worsened economic outlook.,2020-02-28 09:06:00-05:00,MYL,negative
878749.0,"The Daily Biotech Pulse: Sangamo In Genome-Editing Therapy Deal With Biogen, FDA Nod For Biohaven, Passage Bio IPO",2020-02-28 07:28:00-05:00,MYL,neutral
878750.0,Mylan 10-K Shows A Co. Unit Received Subpoena From New York Dept. Of Financial Services In Nov. 2019,2020-02-28 06:36:00-05:00,MYL,neutral
878751.0,"Mylan Doesn't Give Material Comment On Expectation For Impact Of Coronavirus, Says Extent Of Impact Depends On Future Developments",2020-02-28 06:26:00-05:00,MYL,neutral
878752.0,Mylan Exec Expects Some Impact From Coronavirus Due To Global Nature Of Business; Says Business Exposure In China Is Limited,2020-02-27 16:46:00-05:00,MYL,negative
878753.0,Mylan Sees FY20 Sales $11.5B-$12.5B vs $11.92B Est.,2020-02-27 16:03:00-05:00,MYL,neutral
878754.0,"Mylan Q4 Adj. EPS $1.4 Beats $1.28 Estimate, Sales $3.19B Miss $3.23B Estimate",2020-02-27 16:03:00-05:00,MYL,negative
878755.0,Shares of several healthcare companies are trading lower as growing coronavirus fears hamper economic outlook.,2020-02-27 09:28:00-05:00,MYL,negative
878756.0,"The Daily Biotech Pulse: Gilead Kicks Off Coronavirus Drug Trials, Adcom Nod For Lily, FDA Approves Esperion's Lipid-Lowering Adjunctive Combo Therapy",2020-02-27 07:35:00-05:00,MYL,positive
878757.0,"Earnings Scheduled For February 27, 2020",2020-02-27 04:51:00-05:00,MYL,neutral
878758.0,The Week Ahead In Biotech: Biopharma Earnings Pick Up Pace,2020-02-23 18:38:00-05:00,MYL,neutral
878759.0,Mylan shares are trading lower. Not seeing any news to justify the price action.,2020-02-18 11:14:00-05:00,MYL,neutral
878760.0,Biogen Rallies On Tecfidera Patent Decision,2020-02-05 14:18:00-05:00,MYL,neutral
878761.0,"Mylan Says Strongly Disagrees With Decision By US PTAB Upholding Biogen's Patent Covering Tecfidera, Plans To Pursue All Available Options For Appeal",2020-02-05 14:16:00-05:00,MYL,negative
878762.0,UPDATE: USPTO's Final Written Decision Doc For Mylan v Biogen,2020-02-05 13:41:00-05:00,MYL,neutral
878763.0,'Biogen wins IPR patent trial on '514 Tecfidera patent as patent claims challenged by Mylan remain valid.',2020-02-05 13:23:00-05:00,MYL,positive
878764.0,Shares of healthcare companies are trading higher amid a rebound in global equities following last week's selloff on coronavirus fears.,2020-02-04 10:08:00-05:00,MYL,negative
878765.0,Mylan shares are trading higher potentially on a rebound with the overall market after fear of the Wuhan coronavirus worsening caused the market to sell off.,2020-01-28 10:26:00-05:00,MYL,negative
878766.0,"Biogen's Alzheimer's Drug Has 'Decent Shot' At FDA Approval, Analyst Says",2020-01-27 11:18:00-05:00,MYL,positive
878767.0,"Benzinga's Top Upgrades, Downgrades For January 27, 2020",2020-01-27 09:40:00-05:00,MYL,positive
878768.0,Mylan shares are trading lower after SVB Leerink downgrades Mylan from Outperform to Market Perform.,2020-01-27 09:15:00-05:00,MYL,neutral
878769.0,"SVB Leerink Downgrades Mylan to Market Perform, Announces $24 Price Target",2020-01-27 06:53:00-05:00,MYL,neutral
878770.0,"Mylan Says Emerging Markets Like China, Latin America And Asia Will Be Growth Driver Going Ahead",2020-01-15 12:14:00-05:00,MYL,positive
878771.0,Mylan shares are trading higher amid the company's presentation at the JP Morgan Healthcare Conference. The company said it remains confident about its 2020 forecast given in June.,2020-01-15 12:02:00-05:00,MYL,positive
878772.0,Mylan At JP Morgan Healthcare Conference Says On Track To Close Pfizer Deal In 2020,2020-01-15 12:00:00-05:00,MYL,positive
878773.0,From JP Morgan Healthcare Conference: Mylan Says Remains Confident About 2020 Forecast Given In Jul.,2020-01-15 11:43:00-05:00,MYL,positive
878774.0,"A Preview Of JPMorgan's Healthcare Conference: Focus On Value-Creating Themes, 2020 Expectations",2020-01-10 08:52:00-05:00,MYL,neutral
878775.0,"Mylan Initiates Voluntary Nationwide Recall Of Three Lots Of Nizatidine Capsules, USP, Due To Detection Of Trace Amounts Of NDMA Impurity Found In Active Pharmaceutical Ingredient Manufactured By Solara",2020-01-08 10:31:00-05:00,MYL,positive
878776.0,"RBC Capital Yesterday Maintained Outperform on Mylan, Raised Price Target to $27",2020-01-07 11:10:00-05:00,MYL,neutral
878777.0,Mylan shares are trading higher. Not seeing any news to justify the price action.,2020-01-06 15:48:00-05:00,MYL,positive
878778.0,FDA Approves Applications For First Generics Of Eliquis,2019-12-23 15:35:00-05:00,MYL,positive
878779.0,10 Stocks That Could Be Tax-Loss Buying Opportunities,2019-12-19 12:21:00-05:00,MYL,positive
878780.0,25 Stocks Moving in Tuesday's Pre-Market Session,2019-12-10 06:48:00-05:00,MYL,neutral
878781.0,Mylan Announces the Launch of Trastuzumab Biosimilar Ogivri in the US,2019-12-02 07:21:00-05:00,MYL,neutral
878782.0,Mylan Option Alert: Jan 17 $20 Calls Sweep (58) near the Ask: 3095 @ $0.576 vs 34043 OI; Ref=$18.6,2019-11-27 10:29:00-05:00,MYL,positive
878783.0,A Deep Dive Into Aquestive Following The FDA's Approval Of Riluzole,2019-11-26 16:05:00-05:00,MYL,positive
878784.0,36 Healthcare Stocks Moving In Monday's Pre-Market Session,2019-11-25 08:40:00-05:00,MYL,neutral
878785.0,Mylan Issues Statement Regarding FDA Warning Letter To Co.'s API Manufacturer; No Significant Commercial Impact Is Expected And No Significant Launches Are Planned For Unit In 2020,2019-11-12 14:02:00-05:00,MYL,negative
878786.0,"Mylan, Pfizer Report New Of Co. To Be Formed By Planned Combo Of Mylan, Upjohn 'Viatris",2019-11-12 12:16:00-05:00,MYL,neutral
878787.0,FDA Issues Warning Letter To Mylan Concerning Contaminated India Facility,2019-11-12 10:08:00-05:00,MYL,negative
878788.0,"Benzinga's Top Upgrades, Downgrades For November 7, 2019",2019-11-07 09:32:00-05:00,MYL,positive
878789.0,10 Biggest Price Target Changes For Thursday,2019-11-07 08:26:00-05:00,MYL,neutral
878790.0,CORRECTION: Morgan Stanley Downgrades Mylan To Equal-Weight,2019-11-07 07:43:00-05:00,MYL,neutral
878791.0,"Morgan Stanley Downgrades Mylan to Equal-Weight, Lowers Price Target to $18",2019-11-07 07:20:00-05:00,MYL,negative
878792.0,Mylan Q3 Non-GAAP EPS Beats Street Estimate; Drugmaker Narrows Guidance Range,2019-11-05 10:59:00-05:00,MYL,neutral
878793.0,"Mylan Executive Says Ongoing Business Transformation Plan Includes Re-Evaluating Pipeline, Expected To Have A Negative Impact On Revenue; Expects Full-Year Sales From WIXELA To Be Slightly Lower Than Expected Due To 'Aggressive Share Retention Actions'",2019-11-05 10:43:00-05:00,MYL,negative
878794.0,Mylan shares are trading lower after the company reported Q3 results. The company reported worse-than-expected sales and issued inline guidance. NOTE: Shares dipped sharply during the conference call.,2019-11-05 10:29:00-05:00,MYL,positive
878795.0,"Mylan Sees FY19 Adj. EPS $4.20-$4.40 vs $4.29 Est., Sales $11.5B-$12.0B vs $11.61B Est.",2019-11-05 07:01:00-05:00,MYL,neutral
878796.0,"Mylan Q3 EPS $1.17 Beats $1.13 Estimate, Sales $2.96B Miss $3.01B Estimate",2019-11-05 07:01:00-05:00,MYL,negative
878797.0,"The Daily Biotech Pulse: FDA Nod For Sanofi, BioCryst's Edema Drug In Japan, Myriad's Q1 Disappointment",2019-11-05 06:53:00-05:00,MYL,negative
878798.0,"Earnings Scheduled For November 5, 2019",2019-11-05 04:14:00-05:00,MYL,neutral
878799.0,Mylan's Q3 Earnings Preview,2019-11-04 13:10:00-05:00,MYL,neutral
878800.0,"The Week Ahead In Biotech: Smid-Cap Earnings Deluge, SITC Conference In The Spotlight",2019-11-03 10:51:00-05:00,MYL,neutral
878801.0,"Mylan Option Alert: Jan, 2021 $25 Puts at the Bid: 13200 @ $7.35 vs 18488 OI; Earnings 11/5 Before Open Ref=$19.74",2019-11-01 12:13:00-04:00,MYL,positive
878802.0,Shares of several healthcare companies are trading higher after President Trump made positive remarks on the U.S.-China trade talks as traders grew more optimistic over the possibility of a limited trade deal. Trump is scheduled to meet with Chinese Vice Premier Liu He at the White House today.,2019-10-11 11:19:00-04:00,MYL,positive
878803.0,"Biocon and Mylan Launch First Insulin Glargine Biosimilar, Semglee in Australia",2019-10-03 04:27:00-04:00,MYL,neutral
878804.0,"Shares of several healthcare stocks are trading lower in sympathy with the overall market after the Institute for Supply Management said U.S. manufacturing activity shrunk to its lowest level since June 2009, adding fears of an economic slowdown.",2019-10-01 13:02:00-04:00,MYL,negative
878805.0,Mylan PR Confirms SEC Settlement,2019-09-27 10:26:00-04:00,MYL,neutral
878806.0,Hearing Mylan Top Pay $30M To Settle SEC Disclosure Lawsuit,2019-09-27 10:21:00-04:00,MYL,negative
878807.0,UPDATE: SEC Suit Against Mylan Related To Co. Failing To Timely Disclose Possible Loss From Dept. Of Justice Probe On Allegations Of Medicaid Overcharges,2019-09-27 10:06:00-04:00,MYL,negative
878808.0,Hearing Mylan Has Been Sued By SEC,2019-09-27 10:00:00-04:00,MYL,neutral
878809.0,"Mylan shares are trading lower, potentially on news of a Chinese healthcare cost control program, which could force the company to lower prices.",2019-09-24 09:50:00-04:00,MYL,negative
878810.0,"Mylan Shares Trading Lower, Hearing WEakness Being Driven By Drug Bidding Program In China",2019-09-24 09:47:00-04:00,MYL,negative
878811.0,Shares of several drug companies are trading higher after Senate Majority Leader McConnell suggested a new Democratic drug price reform proposal would be dead on arrival.,2019-09-20 13:00:00-04:00,MYL,negative
878812.0,Mylan Option Alert: Jan 17 $22.5 Calls Sweep (30) near the Ask: 993 @ $1.65 vs 10134 OI; Earnings 11/4 After Close [est] Ref=$21.06,2019-09-20 11:21:00-04:00,MYL,positive
878813.0,Mylan Option Alert: Jan 17 $27.5 Calls at the Bid: 7500 @ $0.451 vs 20914 OI; Earnings 11/4 After Close [est] Ref=$21.23,2019-09-20 10:11:00-04:00,MYL,positive
878814.0,Mylan Reports Launch Of Generic Faslodex Injection For Treatment Of Advanced Breast Cancer,2019-09-17 09:31:00-04:00,MYL,negative
878815.0,"SunTrust Robinson Humphrey Maintains Buy on Mylan, Raises Price Target to $27",2019-09-12 08:59:00-04:00,MYL,neutral
878816.0,12 Cheapest Stocks In The S&P 500,2019-09-10 12:14:00-04:00,MYL,neutral
878817.0,Pelosi's Drug Pricing Plan is More Aggressive than Expected,2019-09-09 20:23:00-04:00,MYL,negative
878818.0,Mylan Option Alert: Sep 20 $20 Calls Sweep (11) near the Ask: 500 @ $0.571 vs 11925 OI; Ref=$19.66,2019-09-04 10:19:00-04:00,MYL,positive
878819.0,"The Daily Biotech Pulse: EC Nod For Bristol-Myers Squibb, Kyowa Kirin's Parkinson's Add-On Therapy Approved",2019-08-28 07:31:00-04:00,MYL,positive
878820.0,Novo Nordisk  Files Lawsuit Against Mylan for Patent Infringement of Victoza Diabetes Drug,2019-08-22 04:14:00-04:00,MYL,negative
878821.0,Mylan Option Alert: Sep 20 $20 Calls Sweep (13) near the Ask: 1040 @ $0.85 vs 11069 OI; Ref=$19.72,2019-08-20 09:59:00-04:00,MYL,positive
878822.0,Shares of several healthcare companies are trading higher as optimism increased for a resolution to the US-China trade war.,2019-08-19 12:31:00-04:00,MYL,positive
878823.0,"Shares of healthcare companies are trading higher as US markets rebound from recent weakness following a yield curve inversion, which caused recession fears. Trump also recently announced the US would delay China tariffs, renewing hopes of a trade deal.",2019-08-16 13:27:00-04:00,MYL,negative
878824.0,"Shares of several healthcare companies are trading lower in sympathy with the overall market after the spread between the 2-year and 10-year yield curve inverted for the first time since 2007, potentially signaling an oncoming recession.",2019-08-14 11:17:00-04:00,MYL,negative
878825.0,"House Oversight Panel Chairman Renews Request for Documents From Mylan, Teva Pharmaceutical and Heritage Pharmaceuticals on Generic Drug Price Increases[ Says Panel is Probing Mylan, Teva and Heritage's Apparent Coordinated Obstruction of Drug Pricing Investigation",2019-08-14 06:31:00-04:00,MYL,neutral
878826.0,﻿Shares of several healthcare companies are trading higher with the overall market after the U.S. announced it is excluding and delaying the additional 10% tariff on certain products.,2019-08-13 11:53:00-04:00,MYL,positive
878827.0,"Notable Insider Buys This Past Week: Dish, JPMorgan, Netflix",2019-08-10 15:22:00-04:00,MYL,neutral
878828.0,Mylan Option Alert: Sep 20 $20 Calls at the Ask: 4800 @ $0.681 vs 9870 OI; Ref=$18.63,2019-08-06 10:12:00-04:00,MYL,positive
878829.0,"Biocon, Mylan Launch Ogivri in Australia",2019-08-01 03:59:00-04:00,MYL,neutral
878830.0,"A Look At Benzinga Pro's Most-Searched Tickers For July 30, 2019",2019-07-30 13:13:00-04:00,MYL,neutral
878831.0,Morgan Stanley Downgrades Pfizer In Wake Of Upjohn-Mylan Merger,2019-07-30 12:14:00-04:00,MYL,neutral
878832.0,"Benzinga Pro's Top 10 Most-Searched Tickers For Morning of Tuesday., July 30, 2019",2019-07-30 11:33:00-04:00,MYL,positive
878833.0,"UPDATE: Morgan Stanley Reiterates Overweight On Mylan, Raises Target To $25 As Firm Believes Upjohn Transaction Brings Co. 'Greater global scale and strength', 'Lower leverage', 'Attractive div yield of ~4%', And 'Improved corporate governance'",2019-07-30 09:21:00-04:00,MYL,positive
878834.0,"Morgan Stanley Reiterates Overweight on Mylan, Raises Price Target to $25",2019-07-30 09:17:00-04:00,MYL,negative
878835.0,54 Biggest Movers From Yesterday,2019-07-30 05:00:00-04:00,MYL,neutral
878836.0,Mid-Afternoon Market Update: Crude Oil Up Over 1%; Lexicon Pharmaceuticals Shares Plunge,2019-07-29 14:22:00-04:00,MYL,negative
878837.0,42 Stocks Moving In Monday's Mid-Day Session,2019-07-29 12:30:00-04:00,MYL,neutral
878838.0,Mid-Day Market Update: On Deck Capital Falls On Downbeat Earnings; Medley Management Shares Jump,2019-07-29 12:13:00-04:00,MYL,positive
878839.0,"Hearing JP Morgan Commented On Mylan Amid Pfizer Upjohn News, Sees New Valuation $25-$32/Share Based On Higher Pro-Forma Multiple Warranted For NewCo., Combined Co. Will Have Less US Generics Exposure, Less Leverage But Improved Corporate Governance",2019-07-29 11:48:00-04:00,MYL,positive
878840.0,"A Look At Benzinga Pro's Most-Searched Tickers For July 29, 2019",2019-07-29 11:35:00-04:00,MYL,neutral
878841.0,"Mid-Morning Market Update: Markets Mostly Lower; Mylan, Pfizer's Upjohn To Merge",2019-07-29 10:16:00-04:00,MYL,negative
878842.0,"Benzinga Pro's Top 10 Most-Searched Tickers For Morning of Mon., July 29, 2019",2019-07-29 09:54:00-04:00,MYL,positive
878843.0,"Host Of Earnings Loom With Beyond Meat, Apple Among Highlights Ahead Of Fed, Payrolls",2019-07-29 09:50:00-04:00,MYL,negative
878844.0,30 Healthcare Stocks Moving In Today's Pre-Market Session,2019-07-29 09:35:00-04:00,MYL,neutral
878845.0,Mylan Says Share Repurchases are Possible in 2021 Following Merger Announcement with Pfizer's Upjohn,2019-07-29 08:39:00-04:00,MYL,positive
878846.0,35 Stocks Moving In Monday's Pre-Market Session,2019-07-29 08:30:00-04:00,MYL,neutral
878847.0,"Mylan, Pfizer's Upjohn To Merge And Create New Company",2019-07-29 08:01:00-04:00,MYL,positive
878848.0,Mylan Reports Q2 Earnings Beat,2019-07-29 07:54:00-04:00,MYL,neutral
878849.0,A Peek Into The Markets: US Stock Futures Flat; Mylan To Combine With Pfizer's Upjohn Division,2019-07-29 07:32:00-04:00,MYL,neutral
878850.0,Mylan shares are trading higher after the company announced a business combination with Pfizer's Upjohn	division. The company also reported better-than-expected Q2 results.,2019-07-29 07:29:00-04:00,MYL,positive
878851.0,"Mylan and Pfizer's Upjohn to Merge and Create a New Company, Mylan Shareholders to Own 43% of the New Company",2019-07-29 06:46:00-04:00,MYL,positive
878852.0,"Mylan Reaffirms 2019 EPS, Cash Flow and Sales Guidance",2019-07-29 06:36:00-04:00,MYL,neutral
878853.0,"Mylan Q2 EPS $1.03 Beats $0.94 Estimate, Sales $2.85B Beat $2.82B Estimate",2019-07-29 06:35:00-04:00,MYL,neutral
878854.0,Pfizer in Talks to Merge Off-patent Drugs Business with Mylan,2019-07-28 08:15:00-04:00,MYL,neutral
878855.0,"Najarian Brothers See Unusual Options Activity In FireEye, Oracle, Mylan And Exelon",2019-07-24 17:42:00-04:00,MYL,neutral
878856.0,"Morgan Stanley Downgrades Teva, Endo On Drug Pricing And Litigation Concerns",2019-07-15 10:35:00-04:00,MYL,negative
878857.0,Shares of several healthcare companies in the pharmaceutical space are trading lower after Amneal Pharmaceuticals announced a cost reduction plan in response to the continuing industry challenges. Amneal cut guidance as part of plan.,2019-07-10 11:37:00-04:00,MYL,negative
878858.0,"Cantor Fitzgerald Comments On The Weakness In Healthcare Companies, Notes 'AMRX undertook the additional cost reduction in response to the continuing industry challenges.'; Says This Has Had Readthrough To Other Generics Names",2019-07-10 11:26:00-04:00,MYL,negative
878859.0,U.S. Judge Halts Trump Administration Rule Requiring Drug Prices in TV Ads,2019-07-08 18:26:00-04:00,MYL,neutral
878860.0,"Shares of several healthcare companies are trading lower after Trump on Friday said he was preparing an executive order declaring a 'favored nations clause' for drug prices, lowering the price that consumers will pay prescription drugs.",2019-07-08 12:55:00-04:00,MYL,positive
878861.0,Mylan And Atomo Diagnostics Announce WHO Prequalification Approval For Mylan HIV Self Test,2019-07-08 12:44:00-04:00,MYL,positive
878862.0,20 Best And Worst S&P 500 Stocks Through The First Half Of 2019,2019-07-03 12:34:00-04:00,MYL,neutral
878863.0,"Theravance Biopharma and Mylan Expand YUPELRI Development and Commercialization Agreement to Include China and Adjacent Territories, Theravance to Receive a $18.5M Upfront Payment",2019-06-14 08:12:00-04:00,MYL,positive
878864.0,"Barclays Initiates Coverage On Mylan with Overweight Rating, Announces $26 Price Target",2019-06-11 07:08:00-04:00,MYL,negative
878865.0,"CTW Investment Group Urges Mylan Shareholders To Oppose Re-Election Of Directors Dillon, Cindrich, Parrish, And Vollebregt",2019-06-07 11:57:00-04:00,MYL,neutral
878866.0,"Seeing Social Media Mention Of Mylan CEO, Heather Bresch, Planning On Submitting Resignation Next Week",2019-06-07 09:54:00-04:00,MYL,negative
878867.0,FDA Panel Votes 14-4 In Favor Of Approval Of TB Alliance's Treatment As Part Of A 3-Drug Combination Regimen For Multidrug-Resistant  Tuberculosis,2019-06-06 14:58:00-04:00,MYL,positive
878868.0,Shares of several healthcare companies are trading higher with the overall US market. Recent comments out of China and Mexico has renewed trade optimism and lifted economic outlook.,2019-06-04 13:07:00-04:00,MYL,positive
878869.0,Mylan Option Alert: Jun 7 $17 Calls Sweep (3) near the Ask: 1000 @ $0.48 vs 147 OI; Ref=$16.75,2019-05-31 14:42:00-04:00,MYL,positive
878870.0,Watching Mylan Shares Following Headline US Dept. Of Justice Says Heritage Pharma To Pay $7M To Resolve Claims Over Drug Price Fixing,2019-05-31 11:16:00-04:00,MYL,positive
878871.0,Mylan Option Alert: Aug 16 $20 Calls at the Ask: 1500 @ $0.781 vs 1702 OI; Ref=$16.705,2019-05-31 11:11:00-04:00,MYL,positive
878872.0,"The Daily Biotech Pulse: Merrimack To Stay Independent, Chinese Cheer For Beigene, XBiotech Offering",2019-05-31 07:34:00-04:00,MYL,positive
878873.0,Mylan Option Alert: Oct 18 $20 Calls at the Ask: 8893 @ $1.301 vs 22532 OI; Ref=$17.53,2019-05-29 10:39:00-04:00,MYL,positive
878874.0,Bosnalijek Signs Cooperation Deal With Mylan,2019-05-29 09:07:00-04:00,MYL,neutral
878875.0,"The Daily Biotech Pulse: Inovio's Partner Scales Back R&D Collaboration, Genmab Seeks Nasdaq Listing, Bayer Gets Breakthrough Therapy Designation",2019-05-29 07:38:00-04:00,MYL,neutral
878876.0,Hearing Chatter Elliott Management Has An Activist Stake In Mylan; Unconfirmed,2019-05-22 10:18:00-04:00,MYL,negative
878877.0,"Mylan, Biocon Report Health Canada Approved Ogivri For Treatment Of HER2-Positive Breast, Gastric Cancers",2019-05-22 07:33:00-04:00,MYL,positive
878878.0,"Mylan Shares Unaffected Amid Chatter, Tweet From Anonymous, Unconfirmed Source 'Mylan received a takeover approach at 32$ the details of this deal will be known this week'",2019-05-20 13:19:00-04:00,MYL,positive
878879.0,Mylan Shares Tick Higher Over $19.50 Level On Uptick In Volume As Traders Circulate Earlier Article From Questionable Source 'Warren Buffet is preparing an offer on the company Mylan with the aim of merging it with Teva',2019-05-20 11:57:00-04:00,MYL,neutral
878880.0,"Theravance Biopharma, Mylan Report Presentation Of Data From Pivotal Phase 3 Efficacy Studies, 52-Week Safety Study At American Thoracic Society",2019-05-20 10:18:00-04:00,MYL,positive
878881.0,Mylan Presents Equivalence and Device Usability Data on Wixela Inhub vs Advair Diskus at American Thoracic Society International Conference,2019-05-18 19:59:00-04:00,MYL,neutral
878882.0,"Horizon Therapeutics Shares Dip Lower, Quickly Rebound From Session Low; Hearing Co. Has Lost Appeal Over 2 Patents On Vimovo Pain Drug",2019-05-15 09:56:00-04:00,MYL,negative
878883.0,"Top 10 Most Oversold Stocks Via Benzinga Pro's Radar Tool For Tue., May 14, 2019",2019-05-14 11:59:00-04:00,MYL,positive
878884.0,"The Daily Biotech Pulse: Further Delay in Roche's Spark Acquisition, FDA Nod For Regeneron, Solid Biosciences Sinks On Earnings",2019-05-14 07:42:00-04:00,MYL,positive
878885.0,Mylan Option Alert: Fri $20 Calls Sweep (4) near the Ask: 659 @ $0.781 vs 68 OI; Ref=$20.3173,2019-05-13 10:47:00-04:00,MYL,positive
878886.0,Mylan Option Alert: Oct 18 $20 Calls at the Ask: 5000 @ $2.851 vs 118 OI; Ref=$20.57,2019-05-13 10:16:00-04:00,MYL,positive
878887.0,Shares of several drug manufacturers are trading lower after the United States filed a lawsuit against Teva alleging price fixing.,2019-05-13 09:53:00-04:00,MYL,positive
878888.0,Teva Plummets Amid Massive Price Fixing Accusations; Other Generic Drugmakers Also Fall,2019-05-13 08:40:00-04:00,MYL,negative
878889.0,Shares of several healthcare companies are trading lower in sympathy with the overall market. The S&P 500 is trading lower 1%,2019-05-10 13:09:00-04:00,MYL,positive
878890.0,Mylan Expands Oncology Portfolio With Launch Of Generic Tarceva Tablets,2019-05-10 09:47:00-04:00,MYL,positive
878891.0,"Mylan shares are trading higher amid unconfirmed, questionable reports of takeover interest.",2019-05-09 11:56:00-04:00,MYL,positive
878892.0,Mylan Shares Spike To Session High As Traders Circulate Article From Questionable Source Suggesting Takeover Interest,2019-05-09 10:07:00-04:00,MYL,positive
878893.0,"Now That Mylan Lost A Quarter Of Its Value, The Chart Says To Look For A Bounce",2019-05-08 15:43:00-04:00,MYL,neutral
878894.0,"Top 10 Most Oversold Stocks Via Benzinga Pro's Radar Tool For Wed., May 8, 2019",2019-05-08 14:09:00-04:00,MYL,positive
878895.0,"Benzinga Pro's Top 10 Most-Searched Tickers For Morning of Wed., May 8, 2019",2019-05-08 10:45:00-04:00,MYL,positive
878896.0,"The Daily Biotech Pulse: Daiichi's Positive Breast Cancer Trial, Supernus Slumps, Axovant Reverse Split",2019-05-08 07:53:00-04:00,MYL,negative
878897.0,"Wells Fargo Downgrades Mylan N.V. - Common Stock to Market Perform, Lowers Price Target to $22",2019-05-08 06:28:00-04:00,MYL,positive
878898.0,72 Biggest Movers From Yesterday,2019-05-08 06:17:00-04:00,MYL,neutral
878899.0,64 Stocks Moving In Tuesday's Mid-Day Session,2019-05-07 12:17:00-04:00,MYL,neutral
878900.0,Mylan shares are trading lower after the company reported mixed Q1 EPS and sales results.,2019-05-07 09:39:00-04:00,MYL,neutral
878901.0,"Mylan Q1 Adj. EPS $0.82 Beats $0.8 Estimate, Sales $2.496B Miss $2.7B Estimate",2019-05-07 08:32:00-04:00,MYL,negative
878902.0,"Earnings Scheduled For May 7, 2019",2019-05-07 05:03:00-04:00,MYL,neutral
878903.0,Mylan and TB Alliance Announce Global Collaboration To Commercialize Investigational Drug Pretomanid as Part Of Two Regimens To Treat Tuberculosis,2019-04-18 08:06:00-04:00,MYL,positive
878904.0,Watching Mylan Shares As Traders Circulate Vague Comment From Alphaville Of An Interested Party,2019-04-16 12:59:00-04:00,MYL,positive
878905.0,US Supreme Court Rejects Allergan's Bid to Protect Patents From Review by Transferring Them to Native American Tribe,2019-04-15 09:34:00-04:00,MYL,positive
878906.0,"SunTrust Robinson Humphrey Initiates Coverage On Mylan with Buy Rating, Announces $35 Price Target",2019-03-20 07:17:00-04:00,MYL,neutral
878907.0,"Mylan Is Conducting A Voluntary Nationwide Recall Of Two Lots Of Levoleucovorin Injection, 250 Mg/25 Ml To The Consumer/User Level",2019-03-18 12:51:00-04:00,MYL,neutral
878908.0,Mylan Option Alert: Fri $28.5 Calls Sweep (2) near the Ask: 716 @ $0.331 vs 297 OI; Earnings 5/8 Before Open [est] Ref=$28.24,2019-03-14 11:21:00-04:00,MYL,positive
878909.0,"Benzinga's Top Upgrades, Downgrades For March 6, 2019",2019-03-06 09:17:00-05:00,MYL,positive
878910.0,"CORRECTION: Morgan Stanley Upgrades Mylan to Overweight, Announces $35 Price Target, A Prior Headline Indicated Firm Set $39 Price Target, This Was Incorrect",2019-03-06 06:35:00-05:00,MYL,negative
878911.0,"Morgan Stanley Upgrades Mylan to Overweight, Announces $35 Price Target",2019-03-06 06:33:00-05:00,MYL,negative
878912.0,"The Daily Biotech Pulse: Bristol-Myers Squibb-Celgene Deal Faces Setback, Syneos Hit By SEC Probe, FDA Cheer For T2 Biosystems",2019-02-28 08:24:00-05:00,MYL,positive
878913.0,84 Biggest Movers From Yesterday,2019-02-28 05:10:00-05:00,MYL,neutral
878914.0,"Mylan's Disappointing Outlook Rattles Analysts, Investors",2019-02-27 16:04:00-05:00,MYL,negative
878915.0,72 Stocks Moving In Wednesday's Mid-Day Session,2019-02-27 12:20:00-05:00,MYL,neutral
878916.0,Mylan shares are trading lower after the company reported worse than expected Q4 results. Mylan also announced 2019 expected EPS of $3.80 to $4.80 versus the $5.04 analyst estimate.,2019-02-27 09:17:00-05:00,MYL,negative
878917.0,35 Stocks Moving In Wednesday's Pre-Market Session,2019-02-27 08:25:00-05:00,MYL,neutral
878918.0,"The Daily Biotech Pulse: FDA Panel Vote Sinks KaryoPharm, Refuse-To-file Letter For Adamis, Tandem Diabetes Earnings",2019-02-27 08:13:00-05:00,MYL,neutral
878919.0,Bernstein Downgrades Mylan to Market Perform,2019-02-27 07:45:00-05:00,MYL,neutral
878920.0,Mylan Says Sees Only 5 Of Co'S Top 50 & Only 1 Out Of Top 10 Gross Margin Generating Products To Be Manufactured In Morgantown In 2019,2019-02-27 06:42:00-05:00,MYL,negative
878921.0,"Mylan Sees FY19 Adj. EPS $3.80-$4.80 vs $5.04 Estimate, Sales $11.5B-$12.5B vs $11.9B Est.",2019-02-26 16:51:00-05:00,MYL,neutral
878922.0,"Mylan Q4 EPS $1.30 Misses $1.36 Estimate, Sales $3.08B Inline",2019-02-26 16:50:00-05:00,MYL,negative
878923.0,"The Daily Biotech Pulse: Immunomedics CEO Departs, Ultragenyx Offering, Karyopharm Awaits FDA Panel Vote",2019-02-26 07:56:00-05:00,MYL,positive
878924.0,"Earnings Scheduled For February 26, 2019",2019-02-26 04:02:00-05:00,MYL,neutral
878925.0,"The Week Ahead In Biotech: Conferences, PDUFA Dates, Clinical Trials, Earnings, IPOs",2019-02-22 13:55:00-05:00,MYL,neutral
878926.0,"FDA Commissioner Scott Gottlieb Issues Statement On New Policy To Improve Access, Foster Price Competition For Drugs Which Face Inadequate Generic Competition; FDA To Advance Added Policies To Promote This Over Next Year",2019-02-15 10:21:00-05:00,MYL,positive
878927.0,Mylan Launches Wixela Inhub Generic Of ADVAIR DISKUS At List Price 70% Less Than The Brand,2019-02-12 10:02:00-05:00,MYL,neutral
878928.0,Mylan Option Alert: Mar 8 $31.5 Calls at the Ask: 1000 @ $0.98 vs 3042 OI; Earnings 2/27 After Close [est] Ref=$30.65,2019-02-11 11:27:00-05:00,MYL,positive
878929.0,UPDATE: USPTO Says Mylan Has 'demonstrated a reasonable likelihood of success in proving that at least claim 1 of the '514 patent is unpatentable',2019-02-07 09:50:00-05:00,MYL,positive
878930.0,Biogen shares are trading lower after the U.S. Patent and Trademark Office reportedly stated that Mylan could likely succeed in a patent challenge against a Biogen multiple sclerosis drug.,2019-02-07 09:50:00-05:00,MYL,positive
878931.0,Documents From Wednesday Show Mylan Pharmaceuticals Has Filed Petition Requesting Review Of Patent Claims Against Biogen,2019-02-07 09:47:00-05:00,MYL,neutral
878932.0,Mylan Issues Press Release Highlighting FDA Approval Of Wixela Inhub; BZ NOTE: This Was Previously Reported Wed. Afternoon,2019-01-31 15:00:00-05:00,MYL,positive
878933.0,Innoviva Shares Fall 5.8% Following FDA Approval Of Mylan's Generic Version Of Advair; Innoviva Is A Partner With GlaxoSmithKline For Competing Drug,2019-01-30 15:05:00-05:00,MYL,positive
878934.0,"UPDATE: Mylan Shares Spike As FDA.gov Alert Shows First-Time Generic Drug Approval For Advair Generic, Wixela Inhub",2019-01-30 15:02:00-05:00,MYL,positive
878935.0,"Mylan Shares Spike ~3% Over Last Min., GlaxoSmithKline Shares Fall As Traders Circulate FDA.gov Alert On First Generic Drug Approvals",2019-01-30 15:01:00-05:00,MYL,positive
878936.0,"David Einhorn Says His Greenlight Capital Sold Mylan, Perrigo And Bayer Last Year, Covered Shorts On Core Laboratories, Oil Frackers",2019-01-23 09:51:00-05:00,MYL,neutral
878937.0,"UBS Downgrades Mylan to Neutral, Lowers Price Target to $32",2019-01-23 07:18:00-05:00,MYL,negative
878938.0,"Mylan Option Alert: Jan, 2020 $35 Calls at the Ask: 500 @ $2.201 vs 770 OI; Earnings 2/27 After Close [est] Ref=$29.4",2019-01-16 14:31:00-05:00,MYL,positive
878939.0,Mylan Says Co. Continues To Be 'Extremely Confident' On Generic ADVAIR Approval,2019-01-08 14:15:00-05:00,MYL,positive
878940.0,Mylan Says US Generics Industry Has 'Gone Through An Earthquake' And Industry IS Now At 'Low End Of The Richter Scale',2019-01-08 14:13:00-05:00,MYL,negative
878941.0,"The Daily Biotech Pulse: Aevi's ADHD Drug Flunks Mid-Stage Trial, Bristol-Myers To Buy Celgene, Teva Settles With Amgen",2019-01-03 07:36:00-05:00,MYL,negative
878942.0,Ironwood And Allergan Announce Settlement With Mylan Resolving LINZESS Patent Litigation; Additional Details Not Disclosed,2019-01-02 16:03:00-05:00,MYL,positive
878943.0,"The Daily Biotech Pulse: Proteostasis Delays Data, Akron Gets New CEO, Pfizer Halts Vaccine Trial",2018-12-21 07:58:00-05:00,MYL,neutral
878944.0,"The Daily Biotech Pulse: Tilray Inks Cannabis Drink Pact, Double Delight For Merck, FDA Snub For Spectrum",2018-12-20 07:53:00-05:00,MYL,positive
878945.0,"UPDATE: Phosphagenics Says Mylan, Co. Have Mutually Agreed To Forego All Claims Including Arbitration Costs, Will Terminate Original Master Research Deal",2018-12-18 17:04:00-05:00,MYL,positive
878946.0,"Phosphagenics Reports Full, Final Settlement Of Claims Under Arbitration Between Co., Mylan, Strides",2018-12-18 17:03:00-05:00,MYL,neutral
878947.0,"The Daily Biotech Pulse: Puma Aces Late-Stage Trial, Chinese Cheer For FibroGen, J&J $5B Buyback Plan",2018-12-18 08:00:00-05:00,MYL,positive
878948.0,Mylan Adds First Generic For Canasa Rectal Suppository To Growing Gastroenterology Portfolio,2018-12-17 10:31:00-05:00,MYL,positive
878949.0,"Aspen Global Entered Into Distribution Arrangement With Mylan For Portfolio Of Prescription And OTC Products Primarily Commercialized In Australia And New Zealand; Should Mylan Exercise Purchase Option, Consideration For Divestment Would Be About AUD188M",2018-12-13 10:38:00-05:00,MYL,neutral
878950.0,"Mylan Reports US Patent, Trademark Appeal Board Ruled In Favor Of Co. In IPR Proceedings, Found All Claims Of Sanofi's Lantus Unpatentable",2018-12-13 07:33:00-05:00,MYL,positive
878951.0,"The Daily Biotech Pulse: Management Change At Merck, Jazz Buyback, Arrowhead Earnings",2018-12-11 08:22:00-05:00,MYL,neutral
878952.0,"Stocks Which Set New 52-Week Low The Last Trading Session, Fri., Dec. 7, 2018",2018-12-10 11:01:00-05:00,MYL,negative
878953.0,"Shares of generic drug makers are trading down on reports of expanded investigations into price fixing practices; Notable movers include Mylan down 3.5% Teva down 5.3%, Dr Reddy's Laboratories down 3.0%.",2018-12-10 10:13:00-05:00,MYL,positive
878954.0,Investigation of Generic Cartel Expands to 300 Drugs,2018-12-10 04:12:00-05:00,MYL,positive
878955.0,Novartis to Launch Adamis' EpiPen Rival in U.S. in 2019,2018-12-07 04:25:00-05:00,MYL,neutral
878956.0,Mylan Announces Launch Of Generic For Prevacid SoluTab Delayed-Release Orally Disintegrating Tablets,2018-12-04 07:31:00-05:00,MYL,neutral
878957.0,"'FDA promised a 'lower-cost option' to EpiPen, but the price isn't any lower' -STAT News",2018-11-27 12:36:00-05:00,MYL,positive
878958.0,9 Policy Catalysts For Health Care Investors To Watch Before Year's End,2018-11-25 09:35:00-05:00,MYL,positive
878959.0,"The Daily Biotech Pulse: Mylan Recalls Blood Pressure Drug, Heat Biologics Offering, New Novelion CEO",2018-11-21 08:04:00-05:00,MYL,negative
878960.0,"Hearing Appeals Court Says JNJ Can't Prevent Sales Of Generic Zytiga; Says Teva, Mylan Can Enter Market",2018-11-20 16:02:00-05:00,MYL,neutral
878961.0,Mylan Offers Statement Related To FDA Warning Letter On Its Morgantown Plant,2018-11-20 14:30:00-05:00,MYL,negative
878962.0,Argus Upgrades Mylan to Buy,2018-11-15 12:43:00-05:00,MYL,neutral
878963.0,"Jim Cramer Weighs In On Dropbox, Teva And More",2018-11-14 07:46:00-05:00,MYL,neutral
878964.0,"The Week Ahead In Biotech: Earnings, Conferences, PDUFA Dates, Clinical Trial Results And IPOs",2018-11-11 09:10:00-05:00,MYL,neutral
878965.0,"Theravance, Mylan Press Release Confirms Received FDA Approval For YUPELRI In Adults With Chronic Obstructive Pulmonary Disease",2018-11-09 15:14:00-05:00,MYL,positive
878966.0,"UPDATE: FDA Access Data Doc Shows Medication Guide For Theravance, Mylan's YUPELRI Was Approved By FDA",2018-11-09 13:20:00-05:00,MYL,positive
878967.0,"Traders Circulate FDA Access Data Doc Showing Highlights Of Prescribing Information For Theravance, Mylan's YUPELRI",2018-11-09 13:18:00-05:00,MYL,neutral
878968.0,75 Biggest Movers From Yesterday,2018-11-07 04:00:00-05:00,MYL,neutral
878969.0,Mylan Option Alert: Jan 18 $40 Calls Sweep (4) near the Ask: 957 @ $0.97 vs 21589 OI; Ref=$36.865,2018-11-06 12:39:00-05:00,MYL,positive
878970.0,60 Stocks Moving In Tuesday's Mid-Day Session,2018-11-06 12:36:00-05:00,MYL,neutral
878971.0,Mylan shares are up 13.3%; The company beat Q3 EPS estimates and demonstrated a strong improvement from the company's prior quarter earnings.,2018-11-06 10:45:00-05:00,MYL,positive
878972.0,"Benzinga's Top Upgrades, Downgrades For November 6, 2018",2018-11-06 09:01:00-05:00,MYL,positive
878973.0,24 Stocks Moving In Tuesday's Pre-Market Session,2018-11-06 08:07:00-05:00,MYL,neutral
878974.0,"Bank of America Upgrades Mylan to Buy, Lowers Price Target to $42",2018-11-06 07:30:00-05:00,MYL,negative
878975.0,"The Daily Biotech Pulse: EyePoint Licenses Eye Inflammation Drug, Insys Strategic Review Of Opioid Assets, Neos Offering",2018-11-06 07:04:00-05:00,MYL,positive
878976.0,7 Stocks Moving In Monday's After-Hours Session,2018-11-05 16:53:00-05:00,MYL,neutral
878977.0,"Mylan Q3 EPS $1.25 Beats $1.19 Estimate, Sales $2.862B Miss $2.92B Estimate",2018-11-05 16:02:00-05:00,MYL,negative
878978.0,Mylan's Q3 Earnings Preview,2018-11-05 07:49:00-05:00,MYL,neutral
878979.0,"Earnings Scheduled For November 5, 2018",2018-11-05 04:03:00-05:00,MYL,neutral
878980.0,"The Week Ahead In Biotech: Earnings, Conferences, PDUFA Dates, Clinical Trial Results And IPOs",2018-11-04 13:35:00-05:00,MYL,neutral
878981.0,'FDA alerts patients and health care professionals that some EpiPen auto-injectors may not readily slide out of carrier tube' -FDA Media Affairs tweets,2018-11-02 15:58:00-04:00,MYL,positive
878982.0,UPDATE: Health And Human Services SAys Int.'l. Prices Would Be Phased In Over 5-Year Period,2018-10-25 14:19:00-04:00,MYL,neutral
878983.0,"US Health And Human Services Says Announced, Sought Input On New 'Int'l. Pricing Index' Payment Model Aimed At Reducing Drug Costs",2018-10-25 14:18:00-04:00,MYL,neutral
878984.0,"The Daily Biotech Pulse: AbbVie Takes Full Control Of Cystic Fibrosis Program, Amgen Slashes Cholesterol Drug Price",2018-10-25 08:03:00-04:00,MYL,negative
878985.0,"Stocks Which Set New 52-Week Low Yesterday, October 22nd",2018-10-23 09:54:00-04:00,MYL,negative
878986.0,Mylan Offers Statement On Generic Advair ANDA Status: 'Mylan confirms it has not received any new information request or complete response letter from the FDA and continues to believe that FDA approval is imminent.',2018-10-22 17:11:00-04:00,MYL,positive
878987.0,"Mylan Shares Volatile Over Last Few Mins., But Largely Unaffected As Hearing Bloomberg Report Co. Declined To Offer Update On Status Of Generic Version Of Advair",2018-10-22 15:53:00-04:00,MYL,positive
878988.0,"Mylan Launches Hulio, A Biosimilar To AbbVie's Humira, In Markets Across Europe",2018-10-19 12:54:00-04:00,MYL,neutral
878989.0,"Mylan And Biocon Announce 'Positive' CHMP Opinion For Ogivri, Biosimilar Trastuzumab",2018-10-19 09:31:00-04:00,MYL,neutral
878990.0,"The Daily Biotech Pulse: Novartis Positive Liver Drug Trials, Krytstal Prices Offering, LogicBio To Debut",2018-10-19 08:28:00-04:00,MYL,positive
878991.0,"Mylan Highlights US Launch Of Medroxyprogesterone Acetate Injectable Suspension USP, 150 mg/mL Single-Dose vial, Generic Version Of Pfizer's Depo-Provera",2018-10-18 16:50:00-04:00,MYL,neutral
878992.0,Drug Companies To Disclose Pricing Information In Ads,2018-10-15 15:38:00-04:00,MYL,neutral
878993.0,Mylan Option Alert: Fri $33 Calls Sweep (24) near the Ask: 536 @ $0.53 vs 94 OI; Earnings 11/5 Before Open [est] Ref=$32.5,2018-10-15 14:02:00-04:00,MYL,positive
878994.0,"Bulls & Bears Of The Week: GE, Netflix, Nike, Twitter And More",2018-10-14 13:37:00-04:00,MYL,neutral
878995.0,Mylan Announces United States Court Of Appeals Has Affirmed Prior Court Decision Finding Teva's Copaxone Patent Invalid,2018-10-12 12:29:00-04:00,MYL,positive
878996.0,"The Daily Biotech Pulse: FDA Thumbs Down For Trevena, Corium To Go Private, Immune Design Discontinues Cancer Vaccine Program",2018-10-12 07:34:00-04:00,MYL,negative
878997.0,Mylan Option Alert: Jan 18 $45 Calls at the Ask: 1000 @ $0.201 vs 14031 OI; Earnings 11/5 Before Open [est] Ref=$34.285,2018-10-11 09:31:00-04:00,MYL,positive
878998.0,Theravance Biopharma Mylan Reported Positive Data From Multiple Studies Of YUPELRI At 2018 CHEST Annual Meeting,2018-10-11 08:33:00-04:00,MYL,positive
878999.0,"Stocks Which Set New 52-Week Low Yesterday, October 9th",2018-10-10 11:01:00-04:00,MYL,negative
879000.0,36 Stocks Moving In Tuesday's Mid-Day Session,2018-10-09 12:39:00-04:00,MYL,neutral
879001.0,"Mylan shares are down 4.9% after analysts at Morgan Stanley downgraded the stock from Overweight to Equal-Weight; The firm cited 'uncertain prospects', including Epipen risk, biosimilar pipeline questions and IMS generic trends.",2018-10-09 11:53:00-04:00,MYL,negative
879002.0,FDA Commissioner Scott Gottlieb Issues Statement On 'new efforts to advance the development of generic copies of complex drugs to improve patient access to medicines',2018-10-09 11:19:00-04:00,MYL,positive
879003.0,3 Headwinds Hindering Mylan,2018-10-09 09:46:00-04:00,MYL,neutral
879004.0,"Benzinga's Top Upgrades, Downgrades For October 9, 2018",2018-10-09 09:17:00-04:00,MYL,positive
879005.0,"Morgan Stanley Downgrades Mylan to Equal-Weight, Lowers Price Target to $36",2018-10-09 06:43:00-04:00,MYL,negative
879006.0,Theravance Biopharma And Mylan To Present New Data From Studies Of YUPELRI At 2018 CHEST Annual Meeting,2018-10-08 08:35:00-04:00,MYL,neutral
879007.0,"Benzinga's Top Upgrades, Downgrades For October 5, 2018",2018-10-05 09:42:00-04:00,MYL,positive
879008.0,Mizuho Downgrades Mylan to Neutral,2018-10-05 06:20:00-04:00,MYL,neutral
879009.0,Mylan Option Alert: Jan 18 $40 Calls at the Bid: 8598 @ $1.22 vs 7275 OI; Earnings 11/5 Before Open [est] Ref=$36.73,2018-10-02 09:59:00-04:00,MYL,positive
879010.0,Mylan Extends Commitment to Fight HIV/AIDS by Partnering with Atomo Diagnostics to Expand Access to HIV Self-Testing in Low and Middle Income Countries,2018-09-24 07:14:00-04:00,MYL,positive
879011.0,"Mylan and Biocon Announce Positive CHMP Opinion for Fulphila, Biosimilar Pegfilgrastim",2018-09-21 09:31:00-04:00,MYL,positive
879012.0,Mylan Reports Launch Of Authorized Generic Of Ampyra Tablets,2018-09-21 08:57:00-04:00,MYL,neutral
879013.0,Mylan Reports Received European Marketing Authorization For Hulio,2018-09-20 07:07:00-04:00,MYL,neutral
879014.0,"The Week Ahead In Biotech (Sept. 16-22): Conferences, PDUFA Dates, Clinical Trial Results And IPOs",2018-09-16 14:22:00-04:00,MYL,neutral
879015.0,Mylan Adds to Cardiovascular Portfolio With Launch of First Generic of Brevibloc Injection in Single-Dose Bags,2018-09-13 09:03:00-04:00,MYL,neutral
879016.0,"Acorda Therapeutics Shares Down 21.3% After Earlier Report It Has Lost An Patent Court Appeal Ruling Regarding The Drug Ampyra, Affirming A Trial Ruling In Favor Of Teva and Mylan",2018-09-10 11:44:00-04:00,MYL,positive
879017.0,Watching Mylan Shares; FDA Says Extended Expiration Date Of Specific Lots Of Co.'s 0.3mg EpiPen Products Marketed By Co. By 4 Months Beyond Labeled Expiration Date,2018-08-21 11:33:00-04:00,MYL,positive
879018.0,"The Daily Biotech Pulse: Aveo Slips On Stock Offering, FDA Greenlights Generic EpiPen, Pfenex Exec Resigns",2018-08-17 08:15:00-04:00,MYL,negative
879019.0,"Antares Pharma Shares Close Up 4.1%, Up Another 6.1% After Hours On News Its Partner, Teva, Received FDA Approval For Its Generic Epinephrine, For Which Antares Has the Exclusive License to Market In The U.S.",2018-08-16 17:05:00-04:00,MYL,positive
879020.0,Teva Wins FDA Approval For Generic Epinephrine,2018-08-16 16:00:00-04:00,MYL,positive
879021.0,"FDA Statement Confirms Approval of Teva's Generic Version of Mylan's Epipen; Mylan Shares -0.4%, Teva +6.2%; BZ NOTE: Antares Pharma Has Exclusive License To Market Teva's Epinephrine in the U.S.",2018-08-16 13:09:00-04:00,MYL,positive
879022.0,Hearing Teva Gets FDA Approval For Generic Epinephrine,2018-08-16 12:55:00-04:00,MYL,positive
879023.0,Mylan Launches First Generic for Adcirca Tablets,2018-08-13 10:57:00-04:00,MYL,neutral
879024.0,Mylan NV shares are trading up 3.9% after RBC Capital upgraded the stock from Sector to Outperform.,2018-08-13 09:55:00-04:00,MYL,positive
879025.0,"Benzinga's Top Upgrades, Downgrades For August 13, 2018",2018-08-13 09:04:00-04:00,MYL,positive
879026.0,RBC Capital Upgrades Mylan to Outperform,2018-08-13 07:46:00-04:00,MYL,neutral
879027.0,RBC Upgrades Mylan to Outperfrom from Sector Perform; Raises Price Target to $51 from $42,2018-08-13 04:48:00-04:00,MYL,neutral
879028.0,"Benzinga's Top Upgrades, Downgrades For August 9, 2018",2018-08-09 09:15:00-04:00,MYL,positive
879029.0,"Citigroup Maintains Buy on Mylan, Lowers Price Target to $48",2018-08-09 08:51:00-04:00,MYL,negative
879030.0,Raymond James Downgrades Mylan to Outperform,2018-08-09 07:22:00-04:00,MYL,neutral
879031.0,Mylan Shares Appear Unaffected As Traders Circulate Comment From Deutsche Bank To Buy The Stock Given News Strategic Alternatives Are Being Explored,2018-08-08 11:40:00-04:00,MYL,positive
879032.0,"Mylan CEO On Conf. Call Says A Lot Of Peers Have Significantly Rebased Their Business Over The Past 12 Months And Their Guidance Incorporates Worst Case Scenario, Says 'We're Giving You Guidance We Believe We Are Going To Meet'",2018-08-08 10:53:00-04:00,MYL,negative
879033.0,Mylan CEO On Conf. Call Says They Have Good Months Of Epipen Supply From Pfizer And Then Suddenly Get Erratic Supply; Says They're Working Closely With Pfizer,2018-08-08 10:44:00-04:00,MYL,positive
879034.0,Mylan shares are trading down 7% after the company missed Q2 earnings and issued soft 2018 guidance; The company also announced it is evaluating a range of alternatives.,2018-08-08 10:08:00-04:00,MYL,neutral
879035.0,Mylan's Board Has Formed A Strategic Review Committee And Is Evaluating A Range Of Alternatives To 'Unlock The True Value Of Our One-Of-A-Kind Platform',2018-08-08 08:35:00-04:00,MYL,positive
879036.0,"Mylan Sees FY18 Sales Of $11.25-$12.25B vs $12.17B Est., EPS $4.55-$4.90 vs $5.25 Est.",2018-08-08 08:32:00-04:00,MYL,neutral
879037.0,"Mylan Q2 EPS $1.07 Misses $1.22 Estimate, Sales $2.81B Miss $2.96B Estimate",2018-08-08 08:31:00-04:00,MYL,negative
879038.0,"The Daily Biotech Pulse: FDA Panel Backs Insmed, Eidos' Maiden Earnings, Paratek Awaits Adcom Verdict",2018-08-08 08:15:00-04:00,MYL,positive
879039.0,"Earnings Scheduled For August 8, 2018",2018-08-08 06:03:00-04:00,MYL,neutral
879040.0,Trump Says Administration Will Be Making an Announcement Next Week Regarding Reducing Drug Prices,2018-08-07 20:07:00-04:00,MYL,neutral
879041.0,Q2 Earnings Preview For Mylan,2018-08-07 14:30:00-04:00,MYL,neutral
879042.0,UPDATE: Acorda Says Mylan Will Be Permitted To Market Its Generic Version Of Ampyra In US Sometime In 2025 Or Earlier Under Certain Circumstances,2018-08-03 07:17:00-04:00,MYL,positive
879043.0,"Acorda 8-K Shows Updates On Litigation With Mylan, Teva, West-Ward Pharma, Hikma Related To Ampyra Orange Book-Listed Patents: Entered Into Conditional Settlement Deal",2018-08-03 07:17:00-04:00,MYL,negative
879044.0,"Hearing Mylan Declines To Comment On Status Of Restasis Generic, Co. To Give Relevant Updates On Q2 Call",2018-08-02 11:18:00-04:00,MYL,neutral
879045.0,"Mylan, Fujifilm Kyowa Kirin Biologics Report Positive CHMP Opinion For Hulio, The Biosimilar For Adalimumab",2018-07-27 09:09:00-04:00,MYL,positive
879046.0,"UPDATE: Acorda, Alkermes v. Roxane Labs, Mylan, Teva Doc Shows 'On July 23, 2018, Acorda notified the court that ""Acorda plans to seek an emergency injunction on July 25, 2018 absent a change in circumstances.""'",2018-07-25 11:29:00-04:00,MYL,negative
879047.0,"Hearing Acorda Loses Bid For Emergency Order Blocking Ampyra Copy, Co. Is Awaiting Decision On Validity Of Ampyra Patents",2018-07-25 11:19:00-04:00,MYL,negative
879048.0,Mylan Press Release Highlights Earlier Report Court Denied Allergan's Attempt To Protect Its Drug Patents Through A Deal With A Native American Tribe,2018-07-20 16:12:00-04:00,MYL,negative
879049.0,AbbVie's Stock Hit By Citron Tweet,2018-07-19 11:58:00-04:00,MYL,neutral
879050.0,UPDATE: AbbVie Will Make No Payments To Mylan,2018-07-17 08:08:00-04:00,MYL,negative
879051.0,"UPDATE: Mylan Will Pay AbbVie For Licensing HUMIRA Patents Once Its Biosimilar Product Is Launched, No Terms Disclosed",2018-07-17 08:07:00-04:00,MYL,negative
879052.0,"UPDATE: Mylan's US License For HUMIRA Will Begin On Jul. 31, 2023 And Will Not Be Accelerated By Amgen, Samsung Bioepis Entry",2018-07-17 08:07:00-04:00,MYL,neutral
879053.0,"UPDATE: AbbVie To Grant Mylan Non-Exclusive License On Specified Dates To AbbVie's Intellectual Property Related To HUMIRA In US, Various Other Countries, Excluding Europe",2018-07-17 08:06:00-04:00,MYL,positive
879054.0,AbbVie Reports HUMIRA Patent License With Mylan,2018-07-17 08:06:00-04:00,MYL,neutral
879055.0,"Goldman Sachs Swaps Perrigo, Johnson & Johnson Ratings",2018-07-12 10:28:00-04:00,MYL,neutral
879056.0,Mylan Adds to Central Nervous System Portfolio With Launch of Generic Exelon Patch,2018-07-09 08:47:00-04:00,MYL,negative
879057.0,UPDATE: Bristol-Myers Squibb Is Looking To Sell It's French Over-The-Counter Business Which Is Valued At More Than E$1B,2018-07-05 10:42:00-04:00,MYL,positive
879058.0,"Hearing Bristol-Myers Squibb Is Expected To Draw Interest From European Drug Firms Such As Stada, Zentiva, Recordati Along Withh U.S. Firms Mylan And Procter & Gamble",2018-07-05 10:41:00-04:00,MYL,positive
879059.0,"Benzinga's Daily Biotech Pulse: Eli Lilly, Edge Therapeutics, BioXcel Report Positive Trial Results, 4 Stocks Debut",2018-06-28 08:26:00-04:00,MYL,positive
879060.0,"Lupin, Mylan Partner to Commercialize Enbrel Biosimilar",2018-06-28 04:09:00-04:00,MYL,neutral
879061.0,Mylan Launches Generic Angiomax Injection,2018-06-18 14:09:00-04:00,MYL,neutral
879062.0,Dr. Reddy's In a 6-K Earlier Reports New Jersey District Court Has Issued a Temporary Restraining Order Against The Co. Regarding Further Sales and Commercializing Of Recently Approved Naloxone; Court Order Doesn't Include Prohibition On Manufacturing,2018-06-18 10:58:00-04:00,MYL,positive
879063.0,"Benzinga's Daily Biotech Pulse: Hematology Conference In The Spotlight, Dr. Reddy To Launch Generic Opioid Addiction Drug",2018-06-15 09:13:00-04:00,MYL,neutral
879064.0,40 Biggest Movers From Yesterday,2018-06-15 04:56:00-04:00,MYL,neutral
879065.0,Press Release Confirms FDA Approval of Merck and Dr. Reddy's Suboxone,2018-06-14 16:49:00-04:00,MYL,positive
879066.0,FDA Has Approved Mylan's And Dr. Reddy's Suboxone Film For Opioid Dependence,2018-06-14 16:26:00-04:00,MYL,positive
879067.0,31 Stocks Moving In Thursday's Mid-Day Session,2018-06-14 12:26:00-04:00,MYL,neutral
879068.0,"Benzinga's Daily Biotech Pulse: FDA Nods For Teligent And Keytruda, Sonoma's Q4 Miss, Sage Inks Deal With Japan's Shionogi",2018-06-14 08:11:00-04:00,MYL,negative
879069.0,23 Stocks Moving In Thursday's Pre-Market Session,2018-06-14 08:00:00-04:00,MYL,neutral
879070.0,FDA Identified Minor Deficiencies In Mylan's Generic Advair Diskus To Be Relayed In Complete Response Letter On June 27,2018-06-13 16:20:00-04:00,MYL,neutral
879071.0,35 Stocks Moving In Tuesday's Mid-Day Session,2018-06-05 12:25:00-04:00,MYL,neutral
879072.0,30 Stocks Moving In Tuesday's Pre-Market Session,2018-06-05 08:06:00-04:00,MYL,neutral
879073.0,"Benzinga's Daily Biotech Pulse: Mylan's Neulasta Biosimilar Approved, Portola's CEO To Retire, Regenxbio To Join S&P SmallCap Index",2018-06-05 08:05:00-04:00,MYL,positive
879074.0,"Amgen Shares Down 1.5% After Hours Following FDA Approval Of First Biosimilar To Neulasta, Mylan's Fulphila",2018-06-04 16:54:00-04:00,MYL,positive
879075.0,"Mylan Press Release Confirms FDA Approval Of First Biosimilar To Neulasta, Fulphila",2018-06-04 16:53:00-04:00,MYL,positive
879076.0,Mylan Shares Up 4.6% After Hours Amid FDA.gov Site Showing FDA Approval For Its Biosimilar Neulasta,2018-06-04 16:52:00-04:00,MYL,positive
879077.0,Mylan Option Alert: Jun 15 $38 Puts Sweep (22) at the Ask: 734 @ $0.961 vs 113 OI; Ref=$38.45,2018-06-04 15:04:00-04:00,MYL,positive
879078.0,Mylan Option Alert: Jun 15 $37.5 Calls Sweep (2) near the Bid: 2434 @ $1.7 vs 7580 OI; Ref=$38.38,2018-06-04 11:41:00-04:00,MYL,positive
879079.0,Perspective: Institutional Investor Looks At David Einhorn And The Decline Of Value Investing,2018-05-26 11:06:00-04:00,MYL,positive
879080.0,Cantor Fitzgerald: 18 Drug Companies With Catalysts Worth Watching,2018-05-19 16:10:00-04:00,MYL,positive
879081.0,13F From Einhorn's Greenlight Shows Cut Stake In Mylan,2018-05-15 16:23:00-04:00,MYL,negative
879082.0,13F From Cooperman's Omega Shows Dissolved Mylan Stake,2018-05-15 10:09:00-04:00,MYL,neutral
879083.0,"Proctor & Gamble, Mylan And More Stocks Sending Strong Signals This Week",2018-05-14 14:34:00-04:00,MYL,positive
879084.0,"Benzinga's Daily Biotech Pulse: Transenterix Rises, Mylan Earnings, Deutsche Bank Conference Underway",2018-05-09 07:48:00-04:00,MYL,neutral
879085.0,Mylan Reaffirms FY2018 EPS $5.20-5.60 vs $5.37 Est; Sees Sales $11.75B-13.25B vs $13.0B Est,2018-05-09 07:31:00-04:00,MYL,neutral
879086.0,"Mylan Q1 EPS $0.96 Misses $0.98 Estimate, Sales $2.68B Miss $2.75B Estimate",2018-05-09 07:30:00-04:00,MYL,negative
879087.0,"Earnings Scheduled For May 9, 2018",2018-05-09 04:05:00-04:00,MYL,neutral
879088.0,UPDATE: Pfizer Says Apr. EpiPen Shipments Exceeded Projections,2018-05-08 15:18:00-04:00,MYL,neutral
879089.0,"Pfizer, Manufacturer Of Mylan's EpiPen, Says It Is Currently Shipping Product, Shipments Have Been Increasing Over Last Few Months",2018-05-08 15:17:00-04:00,MYL,neutral
879090.0,"UPDATE: Mylan Says EpiPen Supply Levels Could Vary Across Pharmacies, Wholesalers",2018-05-08 15:00:00-04:00,MYL,neutral
879091.0,"Mylan Says Is Currently Receiving Continual Supply Of EpiPen From Meridian Medical Technologies, Informed FDA 'Few Months Ago' It Had Intermittent Supply Constraints, Cited Manufacturing Delays From Pfizer",2018-05-08 15:00:00-04:00,MYL,neutral
879092.0,"Mylan Shares Drop Sharply, Hearing Epipen Is Said To Be In Short Supply After Manufacturing Issues",2018-05-08 13:54:00-04:00,MYL,neutral
879093.0,"The Week Ahead In Biotech: PDUFA Dates, Earnings, IPOs And More",2018-05-06 18:19:00-04:00,MYL,neutral
879094.0,"Watching Mylan, Allergan, Valeant Shares Amid Report Generic-Drug Cos. Facing First Charges In US Probe",2018-04-24 15:59:00-04:00,MYL,neutral
879095.0,Mylan Presents Equivalence Data on Glatiramer Acetate Compared to Copaxone at #AAN2018,2018-04-22 07:27:00-04:00,MYL,neutral
879096.0,"Health Canada Is Working With FDA, Pfizer Related To Addressing Canadian Shortage Of Mylan's Epipen",2018-04-17 14:50:00-04:00,MYL,negative
879097.0,Mylan Shares Quiet Premarket; Co. Looking For Deal For Merck's Consumer Products Unit,2018-04-13 07:51:00-04:00,MYL,positive
879098.0,"Leerink Upgrades Mylan On Barrage Of Catalysts, Diversified Platforms",2018-04-12 12:26:00-04:00,MYL,neutral
879099.0,Mylan Inks Deal With Mapi Pharma For Multiple Sclerosis Drug,2018-04-12 11:05:00-04:00,MYL,neutral
879100.0,"Benzinga's Top Upgrades, Downgrades For April 12, 2018",2018-04-12 09:27:00-04:00,MYL,positive
879101.0,Leerink Swann Upgrades Mylan to Outperform,2018-04-12 07:20:00-04:00,MYL,neutral
879102.0,"UPDATE: Earlier Reuters Reported Mylan Sees FY18 EPS $5.38 In-line With Est., Sales $12.44B Also In-Line; BZ NOTE: Midpoints of FY18 Guidance Issued Feb. 28th Were EPS $5.40 and Sales $12.5B, This May Be Cause of Chatter That Co. 'Lowered' Guidance",2018-04-11 15:35:00-04:00,MYL,positive
879103.0,Mylan Shares Sell Off As Traders Pass Unconfirmed Chatter Of Lowered Guidance Discussed At Today's Investor Day,2018-04-11 15:30:00-04:00,MYL,positive
879104.0,"Mylan Reaffirms FY18 Guidance, Remains Committed To Deleveraging And Maintaining An Investment Grade Credit Rating",2018-04-11 12:32:00-04:00,MYL,positive
879105.0,"Mylan Acquired Development, Marketing Rights Globally From Prayog Labs To  Bring Meloxicam To Market",2018-04-11 11:48:00-04:00,MYL,neutral
879106.0,Mylan To Submit An Investigational NDA To The FDA For Meloxicam,2018-04-11 11:47:00-04:00,MYL,neutral
879107.0,Mylan and Biocon are Trying to Speed Up the Introduction of Adalimumab Biosimilar in the EU,2018-04-11 07:24:00-04:00,MYL,neutral
879108.0,Mylan to Commercialize Fujifilm Kyowa Kirin Biologics' Generic Humira in Europe,2018-04-11 07:01:00-04:00,MYL,neutral
879109.0,Companies Holding Analyst/Investor Days Today Include Vericel and Mylan; Carnival Corp Holding Annual Shareholder Meeting Today,2018-04-11 06:54:00-04:00,MYL,neutral
879110.0,Mylan to Acquire the Global Marketing Rights to a Once-monthly Glatiramer Acetate Product through an Investment and Partnership with Israeli Company Mapi Pharma,2018-04-10 07:30:00-04:00,MYL,neutral
879111.0,"The Week Ahead: Zuckerberg Goes To Washington, Big Banks Get Earnings Season Underway",2018-04-09 12:38:00-04:00,MYL,neutral
879112.0,Recordati Acquires International Rights to Cystagon from Mylan; Terms Not Disclosed,2018-04-09 04:14:00-04:00,MYL,neutral
879113.0,Mylan Introduces Symfi Triple Combo Once-Daily HIV Treatment In US,2018-03-28 07:03:00-04:00,MYL,neutral
879114.0,"Mylan. Biocon Receive EC, Australia Approvals for Semglee, Biosimilar Insulin Glargine",2018-03-28 04:00:00-04:00,MYL,neutral
879115.0,Cantor Fitzgerald Names 8 Upcoming Biotech Catalysts,2018-03-13 16:32:00-04:00,MYL,neutral
879116.0,Podcast: Want To Be A Buy-And-Hold Investor? 3 Strategies,2018-03-09 08:49:00-05:00,MYL,positive
879117.0,5 Biggest Price Target Changes For Tuesday,2018-03-06 11:19:00-05:00,MYL,neutral
879118.0,"Morgan Stanley: As Generic Competitors Falter, Mylan Is Worth A Shot",2018-03-06 10:52:00-05:00,MYL,positive
879119.0,"Benzinga's Top Upgrades, Downgrades For March 6, 2018",2018-03-06 10:10:00-05:00,MYL,positive
879120.0,"The Market In 5 Minutes: Shkreli, Gun Stocks And 'Flash Boys'",2018-03-06 09:00:00-05:00,MYL,negative
879121.0,"Morgan Stanley Upgrades Mylan to Overweight, Raises Price Target to $50.00",2018-03-06 06:20:00-05:00,MYL,negative
879122.0,Morgan Stanley Upgrades Mylan to Overweight from Equal Weight; Raises PT to $50 from $39,2018-03-06 04:17:00-05:00,MYL,negative
879123.0,Mylan to Introduce Two New Cost-Saving HIV Combination Treatments in the US,2018-03-02 07:30:00-05:00,MYL,neutral
879124.0,"Mylan Sees FY18 Adj. EPS $5.20-$5.60 vs $5.39 Est., Adj. EBITDA $4B-$4.5B, Sales $11.75B-$13.25B vs $12.76B Est.",2018-02-28 16:38:00-05:00,MYL,neutral
879125.0,"Mylan Reports Q4 Adj. EPS $1.43 vs $1.41 Est., Sales $3.24B vs $3.3B Est.",2018-02-28 16:37:00-05:00,MYL,neutral
879126.0,Mylan Q4 Earnings Preview,2018-02-28 08:14:00-05:00,MYL,neutral
879127.0,"Earnings Scheduled For February 28, 2018",2018-02-28 04:20:00-05:00,MYL,neutral
879128.0,Mylan Announces the US Patent and Trial Appeal Board Has Denied the St. Regis Mohawk Tribe's Motion to Terminate Mylan's Patent Challenge for 6 Allergan Patents Related to Restasis,2018-02-26 08:14:00-05:00,MYL,negative
879129.0,"The Week Ahead In Biotech: Earnings, PDUFA Dates And More",2018-02-25 15:50:00-05:00,MYL,neutral
879130.0,"Mylan, Hess, And 3 Other Stocks To Have On Your Radar This Week",2018-02-20 15:26:00-05:00,MYL,neutral
879131.0,How McKesson Will Stand The Test Of Amazon,2018-02-20 11:06:00-05:00,MYL,positive
879132.0,Mylan Receives Tentative Approval for Combination HIV Treatment DTG/FTC/TAF Under FDA's PEPFAR Program,2018-02-20 07:32:00-05:00,MYL,positive
879133.0,"Q4 13F Roundup: How Buffett, Einhorn, Loeb, And Others Adjusted Their Portfolio",2018-02-15 13:43:00-05:00,MYL,neutral
879134.0,13F From Cooperman's Omega Shows New 237K Share Stake In Mylan,2018-02-14 12:24:00-05:00,MYL,positive
879135.0,Vanguard Amended 13G Filing Shows 6.58% Stake In Mylan,2018-02-13 13:14:00-05:00,MYL,neutral
879136.0,Mylan Reports Expansion Of Access To HIV/AIDS Medicines With Launch Of First Generic Sustiva Tablets,2018-02-01 07:34:00-05:00,MYL,neutral
879137.0,"Theravance Biopharma and Mylan Announce FDA Acceptance of New Drug Application for Revefenacin, FDA Assigns PDUFA Target Action Date of November 13, 2018",2018-01-29 08:31:00-05:00,MYL,positive
879138.0,"Mylan, Biocon Receive Positive CHMP Opinion for Semglee, Biosimilar Insulin Glargine",2018-01-29 06:03:00-05:00,MYL,positive
879139.0,Teva's Asthma Therapy Reslizumab Fails In Late-Stage Studies,2018-01-23 10:59:00-05:00,MYL,negative
879140.0,Hearing Justice Dept. Is Conducting Sweeping Generic Price-Fixing Probe,2018-01-19 11:24:00-05:00,MYL,positive
879141.0,"Traders Attributing Weakness In Endo Int'l., Teva, Mylan To Earlier NY Times Article 'Fed Up With Drug Companies, Hospitals Decide to Start Their Own'",2018-01-18 10:05:00-05:00,MYL,negative
879142.0,Greenlight's Q4 Letter Reveals Another Tough Quarter For David Einhorn,2018-01-16 14:19:00-05:00,MYL,negative
879143.0,"Cantor Out With Note On Endo, Says Oxymorphone Subpoena May Not Hurt That Much And Is Isolated To Endo For Now, But More Co.'s Could Be The Target To Investigations Over Time Including Teva, Mylan, Impax, Mallinckrodt, Allergan",2018-01-11 11:18:00-05:00,MYL,positive
879144.0,"Mylan CEO Heather Bresch Sells 75,000 @ Avg Price: $45.00 -Form4",2018-01-11 04:04:00-05:00,MYL,neutral
879145.0,"New Year's Benzinga Bulls & Bears: Apple, Disney, Netflix And More",2018-01-07 13:32:00-05:00,MYL,neutral
879146.0,Teva Vs Mylan: Wells Fargo Weighs In,2018-01-05 13:43:00-05:00,MYL,positive
879147.0,9 Stocks Moving In Wednesday's After-Hours Session,2018-01-03 17:12:00-05:00,MYL,neutral
879148.0,"Momenta and Mylan Announce Development Strategy for M710, Plan To Initiate Pivotal Clinical Trial In 1H18",2018-01-03 16:07:00-05:00,MYL,neutral
879149.0,"Leerink Swann Initiates Coverage On Mylan with Market Perform Rating, Announces $44.00 Price Target",2018-01-03 08:39:00-05:00,MYL,neutral
879150.0,Mylan Reports FDA Approval Of First Generic Estrace Cream,2017-12-29 10:47:00-05:00,MYL,positive
879151.0,"Biocon, Mylan Biosimilar Trastuzumab Receives Approval from Brazil Regulatory Agency",2017-12-29 03:57:00-05:00,MYL,positive
879152.0,Mylan Option Alert: Dec 22 $41 Calls Above Ask!: 4700 @ $0.511 vs 48 OI; Ref=$40.265,2017-12-15 13:56:00-05:00,MYL,positive
879153.0,Mylan Reports US Patent And Trademark Appeal Board Instituted Inter Partes Review Proceedings On All Claims Against Sanofi's Lantus Patents,2017-12-14 07:33:00-05:00,MYL,neutral
879154.0,Guggenheim Initiates Coverage On Mylan with Buy Rating,2017-12-12 09:00:00-05:00,MYL,neutral
879155.0,Mylan Reports Teva Dismissed Litigation After Co. Won Court Ruling On Teva's Cold Filtration Patents For Copaxone 40 mg/mL,2017-12-11 12:17:00-05:00,MYL,positive
879156.0,"Mylan, Aspen Announce Launch of Generic Busulfex Injection",2017-12-04 07:32:00-05:00,MYL,neutral
879157.0,Mylan and Aspen Launch Generic Busulfex,2017-12-04 07:31:00-05:00,MYL,neutral
879158.0,"Mylan Release Confirms FDA Approval Of Co., Biocon's Ogivri For Treatment Of HER2-Positive Breast, Gastric Cancers",2017-12-01 11:35:00-05:00,MYL,positive
879159.0,Mylan Reports FDA Final Approval Of Heparin Sodium Injection ANDA,2017-12-01 10:53:00-05:00,MYL,positive
879160.0,"FDA Approves Mylan's Ogivri, Label Contains Boxed Warning About Increased Risks Of Heart Disease, Reactions, Etc.",2017-12-01 10:39:00-05:00,MYL,positive
879161.0,"BZ NOTE: Adamis' Sympei Had Previously (On Jun. 15, 2017) Been Described As 'lower cost, small size and user-friendly design' By Co. CEO; Comment In Fri. Co. Press Release Does Not Seem To Be New Information",2017-12-01 09:36:00-05:00,MYL,neutral
879162.0,"Watching Adamis, Competitor Mylan Shares Following Adamis Release Previewing Results Of Symjepi Study Will Be Presented At AAAAI; Co. CEO Described Symjepi Results As Demonstrating Device Is 'easy to use, small and intuitive'",2017-12-01 09:32:00-05:00,MYL,positive
879163.0,Watching Generic Drug Makers Following CNBC Article 'Amazon is in exploratory talks with generic-drug makers',2017-11-30 17:00:00-05:00,MYL,positive
879164.0,"Mylan Reports EMA Accepted MAA For Co., Biocon's Proposed Biosimilars Trastuzumab, Pegfligrastim",2017-11-30 12:57:00-05:00,MYL,positive
879165.0,Attention Biotech Investors: Mark Your Calendar For These December PDUFA Dates,2017-11-30 08:34:00-05:00,MYL,neutral
879166.0,CNBC Tweets 'FDA issues guidance that could make it easier for EpiPen rivals to come to market',2017-11-28 09:36:00-05:00,MYL,positive
879167.0,Seeing Notable Block Trade In Mylan; 3.8M Shares At $37.05,2017-11-21 15:20:00-05:00,MYL,negative
879168.0,Theravance Biopharma and Mylan Submit New Drug Application to FDA for Revefenacin in Adults with Chronic Obstructive Pulmonary Disease,2017-11-13 09:29:00-05:00,MYL,neutral
879169.0,Mylan Announces Voluntary Delisting from the Tel Aviv Stock Exchange (TASE),2017-11-10 16:48:00-05:00,MYL,neutral
879170.0,Mylan Launches Generic Clolar for Injection,2017-11-09 07:45:00-05:00,MYL,neutral
879171.0,"Mylan Says on October 10, Co, Meda Pharmaceuticals Got Notice CMA Was Opening Investigation for Possible Infringement of Competition Act 1998, Article 101 Of TFEU, With Respect to Alleged Agreements Related to Nefopam, a Product from Meda's Portfolio",2017-11-07 06:59:00-05:00,MYL,positive
879172.0,"Mylan Says on August 29, 2017 Received Civil Investigative Demand from AG of State Of Missouri -10Q",2017-11-07 06:36:00-05:00,MYL,positive
879173.0,"The Week Ahead: Earnings Season Continues, Several IPOs, Notable Conferences On The Docket",2017-11-06 10:48:00-05:00,MYL,neutral
879174.0,30 Stocks Moving In Monday's Pre-Market Session,2017-11-06 08:06:00-05:00,MYL,neutral
879175.0,"Mylan Raises FY17 Outlook: Adj. EPS From $4.30-$4.70 As Of Aug. 9 To $4.45-$4.70 vs $4.59 Est., Sales From $11.5B-$12.5B To $11.75B-$12.5B vs $12.07B Est.",2017-11-06 07:03:00-05:00,MYL,neutral
879176.0,"Mylan Reports Q3 Adj. EPS $1.10 vs $1.20 Est., Sales $2.99B vs $3.1B Est.",2017-11-06 07:02:00-05:00,MYL,neutral
879177.0,"Earnings Scheduled For November 6, 2017",2017-11-06 04:47:00-05:00,MYL,neutral
879178.0,"Theravance, Mylan To Offer Added Phase 3 Data For TD-4208 At CHEST: 'Presentations Highlight 24-Hour Serial Spirometry Subgroup Findings from 2 Replicate Pivotal Phase 3 Studies; Improvements Observed in St. George's Respiratory Questionnaire...'",2017-11-01 08:32:00-04:00,MYL,positive
879179.0,"Momenta, Mylan On M834 Say, 'Momenta and Mylan continue to gather and analyze these data to inform next steps for the program'",2017-11-01 08:04:00-04:00,MYL,neutral
879180.0,"Momenta Pharma, Mylan Report Initial Results From Phase 1 Trial For M834: Did Not Meet Primary Endpoints",2017-11-01 08:03:00-04:00,MYL,neutral
879181.0,Mylan Sharply Lower Amid Drug Price Fixing Concerns,2017-10-31 13:41:00-04:00,MYL,negative
879182.0,"Mylan Says They've Been Investigating Allegations Of Price Fixing And Has Not Found Evidence On Part Of Its Employees, Says They Have Deep Faith In Integrity Of Its President Rajiv Malik And Stand Behind Him Fully",2017-10-31 12:02:00-04:00,MYL,positive
879183.0,"Mylan Shares Turn Negative, Now Down 0.4% Following Word State Attorney Generals Have Expanded Suit Alleging Price Fixing By Generic Drugmakers",2017-10-31 10:47:00-04:00,MYL,negative
879184.0,"Watching Healthcare, Biotech Stocks, ETFs Amid Report Attorney Generals From 46 States Will Expand Suit Related To Alleged Price Fixing Among Generic Drugmakers to 18 Cos., 15 Medicines",2017-10-31 10:46:00-04:00,MYL,positive
879185.0,Mylan Wins UK Court Ruling Related to Copaxone 40 mg/mL Patent,2017-10-26 05:59:00-04:00,MYL,positive
879186.0,Mylan Shares Spike 0.2% To Session Highs As Traders Circulate Chatroom Chatter Suggesting Icahn Has Taken Stake In Co.,2017-10-24 13:14:00-04:00,MYL,positive
879187.0,"Einhorn's Positions In HPE, Micron, Tempur Sealy Create Curious Volatility",2017-10-24 13:07:00-04:00,MYL,positive
879188.0,The Pharma Stocks Vitaliy Katsenelson Is Buying Now,2017-10-16 12:36:00-04:00,MYL,neutral
879189.0,"Mylan Shares Up 0.44% Premarket; Earlier FDA Issued CRL On Co.'s BLA For MYL-1401H; CRL Related To Facility Re-qualification, Didn't Raise Raise Questions On Data Or Biosimilarity",2017-10-10 08:28:00-04:00,MYL,positive
879190.0,REMINDER: Mylan PDUFA Date For MYL-1401H Today,2017-10-09 16:15:00-04:00,MYL,neutral
879191.0,"The Week Ahead: New IPOs, Bank Earnings, And Some Notable FDA Actions",2017-10-09 10:31:00-04:00,MYL,neutral
879192.0,Mylan and Synthon Receive Marketing Authorization Approval in Europe for First Generic for Copaxone,2017-10-05 13:25:00-04:00,MYL,positive
879193.0,Teva Shares Plummet After Mylan's Copaxone Generic Gets FDA Approval,2017-10-05 12:08:00-04:00,MYL,positive
879194.0,Momenta Pharma Could Face Pressure Following Approval Of Mylan's Generic Copaxone,2017-10-05 08:58:00-04:00,MYL,positive
879195.0,Mylan Launches First AP-rated Generic Avelox Injection,2017-10-05 07:30:00-04:00,MYL,neutral
879196.0,"Mylan And Teva And Copaxone, Explained",2017-10-04 14:35:00-04:00,MYL,neutral
879197.0,Mid-Afternoon Market Update: Real Goods Solar Surges After Licensing Deal With Dow Chemical; Sequans Communications Shares Drop,2017-10-04 14:30:00-04:00,MYL,neutral
879198.0,15 Biggest Mid-Day Gainers For Wednesday,2017-10-04 12:10:00-04:00,MYL,neutral
879199.0,Mid-Day Market Update: Mylan Jumps Following FDA Approval For Generic Copaxone; Strongbridge Biopharma Shares Plunge,2017-10-04 12:02:00-04:00,MYL,positive
879200.0,"Mylan's Generic Copaxone Arrives, Teva Sales To Take A Hit",2017-10-04 11:40:00-04:00,MYL,neutral
879201.0,5 Biggest Price Target Changes For Wednesday,2017-10-04 10:02:00-04:00,MYL,neutral
879202.0,Why Is Teva Falling? Competition,2017-10-04 09:10:00-04:00,MYL,negative
879203.0,What Approval For Generic Copaxone Means For Mylan,2017-10-04 08:27:00-04:00,MYL,positive
879204.0,25 Stocks Moving In Wednesday's Pre-Market Session,2017-10-04 08:07:00-04:00,MYL,neutral
879205.0,A Peek Into The Markets: U.S. Stock Futures Edge Lower Ahead Of Economic Reports,2017-10-04 07:20:00-04:00,MYL,negative
879206.0,Mylan +15+ Premarket @37.40; Co Announced FDA Approval of First Generic for Copaxone 40 mg/mL 3-Times-a-Week,2017-10-04 06:37:00-04:00,MYL,positive
879207.0,Mylan Announces FDA Approval of First Generic for Copaxone 40 mg/mL 3-Times-a-Week; May Be Eligible for 180-Day Exclusivity,2017-10-03 20:16:00-04:00,MYL,positive
879208.0,Mylan Lanches Generic Cancidas Injection In The U.S.,2017-10-02 12:40:00-04:00,MYL,neutral
879209.0,Mylan Launches Generic Gleevec Tablets,2017-09-29 17:10:00-04:00,MYL,neutral
879210.0,"Attention Biotech Investors, Here's Your PDUFA Primer For October",2017-09-28 10:51:00-04:00,MYL,neutral
879211.0,"In a Letter, U.S. Senators Ask Senate Judiciary Committee To Investigate Allergan Transfer Deal And Impact On Drug Prices",2017-09-27 15:54:00-04:00,MYL,neutral
879212.0,Mylan Luanching Generic Minastrin,2017-09-14 12:04:00-04:00,MYL,neutral
879213.0,Meg Tirrell Tweets: FDA publishes warning letter to EpiPen manufacturing facility ( $PFE manufactures EpiPen for $MYL ) fda.gov/ICECI/Enforcem…,2017-09-07 13:21:00-04:00,MYL,negative
879214.0,Attention Biotech Investors: September Ushers In Another Slew Of PDUFA Catalysts,2017-09-01 14:03:00-04:00,MYL,neutral
879215.0,"Otsuka, Mylan Announce License Agreement to Commercialize Delamanid for MDR-TB in High-Burden Countries",2017-08-24 04:05:00-04:00,MYL,positive
879216.0,"Benzinga's Top Upgrades, Downgrades For August 22, 2017",2017-08-22 09:23:00-04:00,MYL,positive
879217.0,Mylan's Stock Is No Longer A Buy According To Analysts At Argus,2017-08-22 09:07:00-04:00,MYL,negative
879218.0,Argus Downgrades Mylan N.V. - Common Stock to Hold,2017-08-22 07:27:00-04:00,MYL,neutral
879219.0,Mylan Press Release Confirms Finalization Of Deal With Dept. Of Justice For EpiPen,2017-08-17 10:45:00-04:00,MYL,positive
879220.0,"Mylan Shares Up ~$0.10 Over Last Min. Amid Settlement Papers Showing Co., US Has Finalized $465M EpiPen Accord",2017-08-17 10:28:00-04:00,MYL,positive
879221.0,Hearing Settlement Papers Show Mylan And The U.S. Finalize $465M Epipen Accord,2017-08-17 10:24:00-04:00,MYL,neutral
879222.0,"Benzinga's Top Upgrades, Downgrades For August 16, 2017",2017-08-16 09:39:00-04:00,MYL,positive
879223.0,Citigroup Upgrades Mylan N.V. - Common Stock to Buy,2017-08-16 07:22:00-04:00,MYL,neutral
879224.0,Columbia Bureau Chief Andy Shain Tweets: Breaking - @AGAlanWilson suing the maker of OxyContin @purduepha. Context from @Andy_Ed_Brown,2017-08-15 10:45:00-04:00,MYL,negative
879225.0,The Prescription For Generic Drugs ETF,2017-08-15 08:39:00-04:00,MYL,neutral
879226.0,13F From Tepper's Appaloosa Shows Liquidated Position In Mylan,2017-08-14 16:24:00-04:00,MYL,neutral
879227.0,Mylan Launches Three Generic Antiretroviral Medicines in Canada For Treatment Of HIV,2017-08-10 08:19:00-04:00,MYL,neutral
879228.0,From Mylan Q2 Earnings Conference Call: Co. Will Be Opportunistic Related To Deal Opportunities To Fill Product Or Geographic Holes,2017-08-09 10:29:00-04:00,MYL,positive
879229.0,18 Stocks Moving In Wednesday's Pre-Market Session,2017-08-09 08:19:00-04:00,MYL,neutral
879230.0,"Mylan Sees FY17 Adj. EPS $4.30-$4.70 vs $5.12 Est., Sales $11.5B-$12.5B vs $12.5B Est.",2017-08-09 08:02:00-04:00,MYL,neutral
879231.0,"Mylan Reports Q2 Adj. EPS $1.10 vs $1.16 Est., Sales $2.96B vs $3.04B Est.",2017-08-09 08:01:00-04:00,MYL,neutral
879232.0,"Earnings Scheduled For August 9, 2017",2017-08-09 04:41:00-04:00,MYL,neutral
879233.0,Mylan Anniounces Launch of HIV Treatment Avonza in India,2017-08-08 04:00:00-04:00,MYL,neutral
879234.0,Mylan Price Target Slashed Even As TLD Drug Receives Tentative Approval,2017-08-07 11:56:00-04:00,MYL,positive
879235.0,25 Stocks Moving In Monday's Pre-Market Session,2017-08-07 08:06:00-04:00,MYL,neutral
879236.0,"Mylan Receives Tentative FDA Approval for ""TLD"" Under PEPFAR",2017-08-07 08:01:00-04:00,MYL,positive
879237.0,Benzinga's Option Alert Recap From August 4,2017-08-04 16:23:00-04:00,MYL,positive
879238.0,"Mylan Option Alert: Jan, 2019 $25 Puts at the Ask: 500 @ $1.42 vs 221 OI; Ref=$33.66",2017-08-04 09:53:00-04:00,MYL,positive
879239.0,Mylan Shares Tick Very Slightly Higher As Traders Circulating Report Express Scripts Will Cover The Co.'s EpiPen And Exclude Rivals,2017-07-31 11:10:00-04:00,MYL,positive
879240.0,Mylan Receives WHO Prequalification For Sovaldi Generic,2017-07-26 09:45:00-04:00,MYL,neutral
879241.0,"Theravance, Mylan Report Results of Phase 3 TD-4208 Study 'demonstrated that revefenacin was generally well-tolerated, and no new safety issues were identified'",2017-07-19 16:26:00-04:00,MYL,positive
879242.0,"Theravance Biopharma, Mylan Report Results From 12-Month Phase 3 Safety Study Of TD-4208 In Patients With COPD: Data Supports NDA Filing Expected For Q4'17",2017-07-19 16:26:00-04:00,MYL,positive
879243.0,ODAC Unanimously Recommends FDA Approve Mylan And Biocon's Biosimilar Trastuzumab,2017-07-13 17:05:00-04:00,MYL,positive
879245.0,Watch These 7 Huge Put Purchases In Wednesday Trade,2017-06-28 04:17:00-04:00,MYL,positive
879246.0,Benzinga's Option Alert Recap From June 27,2017-06-27 16:09:00-04:00,MYL,positive
879247.0,Option Alert: Mylan Jul 38.5 Puts: 1200 @  Above Ask!  $0.88: 1470 traded vs 1 OI:  Earnings 8/8 After Close (est)  $38.75 Ref,2017-06-27 15:05:00-04:00,MYL,positive
879248.0,Horizon Pharma Says a New Jersey Court Upheld Two Patents and Stated That Mylan Would Infringe With At Least 1 Patent with Their Generic Naproxen Products,2017-06-27 07:07:00-04:00,MYL,neutral
879249.0,Andrew Left Predicts Eventual DOJ Prosecution Of Mallinckrodt For Selling HP Acthar Without Proven Efficacy,2017-06-22 12:26:00-04:00,MYL,negative
879250.0,"Companies Holding Shareholder Meetings Today Include: Apogee, Cherokee, Citrix Systems, Kroger, Mylan, Pier 1, TripAdvisor, VBI Vaccines, Universal Display, Ultragenyx Pharma, and ZAGG",2017-06-22 09:15:00-04:00,MYL,neutral
879251.0,Coal Plants Generating Hundreds of Millions in Tax Credits for Mylan -Reuters,2017-06-21 04:19:00-04:00,MYL,positive
879252.0,Watch These 5 Huge Call Purchases In Tuesday Trade,2017-06-20 04:01:00-04:00,MYL,positive
879254.0,Benzinga's Option Alert Recap From June 19,2017-06-19 16:14:00-04:00,MYL,positive
879255.0,Option Option Alert: Mylan Jul 37.5 Calls Sweep: 595 @  ASK  $1.19: 1199 traded vs 2255 OI:  Earnings 8/8 After Close (est)  $37.47 Ref,2017-06-19 11:54:00-04:00,MYL,positive
879256.0,"Cantor Fitzgerald Initiates Coverage On Mylan N.V. - Common Stock with Neutral Rating, Announces $41.00 Price Target",2017-06-16 06:27:00-04:00,MYL,neutral
879257.0,Mylan Shares Down ~$0.14 Over Last Few Mins Following Adamis News Of FDA Approval For Epinephrine Shot,2017-06-15 14:36:00-04:00,MYL,positive
879258.0,"Watching Mylan Shares, iShares Nasdaq Biotech ETF For Volatility As Traders Circulating Chatter From Earlier This Week Suggesting White House Could Be Drafting Exec Order On Drug Pricing",2017-06-15 13:36:00-04:00,MYL,positive
879259.0,A Peek At Adamis Ahead Of FDA Approval,2017-06-15 09:05:00-04:00,MYL,positive
879261.0,Mylan Board Writes Letter to Shareholders before Annual Meeting,2017-06-13 06:12:00-04:00,MYL,neutral
879262.0,Watch These 7 Huge Call Purchases In Tuesday Trade,2017-06-13 04:50:00-04:00,MYL,positive
879263.0,Benzinga's Option Alert Recap From June 12,2017-06-12 16:14:00-04:00,MYL,positive
879264.0,Pegfilgrastim To Help Chemotherapy Patients Fails To Clear Regulatory Hurdle; Coherus Receives CRL,2017-06-12 10:08:00-04:00,MYL,positive
879265.0,Option Alert: Mylan Jun 40.0 Calls Sweep: 500 @  Above Ask!  $0.588: 500 traded vs 4515 OI:  Earnings 8/8 After Close (est)  $39.93 Ref,2017-06-12 09:44:00-04:00,MYL,positive
879266.0,"Mylan, Biocon Present Clinical Data on Insulin Glargine at American Diabetes Association's 77th Scientific Sessions",2017-06-11 10:52:00-04:00,MYL,neutral
879267.0,Watch These 8 Huge Call Purchases In Friday Trade,2017-06-09 06:32:00-04:00,MYL,positive
879268.0,Benzinga's Option Alert Recap From June 8,2017-06-08 16:08:00-04:00,MYL,positive
879269.0,Option Alert: Mylan Jun 23rd 41.0 Calls: 2028 @  ASK  $0.38: 3001 traded vs 162 OI:  Earnings 8/8 After Close (est)  $39.66 Ref,2017-06-08 10:07:00-04:00,MYL,positive
879270.0,"Mylan Earlier Issued Proxy Statements Disclosing Letter to ISS, Shows 'As we have repeatedly stated, Teva never made an offer to acquire Mylan'",2017-06-07 08:33:00-04:00,MYL,neutral
879271.0,Mylan Launches Generic Azilect Tablets,2017-06-02 08:05:00-04:00,MYL,neutral
879272.0,Mylan Launches Generic Reclast Injection,2017-06-02 07:31:00-04:00,MYL,neutral
879273.0,Mylan Shares Moving Lower as Senator Grassley Says Estimate from Dept. of Health & Human Services Shows Taxpayers Could Have Overpaid for EpiPen by as Much as $1.27B from '06-'16,2017-05-31 14:58:00-04:00,MYL,neutral
879274.0,Option Alert: Mylan Jun 39.5 Calls Sweep: 3000 @  Above Ask!  $0.80: 3007 traded vs 823 OI:  Earnings 8/8 After Close (est)  $39.30 Ref,2017-05-31 10:43:00-04:00,MYL,positive
879275.0,Tracking The Busy June PDUFA Calendar,2017-05-30 08:58:00-04:00,MYL,neutral
879276.0,"It's Easy To Be Skeptical Of Mylan, But Don't Ignore This Pending PDUFA Date",2017-05-22 12:25:00-04:00,MYL,positive
879277.0,The Market In 5 Minutes,2017-05-22 09:07:00-04:00,MYL,neutral
879278.0,"UBS Global Health Care Conference Begins Today; Presenters Include: AbbVie, Aetna, Universal Health, Mylan, Community Health, Tenet Healthcare, & Bristol-Myers Squibb",2017-05-22 08:57:00-04:00,MYL,positive
879279.0,Barclays Upgrades Mylan N.V. - Common Stock to Overweight,2017-05-22 05:54:00-04:00,MYL,negative
879280.0,Mylan Prevails In Salix/Valeant '688 Apriso IPR Final Written Decision,2017-05-19 10:12:00-04:00,MYL,neutral
879281.0,Watch These 8 Huge Call Purchases In Tuesday Trade,2017-05-16 04:06:00-04:00,MYL,positive
879282.0,Benzinga's Option Alert Recap From May 15,2017-05-15 16:16:00-04:00,MYL,positive
879283.0,Option Alert: Mylan May 26 $39 Call; 14492 @Bid @$0.47; Ref=$38.66,2017-05-15 13:43:00-04:00,MYL,positive
879284.0,Appaloosa Lowers Stake In Mylan,2017-05-12 16:18:00-04:00,MYL,negative
879285.0,Turing Rejects $100 Million Offer For Daraprim,2017-05-10 11:32:00-04:00,MYL,negative
879286.0,Mylan President Says Epipen Will Account For Less Than 5% Of Global Sales and Less Than 10% Of North American Sales,2017-05-10 10:15:00-04:00,MYL,neutral
879287.0,Mylan 10-Q Filing Just Out,2017-05-10 09:32:00-04:00,MYL,neutral
879288.0,"Mylan Reports Q1 Adj. EPS $0.93 vs $0.92 Est., Sales $2.72B vs $2.84B Est.",2017-05-10 07:30:00-04:00,MYL,neutral
879289.0,"Earnings Scheduled For May 10, 2017",2017-05-10 04:56:00-04:00,MYL,neutral
879290.0,Benzinga's Option Alert Recap From April 27,2017-04-27 17:01:00-04:00,MYL,positive
879291.0,Option Alert: Mylan May 38.0 Calls Sweep: 501 @  ASK  $1.136: 1575 traded vs 451 OI:  Earnings 5/2 Before Open [est]  $37.75 Ref,2017-04-27 14:18:00-04:00,MYL,positive
879292.0,Benzinga's Option Alert Recap From April 26,2017-04-26 16:54:00-04:00,MYL,positive
879293.0,Option Alert: Mylan  May 5th 37.0 Calls Sweep: 502 @  ASK  $0.792: 502 traded vs 294 OI:  Earnings 5/2 Before Open [est]  $37.14 Ref,2017-04-26 09:50:00-04:00,MYL,positive
879294.0,Kmart Pharmacy Lowers Cost of Generic Epinephrine Auto-injector Pens to $200/2-Pack for Cash Payers,2017-04-25 06:11:00-04:00,MYL,negative
879295.0,Hearing A Court Filing Has Shown Sanofi-Aventis Filed Antitrust Suit Against Mylan Related to Latter's EpiPen,2017-04-24 11:02:00-04:00,MYL,neutral
879296.0,EMA Recommends Approval Of Mylan's Febuxostat For Prevention & Treatment of Hyperuricaemia,2017-04-21 13:38:00-04:00,MYL,positive
879297.0,Mylan Announces Launch of Generic Trilafon Tablets,2017-04-20 13:41:00-04:00,MYL,neutral
879298.0,CNBC's Meg Tirrell Tweets: $MYL spox says co does not anticipate any supply disruption; has 9 independent sites to maintain continuous supply,2017-04-11 11:53:00-04:00,MYL,negative
879299.0,"FDA Warns Mylan Over Quality Systems Failures For Its Nashik, India-Based Manufacturing Site",2017-04-11 11:44:00-04:00,MYL,negative
879300.0,What Makes Mylan's Newest EpiPen Lawsuit Different?,2017-04-10 14:01:00-04:00,MYL,negative
879301.0,Hearing Federal Appeals Court Has Ruled Mylan Can Proceed with Generic Version of Angiomax by Medicines Co.,2017-04-06 13:22:00-04:00,MYL,neutral
879302.0,"JPMorgan, Mondelez, Mylan: Fast Money Picks For April 4",2017-04-04 07:18:00-04:00,MYL,neutral
879303.0,Pfizer Subsidiary Meridian Medical Tech Has Expanded A Voluntary Recall Of Select Lots Of Mylan's EpiPen,2017-03-31 17:13:00-04:00,MYL,neutral
879304.0,GlaxoSmithKline Shares Move Higher as Mylan Shares Tumble Following News of CRL for Generic Advair Diskus,2017-03-29 13:18:00-04:00,MYL,positive
879305.0,"UPDATE: Mylan Says, In Conjunction with GDUFA Goal Date, Co. Received CRL from FDA Related to ANDA for Generic Advair Diskus",2017-03-29 13:18:00-04:00,MYL,neutral
879306.0,Mylan Issues Comment on Generic Advair Diskus ANDA,2017-03-29 13:17:00-04:00,MYL,neutral
879307.0,"Abbott Reports 4.81% Stake In Mylan, Sold $4M Shares At $41.60/Share Through Privately-Negotiated Block Trade",2017-03-24 07:34:00-04:00,MYL,negative
879308.0,Bloomberg Reports Mylan 44M Share Block Offered $39.50-$40.25,2017-03-23 16:58:00-04:00,MYL,negative
879309.0,Watching Shares Of Mylan As Reports Recently Published On Recall Of 81000 EpiPen Devices Following 2 Incidents Of Failure To Work In Emergencies; This Was Reported On MYL's Website Monday,2017-03-22 15:35:00-04:00,MYL,negative
879310.0,Imprimis Challenges Mallinckrodt's Acthar,2017-03-21 16:33:00-04:00,MYL,positive
879311.0,Mylan Reports Received Tentative Approval for TLE400 Under PEPFAR,2017-03-20 13:17:00-04:00,MYL,positive
879312.0,Leerink Presents: Your 2017 Biopharma Catalyst Tracker,2017-03-20 09:17:00-04:00,MYL,neutral
879313.0,Mylan Launches Generic Aromasin Tablets,2017-03-13 14:23:00-04:00,MYL,neutral
879314.0,"Mylan Reports Global Settlement, License Agreements with Genentech and Roche on Herceptin",2017-03-13 08:08:00-04:00,MYL,positive
879315.0,How Did A Maligned Mylan Surprise To The Upside With 2017 Outlook?,2017-03-10 11:02:00-05:00,MYL,positive
879316.0,Mylan Launches Generic Pristiq Tablets,2017-03-10 07:30:00-05:00,MYL,neutral
879317.0,Benzinga's Option Alert Recap From March 9,2017-03-09 17:14:00-05:00,MYL,positive
879318.0,Option Alert: Mylan Mar 10th 43.5 Calls Sweep: 500 @  ASK  $0.18: 516 traded vs 213 OI:  Earnings 5/2 Before Open (est)  $43.19 Ref,2017-03-09 11:54:00-05:00,MYL,positive
879319.0,Option Alert: Mylan Mar 44.0 Calls Sweep: 501 @  ASK  $0.348: 509 traded vs 677 OI:  Earnings 5/2 Before Open (est)  $43.09 Ref,2017-03-09 11:22:00-05:00,MYL,positive
879320.0,Mylan Says Cont. Restructuring Actions Expected To Be Implemented Through FY18,2017-03-01 16:57:00-05:00,MYL,neutral
879321.0,Mylan CFO Says $400M Negative Profit Impact From Epipen Built Into Previously Announced 2017 Guidance,2017-03-01 15:52:00-05:00,MYL,negative
879322.0,Mylan Nears Pre-Epipen Crisis Levels After Q4 Beat,2017-03-01 11:08:00-05:00,MYL,negative
879323.0,Mylan Holding Investor Day Today,2017-03-01 09:21:00-05:00,MYL,neutral
879324.0,"Mylan Sees FY17 EPS $5.15-$5.55 vs $5.32 Est., Sales $12.25B-$13.75B vs $12.7B Est.",2017-03-01 07:46:00-05:00,MYL,neutral
879325.0,"Mylan Reports Q4 Adj. EPS $1.57 vs. $1.42 Est., Sales $3.27B vs. $3.18B Est.",2017-03-01 07:45:00-05:00,MYL,neutral
879326.0,Watch These 8 Huge Call Purchases In Friday Trade,2017-02-24 04:17:00-05:00,MYL,positive
879327.0,Benzinga's Option Alert Recap From February 23,2017-02-23 16:54:00-05:00,MYL,positive
879328.0,Option Alert: Mylan Apr 45.0 Calls Sweep: 500 @  ASK  $0.989: 1066 traded vs 11k OI:  Earnings 3/1 Unspecified  $41.88 Ref,2017-02-23 11:36:00-05:00,MYL,positive
879329.0,U.S. FDA Accepts Biologics License Application for Mylan and Biocon's Proposed Biosimilar Pegfilgrastim for Review,2017-02-16 08:12:00-05:00,MYL,positive
879330.0,"13F from Tepper's Appaloosa Shows New Stakes in Mylan, Pfizer, Teva",2017-02-14 16:19:00-05:00,MYL,neutral
879331.0,Watch These 8 Huge Call Purchases In Tuesday Trade,2017-02-07 04:30:00-05:00,MYL,positive
879332.0,Najarian Brothers See Unusual Options Activity In Microsoft And Mylan,2017-02-06 17:25:00-05:00,MYL,neutral
879333.0,Benzinga's Option Alert Recap From February 6,2017-02-06 16:52:00-05:00,MYL,positive
879334.0,Option Alert: Mylan Mar 45.0 Calls: 617 @  ASK  $0.36: 899 traded vs 10 OI:  Earnings 3/1 Unspecified  $40.01 Ref,2017-02-06 13:16:00-05:00,MYL,positive
879335.0,Option Alert: Mylan Mar 42.5 Calls Sweep: 503 @  ASK  $0.801: 961 traded vs 707 OI:  Earnings 3/1 Unspecified  $39.79 Ref,2017-02-06 09:58:00-05:00,MYL,positive
879336.0,Mylan Tests Resistance After Pfizer Takeover Rumor,2017-02-03 11:40:00-05:00,MYL,neutral
879337.0,Mylan Shares Spiking On Rumor Of Takeover Chatter With Pfizer,2017-02-03 10:26:00-05:00,MYL,positive
879338.0,Watch These 7 Huge Put Purchases In Wednesday Trade,2017-02-01 04:09:00-05:00,MYL,positive
879339.0,Benzinga's Option Alert Recap From January 31,2017-01-31 17:16:00-05:00,MYL,positive
879340.0,Teva Pharma Back At January 2007 Levels After Lost Patent Ruling,2017-01-31 11:17:00-05:00,MYL,negative
879341.0,Option Alert: Mylan Apr 35.0 Puts Sweep: 1500 @  ASK  $1.28: 1535 traded vs 7941 OI:  Earnings 2/9 After Close (est)  $37.07 Ref,2017-01-31 09:56:00-05:00,MYL,positive
879342.0,Mylan Wins U.S. District Court Ruling Related to Copaxone 40 mg/mL Patents,2017-01-31 04:21:00-05:00,MYL,positive
879343.0,Benzinga's Option Alert Recap From January 30,2017-01-30 17:15:00-05:00,MYL,positive
879344.0,Option Alert: Mylan Feb 3rd 35.0 Puts Sweep: 541 @  ASK  $0.282: 607 traded vs 173 OI:  Earnings 2/9 After Close (est)  $35.98 Ref,2017-01-30 15:26:00-05:00,MYL,positive
879345.0,CNBC's Meg Tirrell Tweets: $MYL says it received info request from FTC months ago as part of prelim investigation & suggestion of inappropriate action 'without merit',2017-01-30 15:26:00-05:00,MYL,negative
879346.0,Mylan Faces U.S. Antitrust Investigation Into Epipen Practices,2017-01-30 15:16:00-05:00,MYL,neutral
879347.0,"Evercore Out With Color On Mylan, Says EpiPen Competitors Appear To Be Having An Impact, Specifically Impax",2017-01-27 08:44:00-05:00,MYL,neutral
879348.0,Short Sellers Bet Against Generic EpiPen,2017-01-26 16:05:00-05:00,MYL,neutral
879349.0,U.S. Appeals Court Rules In Favor of Cumberland Pharmaceuticals Over Mylan In Patent Dispute Realted To Acetadote,2017-01-26 09:27:00-05:00,MYL,neutral
879350.0,Could Pharmacy Benefit Managers Be Trump's Next Target?,2017-01-25 14:28:00-05:00,MYL,positive
879351.0,Wall Street's M&A Chatter From January 19,2017-01-20 06:52:00-05:00,MYL,neutral
879352.0,"Mylan Said To Have No Epipen Misclassification Settlement With DoJ As Of Yet, According To Letter To U.S. Senator Grassley From U.S. Health Dept.",2017-01-19 15:07:00-05:00,MYL,negative
879353.0,"Mylan Shares Moving Lower as CNBC Discussing EpiPen Competitor, Kaleo's Auvi-Q, as Costing Six Times More Than EpiPen",2017-01-19 14:04:00-05:00,MYL,neutral
879354.0,The Difference Between Mylan's EpiPen And Generic Offerings,2017-01-12 16:01:00-05:00,MYL,neutral
879355.0,"The Market In 5 Minutes: Jobless Claims Lower, Trump Conference Shakes Sectors",2017-01-12 08:55:00-05:00,MYL,negative
879356.0,"Cigna Issues Statement Following Word EpiPen Dropped, Confirms to Benzinga '...we have revised our covered drug list to encourage use of the generic version...'",2017-01-11 19:25:00-05:00,MYL,positive
879357.0,UPDATE: Mylan Says 'formulary changes were anticipated and are why we anticipate successful generic utilization',2017-01-11 19:22:00-05:00,MYL,positive
879358.0,"Mylan Responds to Word Cigna Dropped EpiPen from Coverage, Tells Benzinga Authorized Generic for EpiPen Auto-Injector Now Covered Under Preferred Category",2017-01-11 19:21:00-05:00,MYL,neutral
879359.0,Mylan's EpiPen Dropped From Cigna's Coverage List,2017-01-11 16:59:00-05:00,MYL,neutral
879360.0,All The Markets Trump Moved During His Speech Today,2017-01-11 15:51:00-05:00,MYL,neutral
879361.0,Mylan Shares Falling Here as Traders Circulating Word Cigna Dropped Co.'s EpiPen,2017-01-11 15:45:00-05:00,MYL,positive
879362.0,Mylan Volatile As Trump Makes Negative Statement On Drug Pricing,2017-01-11 12:19:00-05:00,MYL,negative
879363.0,Trump: Drug Industry Is 'Getting Away With Murder',2017-01-11 12:15:00-05:00,MYL,negative
879364.0,"Watching Weakness In Amgen,Biogen, Gilead, Mylan, Pfizer And Other Biotechs After Pres. Elect Trump Negative Statement On Drug Pricing",2017-01-11 11:25:00-05:00,MYL,negative
879365.0,"JP Morgan Healtchare Conf. Continues Today; Presenters Include Novocure, Zoetis, Oxford Immunotec, Enanta, Irhythm Tech, Walgreen's, & Mylan",2017-01-11 08:34:00-05:00,MYL,positive
879366.0,U.S. FDA Accepts Biologics License Application For Mylan and Biocon's Proposed Biosimilar Trastuzumab,2017-01-11 08:00:00-05:00,MYL,positive
879367.0,Option Alert: Mylan Jan 13th 40.5 Calls Sweep: 500 @  ASK  $0.12: 668 traded vs 314 OI:  Earnings 2/9 After Close (est)  $39.05 Ref,2017-01-10 15:34:00-05:00,MYL,positive
879368.0,Mylan Acquires Cold-EEZE Brand From ProPhase to Further Expand OTC Business For $50M,2017-01-09 07:34:00-05:00,MYL,positive
879369.0,"The Market In 5 Minutes: Jobless Claims Fall Again, Retailers Struggle",2017-01-05 09:13:00-05:00,MYL,negative
879370.0,Citigroup Downgrades Mylan N.V. - Common Stock to Neutral,2017-01-05 06:11:00-05:00,MYL,neutral
879371.0,Mylan Higher Following Launch Of Concerta Tablets,2016-12-30 10:40:00-05:00,MYL,neutral
879372.0,Which Wall Street Firm Made The Best Stock Picks Of 2016?,2016-12-30 10:09:00-05:00,MYL,positive
879373.0,Option Alert: MYL Feb 42.5 Calls Sweep: 568 @  ASK  $0.60: 578 traded vs 366 OI:  Earnings 2/9 After Close (est)  $38.04 Ref,2016-12-30 09:54:00-05:00,MYL,positive
879374.0,Competition For Mylan's Generic Concerta Is Limited,2016-12-30 08:13:00-05:00,MYL,negative
879375.0,"Must Watch Stocks for December 30, 2016",2016-12-30 04:57:00-05:00,MYL,neutral
879376.0,Mylan Reports Launch of Generic Concerta Tablets,2016-12-29 16:23:00-05:00,MYL,neutral
879377.0,Mylan Reports Launch of Generic Cerebyx Injection,2016-12-29 07:00:00-05:00,MYL,neutral
879378.0,"Must Watch Stocks for December 29, 2016",2016-12-29 04:55:00-05:00,MYL,neutral
879379.0,Mylan Reports Launch of Generic Zovia Tablets,2016-12-28 16:33:00-05:00,MYL,neutral
879380.0,Valeant Shares Turn Negative On Business Insider Article Report Highlighting The Senate's Massive Report On Drug Pricing,2016-12-21 11:16:00-05:00,MYL,negative
879381.0,How Does Mylan's $300 EpiPen Compare To Other Generics?,2016-12-16 13:26:00-05:00,MYL,neutral
879382.0,U.S. Senator Bernie Sanders Tweets: At $300 generic EpiPens will still cost 3 times more than they did in 2007. This isn't a discount. It's a PR move.,2016-12-16 11:58:00-05:00,MYL,neutral
879383.0,Mylan Launches the First Generic for EpiPen Auto-Injector as an Authorized Generic,2016-12-16 08:01:00-05:00,MYL,neutral
879384.0,Watch These 3 Huge Put Purchases In Friday Trade,2016-12-16 03:14:00-05:00,MYL,positive
879385.0,"New York Times Reporting 20 States Accuse Generic Drug Companies of Price Fixing, Including Teva And Mylan",2016-12-15 12:56:00-05:00,MYL,negative
879386.0,Option Alert: MYL Dec16 37.5 Puts Sweep: 702 @  ASK  $0.184: 1703 traded vs 1412 OI:  Earnings 2/9 After Close (est)  $38.01 Ref,2016-12-15 10:48:00-05:00,MYL,positive
879387.0,First Charges Filed in Generic Drug Price Probe: Connected Stocks Sell Off,2016-12-14 13:32:00-05:00,MYL,negative
879388.0,"Teva, Mylan Shares Selling Off as Hearing US Has Filed First Charges in Generic Drug Price-Fixing Probe",2016-12-14 11:44:00-05:00,MYL,neutral
879389.0,Allergan Weakness Being Attributed to Report Several of Mylan's IPR Petitions Against Restasis Have Been Instituted,2016-12-08 15:41:00-05:00,MYL,negative
879390.0,Biotech Stocks Convalescing After Wednesday's Trump-Inspired Biotech Selloff,2016-12-08 09:53:00-05:00,MYL,neutral
879391.0,Bernie Sanders' 'Trump Proposal' To Lower Drug Prices Blocked By Senate Republicans,2016-12-07 11:13:00-05:00,MYL,negative
879392.0,Trump Vs. Clinton: Who's Had A Bigger Market Impact With Their Tweets?,2016-12-07 10:03:00-05:00,MYL,neutral
879393.0,"Mylan To Restructure Global Operations, To Affect Less Than 10% Of Workforce",2016-12-07 09:56:00-05:00,MYL,neutral
879394.0,Trump: I'm Going To Bring Down Drug Prices,2016-12-07 09:14:00-05:00,MYL,neutral
879395.0,Mylan To Restructure Certain Locations And That 10% Of Workforce Could Be Impacted,2016-12-07 08:27:00-05:00,MYL,positive
879396.0,"Mylan Announces Restructuring of 'Certain Locations,' 10% of Workforce May Be Impacted",2016-12-07 08:16:00-05:00,MYL,positive
879397.0,Trump On Boeing's New $4 Billion Air Force One: 'Cancel Order!',2016-12-06 10:18:00-05:00,MYL,negative
879398.0,Watch These 5 Huge Call Purchases In Tuesday Trade,2016-11-29 01:28:00-05:00,MYL,positive
879399.0,Option Alert: MYL Dec16 42.5 Calls Sweep: 624 @  ASK  $0.08: 1656 traded vs 4330 OI:  Earnings 2/9 After Close (est)  $36.90 Ref,2016-11-28 14:36:00-05:00,MYL,positive
879400.0,Mylan Signs Sub-license Agreement with the Medicines Patent Pool to Increase Access to Hepatitis C Treatment in Developing Countries,2016-11-28 07:30:00-05:00,MYL,positive
879401.0,Why Sector ETFs May Be Better Than Individual Stocks,2016-11-23 08:39:00-05:00,MYL,positive
879402.0,Imprimis Signs Agreement With One Of Nation's Largest Pharmacy Benefit Managers; CEO Talks Disruption,2016-11-22 15:44:00-05:00,MYL,positive
879403.0,"CNBC's Meg Tirrell Tweets: $MYL ""respectfully declines"" to testify at Sen Grassley's Nov 30 EpiPen hearing, following suit from govt agencies grassley.senate.gov/sites/default/",2016-11-21 11:03:00-05:00,MYL,positive
879404.0,"Andrew Left Challenges Mallinckrodt, Compares Acthar To The EpiPen",2016-11-16 15:12:00-05:00,MYL,positive
879405.0,CNBC's Meg Tirrell Tweets: $MYL says it continues to work to finalize DOJ settlement on #EpiPen,2016-11-15 16:43:00-05:00,MYL,neutral
879406.0,CNBC's Meg Tirrell Tweets: DOJ declines @ChuckGrassley request to testify on $MYL EpiPen; says hasn't agreed to any settlement,2016-11-15 16:43:00-05:00,MYL,negative
879407.0,Greenlight Capital Increases Mylan Stake,2016-11-14 16:36:00-05:00,MYL,neutral
879408.0,Option Alert: MYL Jan17 43.0 Calls Sweep: 3300 @  ASK  $0.76: 3320 traded vs 3875 OI:  Earnings 2/9 After Close (est)  $38.15 Ref,2016-11-14 11:38:00-05:00,MYL,positive
879409.0,"10 Stocks That Rallied Four Days, Then Sold Off Yesterday",2016-11-11 06:32:00-05:00,MYL,neutral
879410.0,"Mylan's Q3 Report Tries, Fails To Shift Focus Away From EpiPen Controversy",2016-11-10 11:20:00-05:00,MYL,negative
879411.0,The Market In 5 Minutes: Retail Earnings Come Into Focus,2016-11-10 09:01:00-05:00,MYL,neutral
879412.0,12 Stocks You Should Be Watching Today,2016-11-10 06:04:00-05:00,MYL,neutral
879413.0,From Mylan Conference Call: Sees Generic Drug Pricing Erosion Near the Mid-Single Digits for Remainder of FY16,2016-11-09 16:59:00-05:00,MYL,neutral
879414.0,Mylan Volatile On Top- And Bottom-Line Miss,2016-11-09 16:19:00-05:00,MYL,positive
879415.0,Mylan Sees FY16 Adj. EPS $4.70-$4.90 vs $4.79 Est.; Sees FY18 Adj. EPS $6,2016-11-09 16:08:00-05:00,MYL,neutral
879416.0,"Mylan Reports Q3 EPS $1.38 vs. Est. $1.46, Rev. $3.06B vs. Est. $3.12B",2016-11-09 16:06:00-05:00,MYL,neutral
879417.0,The Things You Need To Know Ahead Of Mylan's Q3 Earnings,2016-11-09 15:25:00-05:00,MYL,neutral
879418.0,Wednesday's Loser: Hospital Stocks,2016-11-09 15:12:00-05:00,MYL,negative
879419.0,"Pharma Stocks Up Post Election: Ariad 16%, Infinity Up 13%, Allergan, Progenics, Endo 10%, Pfizer, Regeneron 8%, AbbVie 7%, Mylan, Medicines Co. 6%, Perrigo, Merck 5%, Bristol-Myers, Eli Lilly, Sanofi, Novartis 3.5%",2016-11-09 09:41:00-05:00,MYL,neutral
879420.0,Biotech Is Getting A Big Boost Following Clinton's Loss,2016-11-09 08:38:00-05:00,MYL,positive
879421.0,"Keep an Eye on These 10 Stocks for November 9, 2016",2016-11-09 05:14:00-05:00,MYL,neutral
879422.0,"Earnings Scheduled For November 9, 2016",2016-11-09 05:04:00-05:00,MYL,neutral
879423.0,Biopharmaceutical Investors Among The Most Fed Up With The Election,2016-11-08 12:53:00-05:00,MYL,neutral
879424.0,Option Alert: MYL Jan17 38.0 Calls Sweep: 666 @  ASK  $2.11: 1727 traded vs 2916 OI:  Earnings tmrrw After Close  $36.51 Ref,2016-11-08 10:29:00-05:00,MYL,positive
879425.0,"Mylan, Biocon Report FDA Submission for Proposed Biosimilar Trastuzumab",2016-11-08 07:30:00-05:00,MYL,neutral
879426.0,Mr. Wonderful's Election Week Trades For A Trump Victory,2016-11-07 11:42:00-05:00,MYL,neutral
879427.0,"Election At Top Of Market's Mind, But More Earnings Could Keep Things Humming",2016-11-07 11:12:00-05:00,MYL,positive
879428.0,Reputation Can Be Much Slower To Recover From Than Fundamentals,2016-11-05 19:33:00-04:00,MYL,neutral
879429.0,"Despite Department Of Justice Investigation, Now May Be The Time To Buy Generic Drug Stocks",2016-11-04 13:53:00-04:00,MYL,negative
879430.0,"The Market In 5 Minutes: Jobs Numbers, Big Earnings Close The Week",2016-11-04 09:00:00-04:00,MYL,neutral
879431.0,UPDATE: DoJ Probe Into Generics Related to Collusion and Price Fixing,2016-11-03 14:24:00-04:00,MYL,neutral
879432.0,UPDATE: US Regulator Charges Related to Latest Generic Drug Probe Rumored to be Filed by End of 2016,2016-11-03 14:22:00-04:00,MYL,negative
879433.0,"Hearing Dept. of Justice is Probing Generic Cos., Mylan, Teva, Actavis, Impax, Endo's Par, Covis, Lannett, Others Received Subpoenas",2016-11-03 14:14:00-04:00,MYL,positive
879434.0,"Teva, Mylan Shares Dip Lower Over Last Min",2016-11-03 14:12:00-04:00,MYL,neutral
879435.0,Mylan and Biocon Announce Regulatory Submission for Insulin Glargine Accepted for Review by European Medicines Agency,2016-11-03 09:16:00-04:00,MYL,positive
879436.0,Momenta and Mylan Initiate Phase 1 Clinical Trial for M834,2016-11-02 08:08:00-04:00,MYL,neutral
879437.0,Express Scripts Is Under More Scrutiny,2016-11-01 14:40:00-04:00,MYL,neutral
879438.0,Watch These 5 Huge Put Purchases In Monday Trade,2016-10-31 03:10:00-04:00,MYL,positive
879439.0,"Andrew Left Currently on CNBC, Says He's Long Mylan and Sees Mallinckrodt as 'the Real Culprit'",2016-10-28 12:34:00-04:00,MYL,neutral
879440.0,Andrew Left Long Mylan,2016-10-28 12:33:00-04:00,MYL,neutral
879441.0,Option Alert: MYL Nov16 32.5 Puts: 3000 @  Above Ask!  $0.42: 3060 traded vs 5897 OI:  Earnings 11/9 After Close  $37.20 Ref,2016-10-28 10:28:00-04:00,MYL,positive
879442.0,Pentagon Paid Average of $509 for Mylan's EpiPen; 3X Higher than Discounted Rate -Reuters,2016-10-28 07:05:00-04:00,MYL,positive
879443.0,"Mylan Reports Launch of First Generic Version of Benicar, Benicar HCT Tablets",2016-10-26 13:30:00-04:00,MYL,neutral
879444.0,"Mizuho Initiates Coverage On Mylan N.V. - Common Stock at Buy, Announces $49.00",2016-10-25 17:20:00-04:00,MYL,neutral
879445.0,Goldman Says These 25 Healthcare Stocks Are Immune To The Election,2016-10-24 10:55:00-04:00,MYL,positive
879446.0,"Exclusive: SunTrust Managing Director Shares Thoughts On Drug Pricing, Impact On Biotech",2016-10-20 13:57:00-04:00,MYL,positive
879447.0,"Abbott Posts Slight Q3 Beat, Narrows Outlook",2016-10-19 08:28:00-04:00,MYL,neutral
879448.0,Analysts Share Their Low Forward P/E Picks,2016-10-12 06:52:00-04:00,MYL,neutral
879449.0,Punishment For This Healthcare ETF Could Create Opportunity,2016-10-11 14:13:00-04:00,MYL,positive
879450.0,Fitch Says Mylan Will Have Sufficient Liquidity To Make Settlement Payment Without Derailing Expected Deleveraging Subsequent To Mostly Debt-Funded Purchase Of Meda,2016-10-10 14:23:00-04:00,MYL,neutral
879451.0,Technical Alert: Mylan Climbs Over $40 And Retreats,2016-10-10 13:38:00-04:00,MYL,positive
879452.0,12 Biggest Mid-Day Gainers For Monday,2016-10-10 13:00:00-04:00,MYL,neutral
879453.0,Mylan Surrenders Some Of Its Gains From EpiPen Settlement,2016-10-10 11:51:00-04:00,MYL,positive
879454.0,"The Market In 5 Minutes: Earnings Season, Tesla, Twitter And The EpiPen",2016-10-10 09:02:00-04:00,MYL,neutral
879455.0,Mylan Analysts Respond Positively Following EpiPen Classification Settlement,2016-10-10 08:47:00-04:00,MYL,positive
879456.0,16 Stocks Moving In Monday's Pre-Market Session,2016-10-10 08:42:00-04:00,MYL,neutral
879457.0,"CNBC's Meg Tirrell Tweets: $MYL also received SEC doc request re Medicaid payments, not disclosed in settlement press release, per @davidmaris sec.gov/Archives/edgar…",2016-10-10 07:59:00-04:00,MYL,neutral
879458.0,Raymond James Upgrades Mylan to Strong Buy,2016-10-10 07:15:00-04:00,MYL,positive
879459.0,Mylan +9.65% Premarket @$39.41; Co Announced $465M Settlement over EpiPen Classification on Friday,2016-10-10 05:01:00-04:00,MYL,neutral
879460.0,"Must Watch Stocks for October 10, 2016",2016-10-10 04:10:00-04:00,MYL,neutral
879461.0,After-Hours: 2 Stocks On The Move On Another Slow Friday Afternoon,2016-10-08 18:22:00-04:00,MYL,neutral
879462.0,Mylan Shares Up ~7.3% in After-Hours Action,2016-10-07 16:53:00-04:00,MYL,positive
879463.0,UPDATE: Mylan Remains Committed To Target Of At Least $6.00 In Adj. EPS In 2018,2016-10-07 16:48:00-04:00,MYL,positive
879464.0,Mylan Lowers FY16 Adj. EPS Guidance From $4.85-$5.15 To $4.70-$4.90,2016-10-07 16:48:00-04:00,MYL,negative
879465.0,"UPDATE: Mylan Agrees to Terms of $465M Settlement with DoJ, Other Gov't Agencies",2016-10-07 16:47:00-04:00,MYL,positive
879466.0,Mylan Reports Deal to Settle on Medicaid Rebate Classification for EpiPen,2016-10-07 16:47:00-04:00,MYL,neutral
879467.0,Ariad Pharmaceuticals Raises Cancer Drug Price For The 4th Time This Year,2016-10-05 14:41:00-04:00,MYL,negative
879468.0,Mylan Says Generic Epipen Will be Available by End of Year vs Original Statement of 'Several Weeks' -Bloomberg,2016-10-04 04:15:00-04:00,MYL,positive
879469.0,The Committee on Oversight & Government Reform Sends Mylan CEO Letter Regarding Her Testimony,2016-10-03 10:42:00-04:00,MYL,neutral
879470.0,Mylan Reports Launch of Generic Fotamet Tablets,2016-09-30 09:50:00-04:00,MYL,neutral
879471.0,"CMS Says It Provided Mylan Guidance ON EpiPen Classification ""On Multiple Occasions""",2016-09-28 16:38:00-04:00,MYL,neutral
879472.0,US Government Says It Provided Mylan Guidance That Its Classification Of Epipen For Medicaid Rebate Program Was Incorrect,2016-09-28 16:37:00-04:00,MYL,neutral
879473.0,Drug Pricing Was Not Even Mentioned At The First Presidential Debate,2016-09-28 13:32:00-04:00,MYL,neutral
879474.0,"CNBC's Meg Tirrell Tweets: Senators ask Justice Dept to investigate $MYL, citing evidence MYL may have knowingly misclassified #EpiPen: blumenthal.senate.gov/imo/media/doc/…",2016-09-28 11:17:00-04:00,MYL,positive
879475.0,Drug Price Bubble A Result Of Decade-Long Economic Policy Issues,2016-09-27 14:01:00-04:00,MYL,neutral
879476.0,"Benzinga's M&A Chatter for Monday September 26, 2016",2016-09-26 20:04:00-04:00,MYL,neutral
879477.0,Andrew Left On Valeant: 'Eliminating Price Gouging' Likely Sole Agreement Between Presidential Nominees,2016-09-26 15:26:00-04:00,MYL,positive
879478.0,"Hearing Mylan, Lupin Weighing Bids for Bayer's Dermatology Unit",2016-09-26 14:54:00-04:00,MYL,neutral
879479.0,UPDATE: Mylan Says Expecting 8M EpiPen's Sold in US During '16,2016-09-26 12:15:00-04:00,MYL,neutral
879480.0,UPDATE: Mylan says EpiPen product and net product profitability per EpiPen unit sold are not GAAP measures and also reflect adjustments for estimated implied interest expense and for the impact of estimated taxes,2016-09-26 12:12:00-04:00,MYL,positive
879481.0,8-K from Mylan Shows 'US EpiPen Profitability Analysis' Following Last Week's Testimony Before House,2016-09-26 12:12:00-04:00,MYL,positive
879482.0,Epipen's Profits Are Actually A Lot Higher Than Mylan Originally Told Congress,2016-09-26 12:03:00-04:00,MYL,positive
879483.0,"Lemelson Capital Tweets: Pricing + acounting impropriety in #pharma widespread, Turing $VRX $MYL tip of iceberg #corpgov #ActivistShorts mf.tt/gIdEL",2016-09-26 11:21:00-04:00,MYL,neutral
879484.0,UPDATE: Mylan Says EpiPen Pretax Profits 60% Higher Than Told Congress Last Week,2016-09-26 11:02:00-04:00,MYL,positive
879485.0,Hearing Mylan Has Issued Clarification on EpiPen Profit Figures Provided to Congress Last Week,2016-09-26 11:01:00-04:00,MYL,positive
879486.0,TheStreet Publishes 'Next Drug Price Scandal Could Be Cost of Naloxone',2016-09-23 15:30:00-04:00,MYL,negative
879487.0,Deutsche Tweaking Its Mylan View Following CEO's Congressional Testimony,2016-09-23 15:04:00-04:00,MYL,neutral
879488.0,USA Today On EpiPen Saga: Calling It 'Controversial' Is Far From Haphazard,2016-09-23 11:03:00-04:00,MYL,neutral
879489.0,Jim Cramer: The Pharmaceutical 'Good Guys' Need To Stand Up,2016-09-22 11:07:00-04:00,MYL,positive
879490.0,Controversy Pullback Offers Good Entry Point For Mylan,2016-09-22 10:16:00-04:00,MYL,positive
879491.0,"Mylan's CEO Showed 'Very Little Empathy,' Bill George Says",2016-09-21 14:37:00-04:00,MYL,neutral
879492.0,"Stat News Has Advance Testimony From Mylan CEO Heather Bresch, Will Tell Congress That Company didn't Anticipate Impact On EpiPen Price Increases",2016-09-20 16:43:00-04:00,MYL,neutral
879493.0,"Kaiser Spokesperson Highlights Medicare Spending on Mylan's EpiPen Before Manufacturer Rebates Was Up 1,150% Through '14, Medicare EpiPen Users Up 164% During Same Time Period",2016-09-20 15:08:00-04:00,MYL,neutral
879494.0,USA Today Reporting Mylan CEO Heather Bresch Used Mother's Position With Education Group National Association Of State Boards Of Education To Boost EpiPen Sales Nationwide,2016-09-20 13:06:00-04:00,MYL,positive
879495.0,"Mylan Shares Falling, Hearing West Virginia Accuses Mylan Of Medicaid Fraud Over Epipen",2016-09-20 10:53:00-04:00,MYL,negative
879496.0,Mylan Investors Should Be Asking Where (And Who) Robert Coury Is,2016-09-20 09:11:00-04:00,MYL,neutral
879497.0,Barclays Sees 44-48% Upside In Perrigo Shares; Co. Remains Vulnerable To Activist Investors,2016-09-19 14:03:00-04:00,MYL,positive
879498.0,House Oversight Committee to Hold Sept 21 Hearing Regarding Mylan's Epipen Price Increases; CEO Heather Bresch to be Called as a Witness  -Reuters,2016-09-14 09:37:00-04:00,MYL,neutral
879499.0,House Oversight Panel To Hold EpiPen Hearing Sept. 21st,2016-09-14 09:22:00-04:00,MYL,neutral
879500.0,Shkreli Thinks The Mylan-Epipen Controversy Is 'Not Very Fair',2016-09-13 06:28:00-04:00,MYL,negative
879501.0,Perrigo-Starboard Investment Merits A Closer Look,2016-09-12 12:59:00-04:00,MYL,positive
879502.0,Perrigo Shares Spike After Starboard Takes 4.6% Stake,2016-09-12 09:46:00-04:00,MYL,positive
879503.0,The Market In 5 Minutes: Hillary Clinton Falls Ill With The Global Stock Markets,2016-09-12 08:55:00-04:00,MYL,negative
879504.0,Martin Shkreli on Mylan EpiPen Debate: 'It's a Really Strange Thing for Generic Cos. to Do Price Hikes',2016-09-12 08:24:00-04:00,MYL,negative
879505.0,"Martin Shkreli on Mylan EpiPen Debate: 'Short-Term Windfall for Co., Had a Several Year Stretch,' Highlights Topic as 'Unwelcome Attention' for Co.",2016-09-12 08:23:00-04:00,MYL,negative
879506.0,Can You Guess This Chart?,2016-09-12 07:23:00-04:00,MYL,neutral
879507.0,Teva Says To Meet With FDA On Possible Re-Application For Approval Of Its EpiPen-Like Device,2016-09-09 10:06:00-04:00,MYL,positive
879508.0,"Teva Exec, at Generic Medicines Business Overview, Says Co. Still Hoping to Launch Generic Version of Mylan's Epipen in US by Late '17 or Early '18",2016-09-09 09:59:00-04:00,MYL,positive
879509.0,FTC To Require Mylan To Sell Rights To Two Generics As Condition Of Acquiring Meda,2016-09-08 11:09:00-04:00,MYL,neutral
879510.0,NY Attorney General Says Prelim. Review Identifies Potential Anti-Competitive Terms In Epipen Sales Contracts With Schools,2016-09-06 12:44:00-04:00,MYL,neutral
879511.0,New York Attorney General Launches Antitrust Investigation Into Mylan,2016-09-06 12:40:00-04:00,MYL,neutral
879512.0,Mylan Sells off to Low of $39.95 on Volume,2016-09-06 12:39:00-04:00,MYL,negative
879513.0,Watch These Huge Put Purchases In Tuesday Trade,2016-09-06 02:38:00-04:00,MYL,positive
879514.0,Technical Alert: Mylan Labs Nears $40,2016-09-02 12:32:00-04:00,MYL,positive
879515.0,"Medicaid May Have 'Grossly' Overapid For Epipen According To Lawmakers, Due To Misclassification",2016-09-02 12:11:00-04:00,MYL,neutral
879516.0,Option Alert: MYL Sep16 40.5 Puts: 2000 @  ASK  $0.99: 2193 traded vs 130 OI: $40.78 Ref,2016-09-02 11:05:00-04:00,MYL,positive
879517.0,Mylan Says Dropping Out Of Morgan Stanley Conf. Due To 'Scheduling Conflict',2016-09-02 10:54:00-04:00,MYL,negative
879518.0,CNN Money Says Mylan CEO Denies Rumors That She Is Stepping Down,2016-09-02 10:47:00-04:00,MYL,negative
879519.0,"Hearing Dealreporter Saying Mylan CEO Bresch May Be Stepping Down, Shares Down ~2%",2016-09-02 09:42:00-04:00,MYL,positive
879520.0,Mylan Invalidates Third Teva Copaxone 40 mg/mL Patent Via U.S. Patent and Trademark Office's Inter Partes Review Proceeding,2016-09-01 15:13:00-04:00,MYL,neutral
879521.0,"MannKind Is 'Making Progress' On Its Alternative To Mylan's EpiPen, Report Says",2016-08-30 15:50:00-04:00,MYL,positive
879522.0,"Impax Provides Update on Epinephrine Injection, USP Auto-Injector, CEO Highlights Auto-Injector Low Cost  Treatment For Patient Who Require Epinephrine Products",2016-08-30 08:03:00-04:00,MYL,negative
879523.0,Watch These 5 Huge Put Purchases In Tuesday Trade,2016-08-30 02:30:00-04:00,MYL,positive
879524.0,"U.S. Representatives Jason Chaffetz, Elijah Cummings Of House Committee On Oversight & Govt. Reform Send Letter To Mylan CEO, Request Documents On EpiPen Price Rise",2016-08-29 14:28:00-04:00,MYL,neutral
879525.0,Technical Alert: Another Failed Rally In Mylan Labs,2016-08-29 11:12:00-04:00,MYL,negative
879526.0,Option Alert: MYL Sep16 42.5 Puts Sweep: 500 @  ASK  $1.39: 568 traded vs 3786 OI: $42.62 Ref,2016-08-29 10:39:00-04:00,MYL,positive
879527.0,10 Stocks Moving In Monday's Pre-Market Session,2016-08-29 08:21:00-04:00,MYL,neutral
879528.0,Mylan +2.6% Premarket @$44.17; Co Launched Generic Version of Epipen for 50% Less than Branded Version,2016-08-29 08:09:00-04:00,MYL,positive
879529.0,A Peek Into The Markets: U.S. Stock Futures Edge Lower Ahead Of Consumer Spending Data,2016-08-29 07:44:00-04:00,MYL,negative
879530.0,Mylan Announces $300 Version Of EpiPen,2016-08-29 07:13:00-04:00,MYL,neutral
879531.0,Mylan to Launch Generic to EpiPen® Auto-Injector at a List Price of $300,2016-08-29 06:01:00-04:00,MYL,neutral
879532.0,Pharma Companies Are Spending Millions To Sustain High Drug Prices,2016-08-28 11:20:00-04:00,MYL,neutral
879533.0,What Tidings From the Tetons? Long-Awaited Yellen Speech Today,2016-08-26 14:21:00-04:00,MYL,neutral
879534.0,"Mylan Is Offering An EpiPen Savings Card, But A Lot Of People Will Still Get Screwed",2016-08-26 14:19:00-04:00,MYL,negative
879535.0,Technical Alert: Mylan labs Finds Support In the $42 Handle For the Third Day In A Row,2016-08-26 13:41:00-04:00,MYL,positive
879536.0,Selling Pressure Continues For Mylan,2016-08-26 11:04:00-04:00,MYL,negative
879537.0,"Traders Attributing 6% Jump In Adamis Pharmaceutical To Positive Barron's Piece Out This Morning, Highlights Mylan's EpiPen Fallout As Beneficial For Adamis",2016-08-26 09:57:00-04:00,MYL,positive
879538.0,"Optimize Advisors' Michael Khouw Tweets 'Specialty pharma at $MYL = EpiPen, >1b in revs, less than 5% of ttl revs, but nearly 20% of net operating income.'",2016-08-25 17:17:00-04:00,MYL,positive
879539.0,CNBC's Tirrell Reporting Association Representing PBMS on Mylan Pricing Has Said 'Blaming Payers for Price Hikes is a Red Herring,2016-08-25 14:54:00-04:00,MYL,negative
879540.0,CNBC's Meg Tirrell Reporting on Comments from Association Representing PBMS on Mylan Pricing,2016-08-25 14:53:00-04:00,MYL,neutral
879541.0,Citron Research @CitronResearch McCaskill  If you don't like Mylan marketing Epipen to elderly better if they threw in a free chickenparm like $MNK pic.twitter.com/KxDkwEKA3H,2016-08-25 13:53:00-04:00,MYL,positive
879542.0,Biotechs Are Down 17% Since Clinton First Put Industry On Blast Last September,2016-08-25 13:47:00-04:00,MYL,neutral
879543.0,Mylan 'Took The Sting' Out Of The EpiPen Controversy,2016-08-25 13:37:00-04:00,MYL,neutral
879544.0,Technical Alert: Mylan Labs Surrenders Gains,2016-08-25 13:00:00-04:00,MYL,positive
879545.0,"Greater EpiPen Access, Price Transparency Should Dampen Concern; Goldman Maintains Mylan's Conviction Buy Status",2016-08-25 12:59:00-04:00,MYL,positive
879546.0,18 Biggest Mid-Day Gainers For Thursday,2016-08-25 12:55:00-04:00,MYL,neutral
879547.0,The Hardest Part? Waiting For Yellen's Speech As Slow Market Action Continues,2016-08-25 11:55:00-04:00,MYL,neutral
879548.0,"Barclays Sees Little Impact To Mylan Numbers Following Announced Patient Assistance Programs As Well As Pricing Actions, Maintains Equal-weight And $57 PT",2016-08-25 11:13:00-04:00,MYL,positive
879549.0,"Godlman Sachs Says Greater Epipen Access And Price Transparency Sould Dampen Concern, Maintains $60 PT On Mylan, Maintains Buy And Conviction Buy List Status",2016-08-25 11:03:00-04:00,MYL,positive
879550.0,Meg Tirrell ‏@megtirrell  Tweet: .@RepCummings requests House Oversight Committee hold hearing in Sept on $MYL EpiPen price increases 1 retweet 0 likes Reply   Retweet  1    Like   More,2016-08-25 10:31:00-04:00,MYL,positive
879551.0,Mylan CEO: The Healthcare System Is Broken,2016-08-25 09:25:00-04:00,MYL,negative
879552.0,"Meg Tirrell Tweets: Evercore ISI's Umer Raffat estimates impact of increased $MYL EpiPen patient assistance = ~$100m, or ~10% sales",2016-08-25 09:17:00-04:00,MYL,positive
879553.0,The Market In 5 Minutes: Earnings And EpiPens,2016-08-25 09:07:00-04:00,MYL,neutral
879554.0,Mylan CEO Says Ready to Work With Congress,2016-08-25 08:50:00-04:00,MYL,positive
879555.0,Mylan CEO Says Epipen Cheaper in other Countries Due to Subsidies,2016-08-25 08:47:00-04:00,MYL,neutral
879556.0,"Mylan CEO Says If Epipen Price was Reduced, We Couldn't Ensure Everyone Could Have an Epipen",2016-08-25 08:44:00-04:00,MYL,negative
879557.0,"Mylan CEO on CNBC Says, Patients Are Paying Twice, High Price At Counter And Retail Premium",2016-08-25 08:43:00-04:00,MYL,neutral
879558.0,Mylan CEO On CNBC Says Healthcare System Is Broken,2016-08-25 08:40:00-04:00,MYL,negative
879559.0,"Mylan CEO Heather Bresch, on CNBC's 'Squawk Box,' Says 'This Isn't A Mylan Issue, This Isn't An EpiPen Issue, It's a Healthcare Issue'",2016-08-25 08:39:00-04:00,MYL,neutral
879560.0,Mylan CEO Says Never Intended for Patients to be Paying List Price,2016-08-25 08:38:00-04:00,MYL,neutral
879561.0,Mylan Shares Seeing Activity But Largely Rangebound as CEO Currently Talking with Brian Sullivan on CNBC's 'Squawk Box',2016-08-25 08:37:00-04:00,MYL,positive
879562.0,Mylan CEO on CNBC Discussing Epipen Pricing,2016-08-25 08:35:00-04:00,MYL,neutral
879563.0,18 Stocks Moving In Thursday's Pre-Market Session,2016-08-25 08:26:00-04:00,MYL,neutral
879564.0,Mylan Cuts EpiPen Costs By Up To 50% Via Coupon,2016-08-25 08:07:00-04:00,MYL,negative
879565.0,"UPDATE: Mylan Savings Card To Reduce Out-Of-Pocket Cost Exposure By 50%, Also Doubling Eligibility For Its Patient Assistance Program For Those Uninsured and Under-Insured",2016-08-25 07:02:00-04:00,MYL,neutral
879566.0,Mylan Taking Immediate Action to Further Enhance Access to EpiPen Auto-Injector; Will Reduce Cost Through Saving Card Which Will Cover Up To $300 For 2-Pak,2016-08-25 07:01:00-04:00,MYL,neutral
879567.0,The Active Traders Guide To Hillary Clinton's Rhetoric,2016-08-25 06:52:00-04:00,MYL,positive
879568.0,Mylan's European Marketing Application For Trastuzumab Accepted For Review,2016-08-25 06:32:00-04:00,MYL,positive
879569.0,"Social Sentiment On Mylan Is Nearly Unanimously Negative, And Could Benefit A Competitor",2016-08-24 17:11:00-04:00,MYL,negative
879570.0,A Cheaper Option To The EpiPen,2016-08-24 16:57:00-04:00,MYL,neutral
879571.0,Mylan Invalidates Two of Teva's Copaxone 40 mg/mL Patents Via U.S. Patent and Trademark Office's Inter Partes Review Proceeding,2016-08-24 16:49:00-04:00,MYL,neutral
879572.0,Rough Month: A Closer Look At Ligand's Fall From All-Time Highs,2016-08-24 15:49:00-04:00,MYL,neutral
879573.0,Drug Price Hike Concerns Spill Over Into Other Pharma Stocks,2016-08-24 15:24:00-04:00,MYL,neutral
879574.0,Biotechs Are Getting Crushed After Clinton And The White House Trash EpiPen Price Hike,2016-08-24 14:28:00-04:00,MYL,negative
879575.0,Technical Alert: Mylan Labs Lower Fourth Third Day In A Row,2016-08-24 13:43:00-04:00,MYL,neutral
879576.0,CNBC Now Tweets: NEW: Senators Collins & McCaskill request information and briefing from Mylan on EpiPen pricing within two weeks.,2016-08-24 13:26:00-04:00,MYL,neutral
879577.0,"Hillary Clinton Calls Hike In Epipen Prices By Mylan ""Outrageous""",2016-08-24 13:12:00-04:00,MYL,neutral
879578.0,Hearing American Medical Association Urged Mylan To Cut Epipen Price,2016-08-24 12:55:00-04:00,MYL,negative
879579.0,The Market In 5 Minutes: Stocks Trading Higher As Earnings Season Quiets Down,2016-08-24 09:07:00-04:00,MYL,neutral
879580.0,Have You Heard About This Generic EpiPen Maker?,2016-08-24 09:01:00-04:00,MYL,neutral
879581.0,"Benzinga's M&A Chatter for Tuesday August 23, 2016",2016-08-23 19:19:00-04:00,MYL,neutral
879582.0,"FBN 'Closing Bell' Anchor Liz Claman Tweets 'OUTRAGE: for 1yr now Robyn O'Brien @foodawakenings has been screaming about price hikes of #epipen WAS $57, NOW $700 for 2? 3pET Justified?'",2016-08-23 13:48:00-04:00,MYL,negative
879583.0,Technical Alert: Mylan Labs Declines For Third Day In A Row,2016-08-23 13:25:00-04:00,MYL,positive
879584.0,Hearing Dealreporter Saying Mylan May Be Interested In Re-Engaging Perrigo According To A Sector Advisor,2016-08-23 11:16:00-04:00,MYL,positive
879585.0,Antares Pharma Shares Up 16% as Co. is Supplier to Teva's Generic Version of EpiPen; BZ NOTE: Mylan Shares Have Been Under Pressure Last Two Sessions Following Major Price Increase to EpiPen,2016-08-23 10:30:00-04:00,MYL,positive
879586.0,Mid-Morning Market Update: Markets Open Higher; Best Buy Beats Q2 Expectations,2016-08-23 10:06:00-04:00,MYL,positive
879587.0,Iowa Senator Chuck Grassley Recently Publishes Press Release 'Grassley Seeks Information on EpiPen Cost Increase from Product Manufacturer After Hearing from Iowans',2016-08-22 15:15:00-04:00,MYL,positive
879588.0,Traders Attributing Spike Lower in Mylan to Word Sen. Chuck Grassley is Seeking Information on Co.'s Epi Pen Cost Increase,2016-08-22 15:11:00-04:00,MYL,neutral
879589.0,Mylan Sells Off to Low of $47.93 on Volume,2016-08-22 15:08:00-04:00,MYL,negative
879590.0,22 Stocks Moving In Wednesday's Pre-Market Session,2016-08-10 08:25:00-04:00,MYL,neutral
879591.0,"Mylan Beats EPS Estimates, But Misses Revenues",2016-08-09 17:05:00-04:00,MYL,negative
879592.0,Mylan Reaffirms FY16 Adj. EPS $4.85-$5.15 vs $4.96 Est.,2016-08-09 16:04:00-04:00,MYL,neutral
879593.0,"Mylan Reports Q2 Adj. EPS $1.16 vs $1.14 Est., Sales $2.56B vs $2.57B Est.",2016-08-09 16:02:00-04:00,MYL,neutral
879594.0,"Keep an Eye on These 10 Stocks for August 9, 2016",2016-08-09 05:50:00-04:00,MYL,neutral
879595.0,"Earnings Scheduled For August 9, 2016",2016-08-09 04:04:00-04:00,MYL,neutral
879596.0,Generic Drugs In The Earnings Spotlight: Mylan And Valeant Pharmaceuticals,2016-08-08 14:21:00-04:00,MYL,neutral
879597.0,"Walt Disney, Alibaba On Deck For Earnings Announcements",2016-08-07 09:56:00-04:00,MYL,neutral
879598.0,Generics Keeping The Pressure On Big Pharma,2016-08-03 17:13:00-04:00,MYL,negative
879599.0,Meda Shareholders Accept Mylan Offer,2016-08-02 08:43:00-04:00,MYL,positive
879600.0,Mylan Reports Launch of Generic Dexedrine Capsules,2016-08-01 07:32:00-04:00,MYL,neutral
879601.0,Mylan Receives FTC Clearance for Meda Aktiebolag Acquisition,2016-07-27 17:37:00-04:00,MYL,neutral
879602.0,"Watch Potential Buyers of Generic Assets Following Report FTC Will Require Teva to Divest Generic Drugs: Valeant, Mylan, Akorn, Novartis",2016-07-27 14:35:00-04:00,MYL,positive
879603.0,"Teva, Mylan Said to have Interest in Pfizer's 40% Interest in Brazil JV -Reuters",2016-07-26 09:39:00-04:00,MYL,positive
879604.0,Watch These 7 Huge Call Purchases In Friday Trade,2016-07-22 02:24:00-04:00,MYL,positive
879605.0,Mylan And Biocon Says EMA Accept Its Regulatory Submission Of Biosimilar Pegfilgrastim,2016-07-21 12:31:00-04:00,MYL,positive
879606.0,"Mylan, Biocon Reports Regulatory Submission for Proposed Biosimilar Pegfilgrastim Accepted for Review by European Medicines Agency",2016-07-21 10:00:00-04:00,MYL,positive
879607.0,Option Alert: MYL Sep16 55.0 Calls: 600 @  ASK  $0.41: 1000 traded vs 0 OI:  Earnings 8/9 After Close  $47.62 Ref,2016-07-21 09:48:00-04:00,MYL,positive
879608.0,Mylan Unveils Generic Crestor Tablets,2016-07-20 11:51:00-04:00,MYL,neutral
879609.0,Mylan Reports Launch of Generic Crestor Tablets,2016-07-20 11:05:00-04:00,MYL,neutral
879610.0,Watch These 7 Huge Put Purchases In Wednesday Trade,2016-07-20 01:06:00-04:00,MYL,positive
879611.0,Option Alert: MYL 7/29 45.0 Puts (Wkly) Sweep: 647 @  ASK  $0.98: 647 traded vs 2 OI:  Earnings 8/9 After Close  $44.91 Ref,2016-07-19 13:14:00-04:00,MYL,positive
879612.0,"Pulmatrix, Mylan Report Positive Pharmacokinetic Bioavailability Data in Pilot Study of PUR0200 in Patients with Chronic Obstructive Pulmonary Disease",2016-07-19 08:35:00-04:00,MYL,positive
879613.0,Watch These 7 Huge Put Purchases In Monday Trade,2016-07-18 03:37:00-04:00,MYL,positive
879615.0,Option Alert: MYL Fri 8/12 45.0 Puts (Wkly) Sweep: 827 @  ASK  $1.48: 827 traded vs 3 OI:  Earnings 8/9 After Close  $45.78 Ref,2016-07-15 10:20:00-04:00,MYL,positive
879616.0,Mylan Unveils Generic Temodar Capsules,2016-07-11 09:59:00-04:00,MYL,neutral
879617.0,Mylan Launches Generic Temodar Capsules,2016-07-11 07:30:00-04:00,MYL,neutral
879618.0,Mylan Unveils Generic Fenoglide Tablets,2016-07-06 13:17:00-04:00,MYL,neutral
879619.0,Mylan Launches Generic Fenoglide Tablets,2016-07-06 07:30:00-04:00,MYL,neutral
879620.0,Mylan Unveils Generic Avodart Capsules,2016-06-24 14:41:00-04:00,MYL,neutral
879621.0,Hearing Acorda Therapeutics Has Said US Appeals Court Denied Mylan's Request for Rehearing in Ampyra Case,2016-06-21 07:42:00-04:00,MYL,negative
879622.0,US Court of Appeals for Federal Circuit Denied Request by Mylan for Rehearing of Court's Previous Decision to Uphold Lower Court Ruling that Acorda's ANDA Litigation vs Mylan can Continue in District Court of Delaware,2016-06-21 07:34:00-04:00,MYL,negative
879623.0,"Argus Sees Perrigo Going Lower After CEO Exit, Guidance Cut",2016-06-20 10:07:00-04:00,MYL,negative
879624.0,Mylan Issues Release Highlighting AG Has Rejected VEB's Request Related to Co.'s Holder Approval of Meda Deal,2016-06-20 09:56:00-04:00,MYL,negative
879625.0,Mylan Spikes to High of $46.42 on Vol,2016-06-15 10:06:00-04:00,MYL,neutral
879626.0,Hearing Mylan Spokesperson Has Said Wells Fargo Note Related to Concerns of Steep Price Increases is a 'Flawed Analysis',2016-06-10 11:14:00-04:00,MYL,positive
879627.0,10 Stocks Moving In Friday's Pre-Market Session,2016-06-10 08:20:00-04:00,MYL,neutral
879628.0,Watch These 7 Huge Put Purchases In Friday Trade,2016-06-10 02:45:00-04:00,MYL,positive
879630.0,Option Alert: MYL Fri 6/10 46.0 Puts (Wkly) Sweep: 755 @  ASK  $0.52: 771 traded vs 23 OI: $45.82 Ref,2016-06-09 12:21:00-04:00,MYL,positive
879631.0,Watch These 7 Huge Put Purchases In Thursday Trade,2016-06-09 03:38:00-04:00,MYL,positive
879632.0,Option Alert: MYL Jun16 47.5 Puts Sweep: 1458 @  ASK  $1.50: 1461 traded vs 43 OI: $46.72 Ref,2016-06-08 13:25:00-04:00,MYL,positive
879633.0,"Director Maroon Buys 1,670 Shares of Mylan @$44.95/Share -Form 4",2016-06-06 10:33:00-04:00,MYL,positive
879634.0,Mylan Reports Launch of Generic Cleocin Solution,2016-06-03 10:57:00-04:00,MYL,positive
879635.0,Mylan Unveils Generic Rythmol Sustained-Release Capsules In US,2016-06-02 07:42:00-04:00,MYL,neutral
879636.0,Mylan Launches Generic Vidaza Injection,2016-06-02 07:30:00-04:00,MYL,neutral
879637.0,Mylan Launches Generic Rythmol Sustained-Release Capsules,2016-06-02 07:02:00-04:00,MYL,neutral
879638.0,EU Antitrust Regulators to Decide by July 6 on Mylan's Bid for Meda -Reuters,2016-06-02 05:30:00-04:00,MYL,neutral
879639.0,Watch These 5 Huge Call Purchases In Thursday Trade,2016-06-01 19:05:00-04:00,MYL,positive
879640.0,Mylan Unveils First Generic Of Doxycycline Hyclate Delayed-Release Tablets,2016-06-01 13:46:00-04:00,MYL,neutral
879641.0,"FBR Midday Desk Comments Note Biotech Flows Are Beginning To Wane Following ASCO Over Weekend, Says Data Being Met With Aggressive Short Covering",2016-06-01 12:43:00-04:00,MYL,negative
879642.0,"Mylan Launches First Generic of Doxycycline Hyclate Delayed-Release Tablets, U.S. Had Sales Of $21.8M  For 12 Mo. Ending Mar. 31st, 2016 According To IMS Health",2016-06-01 11:44:00-04:00,MYL,neutral
879643.0,Option Alert: MYL Jul16 47.5 Calls: 500 @  Above Ask!  $0.92: 527 traded vs 6249 OI: $44.43 Ref,2016-06-01 10:33:00-04:00,MYL,positive
879644.0,Mylan Reports Launch of First Generic Nuvigil Tablets,2016-06-01 10:16:00-04:00,MYL,neutral
879645.0,"Mylan Launches First Generic Doryx® Delayed-Release Tablets, 200 mg",2016-05-23 07:30:00-04:00,MYL,neutral
879646.0,M&A Potential With This Healthcare ETF,2016-05-19 15:57:00-04:00,MYL,neutral
879647.0,"Benzinga's M&A Chatter for Monday May 16, 2016",2016-05-16 20:09:00-04:00,MYL,neutral
879648.0,Mylan Shares Still Not Getting Enough Respect; UBS Likes News Of Expansion Into Tropicals,2016-05-16 16:45:00-04:00,MYL,positive
879649.0,"13F from Einhorn's Greenlight Shows Liquidated Stake in Mylan, Tri Point, Match Group, ON Semiconductor, Owens Illinois, Chicago Bridge & Iron",2016-05-16 16:17:00-04:00,MYL,neutral
879650.0,"Director Higgins Buys 19,900 Shares of Mylan @$38.68/Share -Form 4",2016-05-16 10:07:00-04:00,MYL,positive
879651.0,"David Tepper's Q1 Moves: Apple, Valeant And Much More",2016-05-13 16:56:00-04:00,MYL,neutral
879652.0,Tepper's Appaloosa Closes ~850K Mylan Pharma Position,2016-05-13 16:15:00-04:00,MYL,neutral
879653.0,"Teva, Mylan, Novartis Shares Largely Unaffected Following Bloomberg Report Teva's European Unit Has Drawn Interest from Mylan, Novartis",2016-05-13 11:03:00-04:00,MYL,positive
879654.0,Mylan To Buy Renaissance Acquisition Holdings' Generic And Specialty Business For $950 Million,2016-05-13 10:46:00-04:00,MYL,neutral
879655.0,The Market In 5 Minutes: Friday The 13th,2016-05-13 09:42:00-04:00,MYL,neutral
879656.0,Goldman Removes Mylan From Its Conviction List,2016-05-13 09:17:00-04:00,MYL,neutral
879657.0,"Mylan To Acquire Renaissance Acquisition Holdings For $950M, Plus Additional Payments Of Up To $50M On Closing",2016-05-13 09:03:00-04:00,MYL,neutral
879658.0,"Goldman Sachs Removes Mylan From Conviction Buy List & Maintains Buy Rating With $60 PT, Adds Allergan To Conviction Buy List & Maintains Buy Ratings With $275 PT",2016-05-13 06:32:00-04:00,MYL,neutral
879659.0,Option Alert: MYL May16 39.0 Calls Sweep: 500 @  ASK  $0.86: 1261 traded vs 81 OI: $38.49 Ref,2016-05-12 13:32:00-04:00,MYL,positive
879660.0,Option Alert: MYL May16 39.0 Calls Sweep: 500 @  ASK  $0.91: 662 traded vs 81 OI: $38.67 Ref,2016-05-12 13:26:00-04:00,MYL,positive
879661.0,"Seeing Action In Mylan October 2016 $40 Calls, Shares Spike A Bit On Volume",2016-05-12 11:03:00-04:00,MYL,positive
879662.0,Mylan Names Kenneth Parks As CFO,2016-05-03 09:06:00-04:00,MYL,neutral
879663.0,12 Stocks Moving In Tuesday's Pre-Market Session,2016-05-03 08:25:00-04:00,MYL,neutral
879664.0,Mylan Names Kenneth Parks CFO,2016-05-03 07:30:00-04:00,MYL,neutral
879665.0,Mylan Reports Q1 EPS $0.76 vs $0.74 Est; Revenue $2.191B vs $2.23B Est,2016-05-03 04:56:00-04:00,MYL,neutral
879666.0,"Earnings Scheduled For May 3, 2016",2016-05-03 04:02:00-04:00,MYL,neutral
879667.0,"Director Higgins Buys 35,000 Shares of Mylan @$42.92/Share -Form 4",2016-04-29 14:33:00-04:00,MYL,positive
879668.0,Nothing Generic About This ETF's Long-Term Outlook,2016-04-28 08:14:00-04:00,MYL,neutral
879669.0,David Faber Reports Mylan Not Interested in Perrigo,2016-04-27 09:39:00-04:00,MYL,negative
879670.0,"Goldman Selling Perrigo, Prefers Mylan And Teva",2016-04-26 07:38:00-04:00,MYL,neutral
879671.0,"Monday's After-Hours Recap: Index Movers, Alcoa's Earnings & More",2016-04-11 17:22:00-04:00,MYL,neutral
879672.0,Mylan Announces Intermediate Dosage of Generic Lopressor,2016-04-11 07:02:00-04:00,MYL,neutral
879673.0,Mylan Is 'Comfortable Moving Forward' With Acquisition Of Sweden-Based Meda,2016-04-06 13:23:00-04:00,MYL,positive
879674.0,Mylan Rolls Out Generic Version Of Epivir Tablets,2016-04-06 13:10:00-04:00,MYL,neutral
879675.0,"Dir Maroon Buys 4,337 Shares of Mylan @$46.36/Share",2016-04-04 17:34:00-04:00,MYL,positive
879676.0,Mylan Launches Generic Ultram Extended-Release Tablets,2016-03-28 13:31:00-04:00,MYL,neutral
879677.0,Acorda Therapeutics Announces Federal Court Upheld Ruling Against Mylan that NDA Can Continue,2016-03-21 07:31:00-04:00,MYL,neutral
879678.0,Dutch and European Investors Associations Tell Mylan They Fell Short of Soliciting Support from Mylan Shareholders for VEB's Actions in Respect to Mylan's Proposed Acquisition of Meda,2016-03-11 10:04:00-05:00,MYL,positive
879679.0,"The Stocks That Moved The S&P, Dow And Nasdaq Today",2016-03-09 16:30:00-05:00,MYL,neutral
879680.0,Mylan Sees FY16 EPS $4.85-$5.15 vs. Est. $5.36,2016-03-09 09:05:00-05:00,MYL,neutral
879681.0,ICYMI: Everything Barron's Covered This Weekend,2016-03-07 15:57:00-05:00,MYL,neutral
879682.0,BTIG Recommends 'Beaten Down' Drug Manufacturers Like Teva,2016-03-07 10:31:00-05:00,MYL,positive
879683.0,Should Investors Root For Trump Or Clinton? Go With The 'Devil You Know',2016-03-07 07:00:00-05:00,MYL,negative
879684.0,"Barron's Picks & Pans: Martin Marietta Materials, Deutsche Bank, Mylan And More",2016-03-07 06:55:00-05:00,MYL,neutral
879685.0,"Director Cindrich Buys 2,187 Shares of Mylan @$45.83/Share -Form 4",2016-03-03 13:48:00-05:00,MYL,positive
879686.0,Teva Says Its Generic EpiPen Will Be 'Significantly Delayed',2016-03-01 13:53:00-05:00,MYL,negative
879687.0,Mylan Board Responds to Letter from Dutch and European Investors' Associations -8-K,2016-03-01 12:13:00-05:00,MYL,neutral
879688.0,Mylan Shares Rise 2% Premarket to $45.99; Report Teva's Generic EpiPen Facing More Delays,2016-03-01 07:32:00-05:00,MYL,positive
879689.0,"The Stocks That Moved The S&P, Dow And Nasdaq Today",2016-02-29 16:36:00-05:00,MYL,neutral
879690.0,Highlights Of Greenlight Capital's Q4 Conference Call,2016-02-23 15:43:00-05:00,MYL,neutral
879691.0,UPDATE: FTC's Modified Final Order Shows Mylan Must Submit Annual Compliance Reports for Three Years Instead of Ten Years,2016-02-22 12:08:00-05:00,MYL,neutral
879692.0,Hearing FTC Has Approved Modified Final Order Which Settled Charges Related to Mylan's Proposed Hostile Bid for Perrigo Would Hurt Competition,2016-02-22 12:07:00-05:00,MYL,negative
879693.0,Mylan Names Anthony Mauro Chief Commercial Officer,2016-02-22 08:04:00-05:00,MYL,neutral
879694.0,Wells Fargo Initiates Coverage on Mylan at Market Perform,2016-02-19 08:40:00-05:00,MYL,positive
879695.0,"Argus Research Maintains Buy on Mylan, Lowers PT to $55.00",2016-02-19 07:10:00-05:00,MYL,negative
879696.0,13F from Einhorn's Greenlight Shows New Stake in Mylan,2016-02-16 17:10:00-05:00,MYL,neutral
879697.0,Meeting With Mylan Management Shows This Is The Stock's Biggest Problem,2016-02-16 09:25:00-05:00,MYL,negative
879698.0,"Vetr Top Raters Pound Table On Mylan, 87% Bullish",2016-02-12 12:03:00-05:00,MYL,positive
879699.0,12 Stocks Moving In Thursday's Pre-Market Session,2016-02-11 08:24:00-05:00,MYL,neutral
879700.0,"Benzinga's M&A Chatter for Wednesday February 10, 2016",2016-02-10 21:59:00-05:00,MYL,neutral
879701.0,"Mylan Sees FY16 Sales With or Without Meda $10.5B-$11.5B vs $10.7B Est., Adj. EPS $4.85-$5.15 vs $4.97 Est.",2016-02-10 16:13:00-05:00,MYL,neutral
879702.0,"Mylan Reports Q4 Adj. EPS $1.22 vs $1.27 Est., Sales $2.491B vs $2.7B Est.",2016-02-10 16:12:00-05:00,MYL,neutral
879703.0,Mylan To Acquire Meda For $9.9B,2016-02-10 16:02:00-05:00,MYL,neutral
879704.0,FT Reports Mylan to Acquire Sweden's Meda,2016-02-10 15:48:00-05:00,MYL,neutral
879705.0,Option Alert: MYL Apr16 42.5 Puts: 500 @  ASK  $1.05: 5000 traded vs 1071 OI:  Earnings today After Close  $50.54 Ref,2016-02-10 11:41:00-05:00,MYL,positive
879706.0,"Earnings Scheduled For February 10, 2016",2016-02-10 04:09:00-05:00,MYL,neutral
879707.0,Mylan And Teva Earnings Are Coming: Here's What To Expect,2016-02-08 15:35:00-05:00,MYL,neutral
879708.0,Hearing Unconfirmed Market Chatter of Big Pharma Bid for Mylan; Hearing $83.50/Share,2016-02-02 10:44:00-05:00,MYL,negative
879709.0,Option Alert: MYL Fri 2/12 51.0 Calls (Wkly) Sweep: 1903 @  ASK  $2.29: 2696 traded vs 24 OI:  Earnings 2/10 After Close  $51.14 Ref,2016-01-28 11:09:00-05:00,MYL,positive
879710.0,Option Alert: MYL Fri 1/29 53.0 Puts (Wkly) Sweep: 2671 @  ASK  $1.10: 2990 traded vs 1 OI:  Earnings 2/10 After Close  $52.77 Ref,2016-01-25 15:24:00-05:00,MYL,positive
879711.0,David Einhorn's New Long Position In Mylan,2016-01-19 14:33:00-05:00,MYL,neutral
879712.0,A Look Into David Einhorn's Q4 Letter To Greenlight Investors,2016-01-19 13:11:00-05:00,MYL,neutral
879713.0,"UPDATE: Greenlight Sees Mylan Earning $7/Share in '18, 'driven by a robust pipeline of respiratory, injectable, biologic drugs and by further capital deployment including share repurchases.'",2016-01-19 11:09:00-05:00,MYL,positive
879714.0,UPDATE: Greenlight's Position in Mylan Initiated at Average Price of $45.32/Share,2016-01-19 11:08:00-05:00,MYL,neutral
879715.0,UPDATE: Greenlight Says Initiated Position in Mylan,2016-01-19 11:00:00-05:00,MYL,neutral
879716.0,"UPDATE: Greenlight Initiated New Positions In MYL, M; Entered AMAT; Sold BK For 'small profit'",2016-01-19 10:56:00-05:00,MYL,positive
879717.0,Mylan Shares Spike ~$0.71 Over Last Few Mins as Hearing Bloomberg Saying David Einhorn's Greenlight Has Stake,2016-01-19 10:36:00-05:00,MYL,positive
879718.0,"Mylan Launches Generic Felbatol Tablets, According To IMS Health, U.S. Sales For Felbatol Were $53M In FY15",2016-01-19 10:28:00-05:00,MYL,neutral
879719.0,New ETF Is A Refined Pharmaceuticals Play,2016-01-14 10:00:00-05:00,MYL,positive
879720.0,Mylan Confirms FDA Submission of ANDA for Generic Advair Diskus,2016-01-11 17:12:00-05:00,MYL,neutral
879721.0,Mylan Reports CFO John Sheehan to Retire; Co. Has Initiated Search for Repalcement,2016-01-08 09:01:00-05:00,MYL,neutral
879722.0,"Mylan, Momenta Pharma Report Global Collab for Joint Development, Commercialization of Six Biosimilar Products",2016-01-08 08:10:00-05:00,MYL,neutral
879723.0,Mylan Launches Generic HarvoniUnder the Brand Name MyHep LVIR in India,2016-01-07 08:01:00-05:00,MYL,neutral
879724.0,Mylan Reports Launch of Generic Ortho Tri-Cyclen Lo Tablets,2016-01-05 10:36:00-05:00,MYL,neutral
879725.0,Option Alert: MYL Jan16 55.0 Calls: 700 @  Above Ask!  $0.69: 2177 traded vs 18k OI: $53.21 Ref,2016-01-04 10:09:00-05:00,MYL,positive
879726.0,Shares Of Mylan Slightly Higher Following Launch Of Generic Drug,2015-12-29 08:56:00-05:00,MYL,positive
879727.0,Mylan Launches Generic Zyvox Tablets For Treatment Of Certain Infections Caused By Susceptible Gram-Positive Bacteria,2015-12-29 07:01:00-05:00,MYL,positive
879728.0,Goldman Sachs Upgrades Mylan to Conviction Buy,2015-12-17 08:42:00-05:00,MYL,neutral
879729.0,"Argus Upgrades Perrigo, Stock Is At A Favorable Entry Point",2015-12-10 08:07:00-05:00,MYL,positive
879730.0,"8-K Filing: Mylan Says They Have Received Subpoena From DOJ Antitrust Division Regarding Marketing, Pricing Of Doxycycline Products, Company Intends To Cooperate With DOJ Inquiry",2015-12-04 08:15:00-05:00,MYL,neutral
879731.0,"Morgan Stanley Assumes Mylan at Equal-weight, Announces $56.00 PT",2015-12-03 09:21:00-05:00,MYL,neutral
879732.0,"Mylan Reports Plans to be the First to Market Newly-Recommended Antiretroviral Treatment for $99 Per Patient, Per Year",2015-12-01 12:19:00-05:00,MYL,neutral
879733.0,"EXCLUSIVE: FBB's Mike Bailey On Pfizer-Allergan Deal, Taxes, Rate Hike And Biotech Picks",2015-11-25 09:53:00-05:00,MYL,positive
879734.0,"FBB Capital's Bailey Believes Next Mega-Cap Deal in Pharma Could Be 'Awhile,' Sees Mylan, Perrigo as Next Takeover Targets",2015-11-24 13:46:00-05:00,MYL,neutral
879735.0,Mylan Launches Generic FazaClo Orally Disintegrating Tablets,2015-11-24 07:32:00-05:00,MYL,neutral
879736.0,Benzinga's Top #PreMarket Gainers,2015-11-23 08:10:00-05:00,MYL,positive
879737.0,Mylan Confirms First-to-File Patent Challenge Relating to DELZICOL,2015-11-19 15:27:00-05:00,MYL,positive
879738.0,Mylan Launches Generic Adderall Tablets,2015-11-19 13:51:00-05:00,MYL,neutral
879739.0,"Time To Buy Mylan's Clear Path To EPS Upside, JP Morgan Says",2015-11-18 10:22:00-05:00,MYL,positive
879740.0,Mid-Afternoon Market Update: Dow Surges More Than 200 Points; Dillard's Shares Dip On Earnings Miss,2015-11-16 15:12:00-05:00,MYL,positive
879741.0,Mylan Announces $1B buyback Plan,2015-11-16 11:41:00-05:00,MYL,neutral
879742.0,Benzinga's Weekend M&A Chatter,2015-11-15 20:01:00-05:00,MYL,neutral
879743.0,"Worst Performing Industries For November 13, 2015",2015-11-13 12:28:00-05:00,MYL,negative
879744.0,Mid-Day Market Update: Planet Fitness Surges On Upbeat Results; Fossil Group Shares Slide,2015-11-13 12:26:00-05:00,MYL,positive
879745.0,Benzinga's Volume Movers,2015-11-13 10:23:00-05:00,MYL,neutral
879746.0,Mid-Morning Market Update: Markets Open Lower; J C Penney Revenue Tops Views,2015-11-13 10:04:00-05:00,MYL,positive
879747.0,Morning Market Losers,2015-11-13 09:51:00-05:00,MYL,negative
879748.0,Morning Market Gainers,2015-11-13 09:42:00-05:00,MYL,neutral
879749.0,"Perrigo Shareholders Convincingly Reject Mylan's Tender Offer, Expressing Confidence in Perrigo's Long-Term Strategy",2015-11-13 09:23:00-05:00,MYL,positive
879750.0,Mylan To Lose Hostile Takeover Of Perrigo,2015-11-13 09:03:00-05:00,MYL,negative
879751.0,Mylan Announces Results of Offer to Acquire Perrigo and Lapse of Offer,2015-11-13 08:40:00-05:00,MYL,neutral
879752.0,Benzinga's Top #PreMarket Losers,2015-11-13 08:20:00-05:00,MYL,negative
879753.0,Benzinga's Top #PreMarket Gainers,2015-11-13 08:14:00-05:00,MYL,positive
879754.0,Perrigo -6.8% Premarket Following Report of Expected Failed Tender Offer by Mylan,2015-11-13 06:33:00-05:00,MYL,negative
879755.0,"Only 40% of Perrigo's Shares Said to have been Tendered Ahead of Mylan Deadline; Takeover Bid Unlikely to Succeed, According to Sources -Reuters",2015-11-13 04:26:00-05:00,MYL,positive
879756.0,"Perrigo Sends Letter to Holders, Discusses Mylan Deal; Says 'Corporate Governance, Mylan Style: A Question Of Trust",2015-11-09 07:05:00-05:00,MYL,positive
879757.0,"Mylan Shares Falling, Down 2% On The Morning",2015-11-05 10:12:00-05:00,MYL,positive
879758.0,Mylan Reports Received FTC Clearance for Proposed Deal with Perrigo,2015-11-03 15:19:00-05:00,MYL,neutral
879760.0,Hearing FTC to Require Mylan to Sell Rights to Seven Generic Pharmas Related to Perrigo Deal,2015-11-03 14:02:00-05:00,MYL,neutral
879761.0,Mylan Shares to Begin Trading on Tel Aviv Stock Exchange on November 4 -Reuters,2015-11-02 04:59:00-05:00,MYL,positive
879762.0,Perrigo Continues to Oppose Mylan's Inadequate Offer,2015-10-30 15:39:00-04:00,MYL,negative
879763.0,Mylan Says Remains Steadfastly Committed to Offer for Perrigo,2015-10-30 07:05:00-04:00,MYL,positive
879764.0,Mylan Sees FY15 Outlook at the High End of $4.15-$4.35 vs $4.23 Est.,2015-10-30 07:02:00-04:00,MYL,neutral
879765.0,"Mylan Reports Q3 Adj EPS $1.43 vs $1.38 Est., Sales $2.71B vs $2.79B Est.",2015-10-30 07:00:00-04:00,MYL,neutral
879766.0,Mylan Reports NY District Court Denied Motion by Perrigo for Prelim. Injunction Related to Deal,2015-10-30 06:45:00-04:00,MYL,negative
879767.0,"Earnings Scheduled For October 30, 2015",2015-10-30 05:03:00-04:00,MYL,neutral
879768.0,Mylan Confirms Availability of EpiPen Auto-Injector for U.S. Patients Affected by Sanofi's Auvi-Q Recall,2015-10-29 13:24:00-04:00,MYL,negative
879769.0,UPDATE: Tel Aviv District Court Rules in Favor of Mylan Listing on Tel Aviv Stock Exchange,2015-10-28 15:15:00-04:00,MYL,positive
879770.0,Mylan Reports Tel Aviv District Court Has Ruled in Favor of Co. Listing on Tel Aviv Exchange,2015-10-28 15:14:00-04:00,MYL,positive
879771.0,Perrigo CEO Tells Shareholders Not to Vote in Favor of Mylan Bid -Reuters,2015-10-27 09:52:00-04:00,MYL,positive
879772.0,Mylan Launches Generic Fusilev for Injection,2015-10-27 08:32:00-04:00,MYL,neutral
879773.0,Top 4 NASDAQ Stocks In The Drugs-Generic Industry With The Lowest PEG Ratio,2015-10-27 04:23:00-04:00,MYL,negative
879774.0,11 Large-Caps Trading At Bargain Bin Prices,2015-10-22 13:39:00-04:00,MYL,positive
879776.0,Perrigo Urges Federal Judge in Manhattan to Stop Mylan from Pursuing Bid Until it Corrects Misleading Statements Made to Perrigo Shareholders -Reuters,2015-10-21 14:01:00-04:00,MYL,negative
879777.0,"Mylan, Teva, Juno Shares Falling",2015-10-19 12:24:00-04:00,MYL,positive
879779.0,Mylan Highlights Clear Value Creation to Perrigo Shareholders Available Through its Offer,2015-10-13 16:19:00-04:00,MYL,positive
879780.0,Irish Takeover Panel Rejects Perrigo's Request to Declare Mylan's Unsolicited Tender Offer to have Lapsed -Reuters,2015-10-13 06:30:00-04:00,MYL,negative
879781.0,14 Healthcare Stocks Fundstrat Is Buying,2015-10-05 11:39:00-04:00,MYL,neutral
879782.0,"Mylan Shares Moving Lower, Currently $42.94",2015-10-05 11:20:00-04:00,MYL,neutral
879783.0,U.S. District Court Rules in Favor of Cumberland Pharmaceuticals in Lawsuit vs Mylan for Infringement of Co's 445 Acetadote Patent -8-K,2015-10-05 06:20:00-04:00,MYL,negative
879784.0,Spokesperson from York Capital Declines Comment Following Reuters Report Tues. Suggesting Large Shareholder(s) in Co. Urging Mgmt to Explore Sale,2015-09-30 09:38:00-04:00,MYL,neutral
879785.0,"Spokesperson from Wellington Management Group, a Large Holder in Perrigo, Declines Comment on Speculation Related to Rumor of Investor Interest in Mgmt Pursuing Sale",2015-09-29 12:38:00-04:00,MYL,positive
879786.0,Hearing Perrigo Holder is Calling for Co. to Explore Sale,2015-09-29 12:22:00-04:00,MYL,neutral
879787.0,Mylan Reports Launch of Generic Invega Tablets,2015-09-28 07:31:00-04:00,MYL,neutral
879788.0,Benzinga's Weekend M&A Chatter,2015-09-27 18:53:00-04:00,MYL,neutral
879789.0,"Perrigo Commenced Litigation Against Mylan, Israeli Securities Authority Seeking Declaratory, Injunctive Relief, Says Mylan Failed to Publish Lawful Tender Offer in Israel On September 14, 2015",2015-09-25 14:55:00-04:00,MYL,positive
879790.0,UPDATE: Mylan Says Suit 'Entirely Without Merit...Mylan's Offer in Israel is Valid and Proper in All Respects',2015-09-24 15:22:00-04:00,MYL,positive
879791.0,Mylan Offers Comment on 'Meritless' Perrigo Suit,2015-09-24 15:21:00-04:00,MYL,neutral
879792.0,Should Biotech Investors Take Hillary Clinton's Drug Pricing Plan Seriously?,2015-09-23 07:56:00-04:00,MYL,negative
879793.0,"Barclays Initiates Coverage on Mylan at Equal-weight, Announces $57.00 PT",2015-09-21 04:06:00-04:00,MYL,neutral
879794.0,Mylan Launches One of First Generic Lescol XL Tablets,2015-09-18 07:30:00-04:00,MYL,neutral
879795.0,"Benzinga's M&A Chatter for Thursday September 17, 2015",2015-09-17 19:11:00-04:00,MYL,neutral
879796.0,Perrigo Maints FY 2015 Guidance EPS $7.50 to $8,2015-09-17 06:18:00-04:00,MYL,neutral
879797.0,Perrigo Issues Statment On Mylan,2015-09-17 06:16:00-04:00,MYL,neutral
879798.0,Mylan-Perrigo Buyout Offer: What's Next?,2015-09-14 11:51:00-04:00,MYL,neutral
879799.0,Perrigo Announcement Regarding Unsolicited Offer From Mylan N.V.,2015-09-14 09:44:00-04:00,MYL,neutral
879800.0,Mylan Begins Offer To Acquire Perrigo For $75/Share Cash & 2.3 Mylan Ordinary Shares For Each Perrigo Share,2015-09-14 08:31:00-04:00,MYL,positive
879801.0,"Theravance Biopharma, Mylan Report Initiation of Phase 3 Program for Revefenacin for the Treatment of COPD",2015-09-14 08:06:00-04:00,MYL,neutral
879802.0,Mylan Reports Launch of Generic Version of Unasyn for Injection,2015-09-14 07:30:00-04:00,MYL,neutral
879803.0,"UPDATE: Perrigo's Chair, Pres, CEO Papa Clarifies Numerous Misleading Statements, Reiterates Co.'s Confidence Holders Will Not Tender Mylan's Bid",2015-09-10 07:57:00-04:00,MYL,positive
879804.0,Perrigo Response To Mylan Executive Chairman Letter,2015-09-10 07:56:00-04:00,MYL,neutral
879805.0,Perrigo Issues Response to 'Misleading Letter' from Mylan's Chair Coury,2015-09-10 07:56:00-04:00,MYL,negative
879806.0,"Benzinga's M&A Chatter for Tuesday September 8, 2015",2015-09-08 21:02:00-04:00,MYL,neutral
879807.0,Mylan Launch Offer FOr Perrigo Directly To Perrigo Shareholders on Sept. 14,2015-09-08 08:48:00-04:00,MYL,neutral
879808.0,Mylan Confirms the U.S. Patent and Trademark Office Institutes Inter Partes Review Proceeding against Third Copaxone 40 mg/mL Dosing Patent on All Claims,2015-09-02 08:04:00-04:00,MYL,neutral
879809.0,Benzinga's Weekend M&A Chatter,2015-08-30 20:30:00-04:00,MYL,neutral
879810.0,Perrigo Confident Its Shareholders Will Reject Mylan's Value Destructive Transaction,2015-08-28 08:05:00-04:00,MYL,negative
879811.0,Mylan Reports Holders Have 'Overwhelmingly' Approved Deal with Perrigo,2015-08-28 07:26:00-04:00,MYL,positive
879812.0,"Standpoint Research Initiates Coverage on Mylan at Buy, Announces $70.00 PT",2015-08-26 10:05:00-04:00,MYL,neutral
879813.0,Mylan Confirms USPTO Institutes Inter Partes Review Proceedings vs Two Copaxone 40 mg/mL Dosing Patents,2015-08-25 15:05:00-04:00,MYL,neutral
879814.0,Mylan Launches Generic Zosyn Injection,2015-08-25 14:14:00-04:00,MYL,neutral
879815.0,Irish Takeover Panel Says Perrigo's August 13 Statement 'Mylan Already Proposed a Dilutive Deal That Substantially Undervalues Perrigo' Violated Rule -Reuters,2015-08-25 11:11:00-04:00,MYL,negative
879816.0,"6-K from Teva Pharma Shows Co. Will Refrain from Attending, Voting at Mylan Special General Meeting on Aug. 28; Says 'Wishes to Remain Neutral' Given Withdrawal of Mylan Offer",2015-08-25 11:11:00-04:00,MYL,positive
879817.0,Mylan Offers Clarification on Inaccuracies by Third Parties Related to Lowered Acceptance Condition for Purchase of Perrigo: Remains Fully Confident PRGO Holders Will See Value in Combo,2015-08-21 15:21:00-04:00,MYL,positive
879818.0,The Coming Drug-Patent Cliff Is Pushing This Portfolio Up,2015-08-20 14:48:00-04:00,MYL,neutral
879819.0,Is Mylan's FDA Warning Letter Worth Worrying About?,2015-08-18 14:33:00-04:00,MYL,negative
879820.0,UPDATE: Raffat Warns 'FDA may withhold approval of new applications/supplements from products made in...' Mylan Facilities Named in FDA Letter,2015-08-18 12:47:00-04:00,MYL,positive
879821.0,"UPDATE: Raffat Notes FDA Warning Letter to Mylan Does Not Include Discussion of 'declining product entry into US' from Co.'s Three Named Facilities, Suggests Co. Will Not Lose Out on Existing Sales",2015-08-18 12:46:00-04:00,MYL,neutral
879822.0,Evercore ISI's Raffat Comments Following FDA's Warning Letter to Mylan: Believes 'most of the FDA observations should be addressable',2015-08-18 12:44:00-04:00,MYL,negative
879823.0,Mylan Statement Regarding Certain Agila Facilities FDA Warning Letter,2015-08-18 11:31:00-04:00,MYL,negative
879824.0,Option Alert: Mylan Aug $56 Call; 4022 Contracts Traded vs 7926 OI; Now $55.98,2015-08-18 10:08:00-04:00,MYL,positive
879825.0,Hearing Unconfirmed Market Chatter of Potential Icahn Involvement in Mylan,2015-08-18 10:04:00-04:00,MYL,negative
879826.0,Mylan Confirms First-To-File Patent Challenge Regarding Zytiga,2015-08-18 07:32:00-04:00,MYL,positive
879827.0,Mylan: Paulson 13F Shows Increased Stake To 21.913M Shares From 14.948M Shares,2015-08-14 16:21:00-04:00,MYL,positive
879828.0,Appaloosa Management 13F Initiates 989K Mylan Stake,2015-08-14 16:12:00-04:00,MYL,neutral
879829.0,Paulson & Co. Votes in Support of Mylan's Proposed Merger with Perrigo,2015-08-14 13:32:00-04:00,MYL,positive
879830.0,Perrigo +1% Following DJ Report on Paulson Stake,2015-08-14 11:57:00-04:00,MYL,neutral
879831.0,"Hedge Fund Paulson Buying Perrigo Shares, According to Sources -DJ",2015-08-14 11:50:00-04:00,MYL,positive
879832.0,ISS Affirms Perrigo's Position That Proposed Mylan Transaction Would Be Value Destructive,2015-08-14 11:08:00-04:00,MYL,negative
879833.0,"Mylan Responds to ISS Recommendation Regarding Perrigo Transaction, Confident Acquiring Perrigo Is Right Next Strategic Step",2015-08-14 09:21:00-04:00,MYL,positive
879834.0,"Benzinga's M&A Chatter for Thursday August 13, 2015",2015-08-13 19:01:00-04:00,MYL,neutral
879835.0,"UPDATE: Perrigo Says Tender Reduction 'Would further dilute an already dilutive transaction,' 'Would have significant negative impacts on ongoing operations'",2015-08-13 13:43:00-04:00,MYL,negative
879836.0,Perrigo Issues Comments on Mylan's 'Reckless' Lowering of Tender Threshold,2015-08-13 13:42:00-04:00,MYL,negative
879837.0,"Top Performing Industries For August 13, 2015",2015-08-13 10:46:00-04:00,MYL,positive
879838.0,Mylan Lowers Acceptace Condition On Perigo From Not Less Than 80% To Greater Than 50%,2015-08-13 07:08:00-04:00,MYL,positive
879839.0,Mylan Lowers Acceptance Condition on Perrigo Offer to Greater than 50%,2015-08-13 07:03:00-04:00,MYL,positive
879840.0,Egan-Jones Sides With Glass Lewis In Recommending Mylan Shareholder To Vote For Perrigo Transaction Proposal,2015-08-12 14:11:00-04:00,MYL,neutral
879841.0,Mylan Announces Glass Lewis Has Recommended Co. Holders Vote for Perrigo Deal,2015-08-12 09:06:00-04:00,MYL,positive
879842.0,Mylan Reports Launch of Generic Version of Lidoderm Patch,2015-08-10 07:31:00-04:00,MYL,neutral
879843.0,Mylan CEO Says Does Not Have to Have Perrigo; Looking at Other Targets,2015-08-06 10:36:00-04:00,MYL,neutral
879844.0,"Mylan Reports Q2 EPS $0.91 vs Est $0.89, Sales $2.372B Vs Est $2.39B",2015-08-06 07:04:00-04:00,MYL,neutral
879845.0,"Earnings Scheduled For August 6, 2015",2015-08-06 04:15:00-04:00,MYL,neutral
879846.0,"Benzinga's M&A Chatter for Wednesday July 29, 2015",2015-07-29 20:06:00-04:00,MYL,neutral
879847.0,Hearing Deal Report Says Mylan is Tax Inversion Target for Pfizer,2015-07-29 10:18:00-04:00,MYL,neutral
879848.0,"RBC Says Stay Away From Mylan, Perrigo; Go Long Teva, Allergan",2015-07-29 08:54:00-04:00,MYL,neutral
879849.0,Mylan Receives Unconditional Clearance from EC on Acquisition of Perrigo,2015-07-29 07:10:00-04:00,MYL,neutral
879850.0,ETFs For The Next Pharma Takeover Candidates,2015-07-28 13:08:00-04:00,MYL,neutral
879852.0,"Benzinga's M&A Chatter for Monday July 27, 2015",2015-07-27 18:39:00-04:00,MYL,neutral
879853.0,Market Update: Monday's Top 10 Volume Movers,2015-07-27 13:43:00-04:00,MYL,positive
879854.0,"Market Update: Monday's Mid-Day Movers, China's Stock Market Crash And More",2015-07-27 12:36:00-04:00,MYL,negative
879855.0,"Teva Buys Allergan Unit: How Mylan, Other Biotech Stocks Are Reacting",2015-07-27 12:08:00-04:00,MYL,neutral
879856.0,Benzinga's Volume Movers,2015-07-27 10:23:00-04:00,MYL,neutral
879857.0,Morning Market Losers,2015-07-27 09:50:00-04:00,MYL,negative
879858.0,Morning Market Gainers,2015-07-27 09:39:00-04:00,MYL,neutral
879860.0,Teva Says Allergan Deal to have Fewer Antitrust Issues than Mylan Deal Would Have -Reuters,2015-07-27 08:36:00-04:00,MYL,neutral
879861.0,Benzinga's Top #PreMarket Losers,2015-07-27 08:22:00-04:00,MYL,negative
879862.0,Cowen & Company Downgrades Mylan to Market Perform,2015-07-27 07:15:00-04:00,MYL,neutral
879863.0,UPDATE: Mylan Issues Comment on Teva Deal to Buy Allergan's Generic Drug Unit,2015-07-27 06:43:00-04:00,MYL,neutral
879864.0,Mylan Issues Comment on Teva Deal to Buy Allergan's Generic Drug Unit,2015-07-27 06:43:00-04:00,MYL,neutral
879865.0,"Teva +10% Premarket, Mylan -13%; Perrigo +3%",2015-07-27 05:11:00-04:00,MYL,neutral
879866.0,Teva Preliminary Q2 EPS $1.43 vs $1.31 Est,2015-07-27 04:56:00-04:00,MYL,neutral
879867.0,Teva Sees FY 2015 EPS $5.15-$5.40 vs $5.23 Est,2015-07-27 04:54:00-04:00,MYL,neutral
879869.0,UPDATE: Teva to Review Options With Respect to 4.6% Stake in Mylan,2015-07-27 04:37:00-04:00,MYL,positive
879870.0,UPDATE: Teva Withdraws Proposal to Acquire Mylan,2015-07-27 04:32:00-04:00,MYL,neutral
879871.0,Teva Withdraws Proposal to Acquire Mylan,2015-07-27 04:31:00-04:00,MYL,neutral
879872.0,Tel Aviv Stock Exchange Halts Trading in Teva Pending Announcement -Reuters,2015-07-27 04:29:00-04:00,MYL,neutral
879873.0,Benzinga's Weekend M&A Chatter,2015-07-26 20:26:00-04:00,MYL,neutral
879874.0,Benzinga's Top #PreMarket Losers,2015-07-23 08:18:00-04:00,MYL,negative
879875.0,UPDATE: Mylan 8-K Shows Company Entered Credit Agreement For $1.6B Term Loan,2015-07-21 17:10:00-04:00,MYL,positive
879876.0,Mylan 8-K Filing Out,2015-07-21 17:09:00-04:00,MYL,neutral
879877.0,"Deutsche Bank Highlights 'Hidden Gem' In Teva, Says It Could Be Laquinimod",2015-07-16 09:06:00-04:00,MYL,neutral
879878.0,"York Capital's James Dinan Mentions Healthcare Deals; Likes Mylan, Perrigo",2015-07-15 12:11:00-04:00,MYL,positive
879879.0,Mylan Reports Launch of Generic Version of Namenda Tablets,2015-07-14 07:33:00-04:00,MYL,neutral
879880.0,"Related to Earlier Post-Market Price Volatility in Marathon, Valero, JP Morgan, Etc, Nanex Data Confirms Erratic, Inconsistant Orders in At Least 20 Stocks",2015-07-13 17:38:00-04:00,MYL,positive
879881.0,Mylan Launches First Generic Targretin Capsules,2015-07-09 07:31:00-04:00,MYL,neutral
879882.0,Fast Money Picks For July 8,2015-07-08 07:05:00-04:00,MYL,neutral
879883.0,"Leerink Says Teva Likely to Raise Offer for Mylan, Says Sub $95/Share Offer Makes Sense for Teva; Mylan Could Ask for $100+ -Wall Street Journal",2015-07-07 08:53:00-04:00,MYL,neutral
879884.0,"Benzinga's M&A Chatter for Monday July 6, 2015",2015-07-06 18:10:00-04:00,MYL,neutral
879886.0,Hearing Teva To Raise Bid For Mylan To $86-$88/Share This Week - UNCONFIRMED,2015-07-06 12:18:00-04:00,MYL,negative
879887.0,Mylan Shares Moving Lower Now,2015-07-02 15:02:00-04:00,MYL,neutral
879888.0,Shares of Mylan Spiking Higher Ahead Of Vertex Resumption At 3PM EDT,2015-07-02 15:00:00-04:00,MYL,positive
879889.0,Top Takeaways From BMO's Specialty Pharma Day,2015-07-01 13:13:00-04:00,MYL,positive
879890.0,Hearing Mylan's CFO John Sheehan Has Said Co. Will Be Interested in Listing on the Tel Aviv Exchange if Perrigo Purchase Goes Through,2015-06-24 09:08:00-04:00,MYL,positive
879891.0,"Mylan to Discuss Possible Listing on Tel Aviv Stock Exchange Dependent on Acquiring Perrigo, According to Source -Reuters",2015-06-23 08:18:00-04:00,MYL,neutral
879892.0,Teva Completes 4.61% Interest Purchae In Mylan,2015-06-19 08:33:00-04:00,MYL,positive
879893.0,Teva Bid for Mylan Could Be 'Imminent'- Barron's Blog,2015-06-18 15:17:00-04:00,MYL,neutral
879894.0,Teva Bid for Mylan Could Be 'Imminent'- Barron's Blog,2015-06-18 15:17:00-04:00,MYL,neutral
879895.0,U.S. Court of Appeals for the Federal Circuit Finds Teva's '808 Copaxone Patent Invalid,2015-06-18 11:59:00-04:00,MYL,neutral
879896.0,"Top Performing Industries For June 16, 2015",2015-06-16 10:36:00-04:00,MYL,positive
879897.0,Mylan Offers Response to Abbott's Support for Perrigo Deal,2015-06-16 09:21:00-04:00,MYL,positive
879898.0,"Abbott Reports Affirmation of Support for Mylan as Standalone Strategy, Says Will Vote MYL Shares in Favor of Co.'s Proposed Deal with Perrigo",2015-06-16 09:01:00-04:00,MYL,positive
879899.0,Pulmatrix and Mylan Enter Into ex-U.S. Development Agreement for PUR0200,2015-06-16 07:30:00-04:00,MYL,positive
879900.0,"Citigroup Maintains Neutral on Mylan, Raises PT to $75.00",2015-06-12 07:36:00-04:00,MYL,neutral
879901.0,Fast Money Picks For June 10,2015-06-10 07:27:00-04:00,MYL,neutral
879902.0,"Judge Recommends Barring Law Firm Kirkland & Ellis from Advising Teva on Mylan Takeover Bid; Kirkland had Represented Mylan in FDA Dealings, According to Filing -DJ",2015-06-09 19:20:00-04:00,MYL,positive
879903.0,"Mylan Says They sent A Letter To Teva Pharma. Says ""Your Public Statements Continue To Leave Mylan And Its Stakeholders With Great Uncertainty Regarding Teva's Intentions""",2015-06-08 15:32:00-04:00,MYL,positive
879904.0,Mylan Shares Trading On Session Low Of $73.50,2015-06-08 13:41:00-04:00,MYL,neutral
879905.0,UPDATE: Mylan Lots Were Distributed In US Btwn 12/8/2014 And 12/19/2014,2015-06-08 13:41:00-04:00,MYL,neutral
879906.0,"Maylan Expanding Voluntary Recall Of Injectables, Has Not Received Any new Reports Of Aderse Events Related To Recall",2015-06-08 13:40:00-04:00,MYL,neutral
879907.0,Hearing Teva Has Said Co. Remains Committed to Mylan Deal,2015-06-08 10:09:00-04:00,MYL,positive
879908.0,"6-K from Teva Pharma Shows Letter from CEO Vigodman, Chair Peterburg to Mylan Chair Coury",2015-06-08 08:56:00-04:00,MYL,neutral
879909.0,Mylan Launches Sirdupla in the UK; Bioequivalent alternative to GlaxoSmithKline's Seretide Evohaler,2015-06-08 04:18:00-04:00,MYL,neutral
879910.0,UPDATE: Teva Increases Mylan Stake From 1.8% To 2.2%,2015-06-05 13:26:00-04:00,MYL,neutral
879911.0,Teva Pharmaceuticals Raises Stake In Mylan To 2.2%; As It Continues To Press Unsolicited Bid -Reuters,2015-06-05 13:25:00-04:00,MYL,neutral
879912.0,Fast Money Picks For June 4,2015-06-04 07:09:00-04:00,MYL,neutral
879913.0,Analyst Knocks High-Profile Biotech Merger Battle; Opportunities Elsewhere,2015-06-03 17:05:00-04:00,MYL,neutral
879914.0,Raymond James Initiates Coverage on Mylan at Market Perform,2015-06-03 06:33:00-04:00,MYL,neutral
879915.0,"Teva to Raise Stake in Mylan, According to Sources -Reuters",2015-06-02 18:18:00-04:00,MYL,neutral
879916.0,Mylan Launches Generic Seasonique Tablets,2015-06-02 15:51:00-04:00,MYL,neutral
879917.0,Mylan Launches Generic INTUNIV Tablets,2015-06-02 15:31:00-04:00,MYL,neutral
879918.0,UPDATE: Mylan Says There Still Is No Clarity On Whether Or Not Teva Will Make An Actual Offer To Acquire Mylan,2015-06-01 16:05:00-04:00,MYL,positive
879919.0,Mylan Sends Letter to Teva CEO,2015-06-01 16:04:00-04:00,MYL,neutral
879920.0,Who's The Next Big Pharma Acquisition?,2015-05-29 11:20:00-04:00,MYL,neutral
879921.0,Option Alert: Teva Jan $60 Call; 1126 Contract Trade at Ask @$5.00,2015-05-28 11:45:00-04:00,MYL,positive
879922.0,"Benzinga's M&A Chatter for Wednesday May 27, 2015",2015-05-27 20:08:00-04:00,MYL,neutral
879923.0,Teva Release Confirms Co. 'Ready to Meet with Mylan and Its Advisers',2015-05-27 16:46:00-04:00,MYL,positive
879924.0,Report: Mylan Could See Sweetened Bid From Teva Pharmaceutical,2015-05-27 15:55:00-04:00,MYL,neutral
879925.0,Mylan Shares Volatile Over Last Few Mins as NY Post Reporting Teva Could 'Sweeten Offer Before July;' MYL Shares Now Up ~2.3%,2015-05-27 12:16:00-04:00,MYL,positive
879926.0,Teva Could Turn to John Paulson for Help in Mylan Takeover Bid -NY Post,2015-05-27 12:05:00-04:00,MYL,positive
879927.0,Mylan Spikes Higher,2015-05-26 11:36:00-04:00,MYL,neutral
879928.0,"Mylan Asked By Irish Takeover Panel to Issue Clarification, Retraction In Accordance With Takeover Rules",2015-05-25 09:55:00-04:00,MYL,neutral
879929.0,Hearing Perrigo Saying A Price Point Exists With Mylan That The Company Would Engage At,2015-05-18 12:05:00-04:00,MYL,positive
879930.0,Hearing Cowen & Co Saying Clients Should Aggressively Buy Shares At These Levels In Mylan and Teva,2015-05-11 14:39:00-04:00,MYL,neutral
879931.0,Analysts Met With UnitedHealth And Mylan Management; What Happened?,2015-05-11 10:08:00-04:00,MYL,neutral
879932.0,Benzinga's Weekend M&A Chatter,2015-05-10 20:50:00-04:00,MYL,neutral
879933.0,Mylan Chairman Coury Tells Investors He Would Consider Acquisition of Teva Pharmaceuticals Down The Road -Reuters,2015-05-08 15:21:00-04:00,MYL,neutral
879934.0,Report: Mylan Might See Higher Bid From Teva,2015-05-08 14:20:00-04:00,MYL,neutral
879935.0,Option Alert: Mylan Jun $75 Call; 1650 Contract Trade at Ask @$2.15,2015-05-08 12:40:00-04:00,MYL,positive
879936.0,Report Teva Seeking $25B in Financing for Mylan Offer,2015-05-08 12:38:00-04:00,MYL,neutral
879937.0,Mylan Shares Spike Higher,2015-05-08 12:38:00-04:00,MYL,positive
879938.0,"Jim Chanos, Kyle Bass Rip Oil And Pharma At SALT 2015",2015-05-07 17:39:00-04:00,MYL,neutral
879939.0,Fast Money Picks For May 7,2015-05-07 06:36:00-04:00,MYL,neutral
879940.0,Stada CEO Says Teva-Mylan Deal Could Create Antitrust-Related Asset Sales That We Will Look Into -Reuters,2015-05-07 06:24:00-04:00,MYL,positive
879941.0,Perrigo Spikes to High,2015-05-06 15:59:00-04:00,MYL,neutral
879942.0,"Mylan Reports Q1 EPS $0.70 vs. Est. $0.71, Rev. $1.87B vs. Est. $2.06B",2015-05-05 16:06:00-04:00,MYL,neutral
879943.0,Mylan Launches Seasonale Generic Tablets,2015-05-05 13:46:00-04:00,MYL,neutral
879944.0,Apple's Angela Ahrendts Is Nation's Best-Paid Female Executive,2015-05-05 13:40:00-04:00,MYL,neutral
879945.0,UPDATE: Mylan Confirms In PR Minivelle First-to-File Patent Challenge,2015-05-05 13:18:00-04:00,MYL,positive
879946.0,Mylan Confirms In PR Minivelle First-to-File Patent Challenge,2015-05-05 13:17:00-04:00,MYL,positive
879947.0,Teva Says Expects All Necessary Antitrust Clearances for Mylan Acquisition Within 4-7 Months -Reuters,2015-05-05 12:45:00-04:00,MYL,neutral
879948.0,"Earning & Economic Calendar for Tuesday May 5, 2015",2015-05-05 05:38:00-04:00,MYL,neutral
879949.0,"Earnings Scheduled For May 5, 2015",2015-05-05 04:27:00-04:00,MYL,neutral
879950.0,Report Sees 'Cognitive Dissonance' In Mylan's Internal Price Target,2015-05-04 16:30:00-04:00,MYL,neutral
879951.0,Mylan Launches Gilead Sciences' Sovaldi Tablets in India,2015-05-04 05:31:00-04:00,MYL,neutral
879952.0,"Groupon, Alibaba, Tesla & Others On Deck: Earnings Season Rolls On",2015-05-03 17:58:00-04:00,MYL,neutral
879953.0,Analyst: Mylan Shareholders Might Get Convinced By Vigodman Letter,2015-04-30 16:25:00-04:00,MYL,positive
879954.0,From Conf Call: Teva CEO Says Intends to Devote All Necessary Resources to Complete Mylan Acquisition; Won't Comment Further,2015-04-30 08:10:00-04:00,MYL,positive
879955.0,"Benzinga's M&A Chatter for Wednesday April 29, 2015",2015-04-29 20:01:00-04:00,MYL,neutral
879956.0,Letter From Teva Pharma CEO To Mylan Board Of Directors,2015-04-29 16:14:00-04:00,MYL,neutral
879957.0,Perrigo Release Confirms Rejection of Most-Recent Mylan Offer,2015-04-29 11:03:00-04:00,MYL,negative
879958.0,Hearing Teva Has Said Remains Commmitted to Mylan Deal,2015-04-29 10:53:00-04:00,MYL,neutral
879959.0,"David Faber @davidfaber Says: ""Perrigo to reject Mylan's latest offer. $PRGO using $55 as unaffected price. Believes this bid still below the $205 it originally rejected.""",2015-04-29 10:41:00-04:00,MYL,negative
879960.0,"Perrigo Company Expected To Reject Latest Mylan Offer, According to Source -Reuters",2015-04-29 10:06:00-04:00,MYL,negative
879961.0,"UPDATE: New Mylan Offer for Perrigo is $242.33/Share in Cash, Stock Based on Tuesday Closing Price",2015-04-29 09:28:00-04:00,MYL,neutral
879962.0,"Perrigo Shares Spike Over $210 Following News Mylan Ups Offer To Acquire Company, Mylan Shares Down Slightly",2015-04-29 09:24:00-04:00,MYL,positive
879963.0,"Mylan Announces raised Offer for Perrigo to $75/Share in Cash, 2.3 Shares of MYL",2015-04-29 09:21:00-04:00,MYL,positive
879964.0,"CNBC Currently Discussing Mylan, Perrigo; David Faber Reports Mylan Could Come Back with Another Offer for Perrigo",2015-04-28 09:43:00-04:00,MYL,neutral
879965.0,Fast Money Picks For April 28,2015-04-28 06:55:00-04:00,MYL,neutral
879966.0,"Benzinga's M&A Chatter for Monday April 27, 2015",2015-04-27 22:58:00-04:00,MYL,neutral
879967.0,Hearing Cowen Says Teva Could Raise Bid for Mylan to $90/Share,2015-04-27 15:23:00-04:00,MYL,neutral
879968.0,"DAVID FABER @davidfaber Tweet: Mylan's response to Teva is one of the most condescending, sarcastic and nasty letters I've come across. Read it here bit.ly/1KnwFpe",2015-04-27 14:18:00-04:00,MYL,negative
879970.0,Hearing Teva Has Considered Proceeding with Hostile Offer for Mylan,2015-04-27 10:56:00-04:00,MYL,negative
879971.0,"Teva Reiterates $82.00 Cash, Stock Bid for Mylan",2015-04-27 10:40:00-04:00,MYL,neutral
879972.0,"Mylan Announces Board Has Unanimously Rejected Unsolicited Bid from Teva, Says Remains Committed to Firm Offer for Perrigo",2015-04-27 09:21:00-04:00,MYL,negative
879973.0,Perrigrine Shares Fall 1.5% Following Downgrade at B Riley from Buy to Neutral,2015-04-27 06:24:00-04:00,MYL,positive
879974.0,Mylan Enters Bridge Credit Facility For Up To $11B,2015-04-24 17:27:00-04:00,MYL,positive
879975.0,Deutsche Bank Boosts Mylan's Price Target On This Scenario,2015-04-24 15:18:00-04:00,MYL,positive
879976.0,Release from Perrigo Confirms Co. Has Rejected Mylan Offer,2015-04-24 12:10:00-04:00,MYL,negative
879977.0,Hearing Perrigo Has Rejected Mylan Offer,2015-04-24 11:28:00-04:00,MYL,negative
879978.0,"Worst Performing Industries For April 24, 2015",2015-04-24 11:16:00-04:00,MYL,negative
879979.0,"Teva Spokesperson Says Teva Board, Management Team Remain Fully Committed to Completing Combination of Teva, Mylan -Reuters",2015-04-24 10:45:00-04:00,MYL,positive
879980.0,DAVID FABER @davidfaber Tweet:  Mylan stock certainly inflated due to $TEVA $82 bid for company (even if it has many obstacles). Hence PRGO not moving.,2015-04-24 10:13:00-04:00,MYL,positive
879981.0,UPDATE: Mylan Offer for Perrigo Boosted from $205/Share Previously to $60/Share in Cash + 2.2 MYL Shares ($73.69 as of Thursday's Close) = ~$222/Share,2015-04-24 09:51:00-04:00,MYL,positive
879982.0,"Mylan Announces Will Commence Formal Offer for Purchase of Perrigo at $60/Share in Cash, 2.2 MYL Shares",2015-04-24 09:45:00-04:00,MYL,positive
879983.0,Mylan Launches Generic Sofosbuvir Tablets in India,2015-04-23 05:06:00-04:00,MYL,neutral
879984.0,Mylan Shares Spike to Low,2015-04-22 15:34:00-04:00,MYL,neutral
879985.0,Analyst Finds Perrigo 'Still Attractive' As Take Out Target,2015-04-22 11:59:00-04:00,MYL,positive
879986.0,What's Gabelli Saying About Teva Now?,2015-04-22 11:51:00-04:00,MYL,neutral
879987.0,Option Alert: Mylan May $75 Call; 1643 Contract Trade above Ask @$3.11,2015-04-22 10:21:00-04:00,MYL,positive
879988.0,"Abbott CEO Says Initial $5.3B Return from Sale of Generics to Mylan Now Worth $7B+, Due to Appreciation of Mylan Shares Abbott Obtained In Deal -Reuters",2015-04-22 10:17:00-04:00,MYL,positive
879989.0,"CNBC's David Faber Reporting He Expects Mylan to Come Out with a 'Firm' bid for Perrigo, Offer Will Include a Financing Committment",2015-04-22 09:44:00-04:00,MYL,neutral
879990.0,"CNBC Now @CNBCnow Tweet; : Mylan is planning a new offer for Perrigo in near term, sources tell @davidfaber.• $MYL $PRGO",2015-04-22 09:43:00-04:00,MYL,neutral
879991.0,Teva Files for Hart-Scott-Rodino Notification Regarding Proposed Acquisition of Mylan,2015-04-22 08:33:00-04:00,MYL,neutral
879992.0,Teva Announces Filing of HSR Notification Related to Proposed Deal with Mylan,2015-04-22 08:30:00-04:00,MYL,neutral
879993.0,"Benzinga's M&A Chatter for Tuesday April 21, 2015",2015-04-21 19:37:00-04:00,MYL,neutral
879994.0,"Top Mylan Investors, including Paulson & Co, Encouraging Mylan Board to Consider Teva Offer, According to Sources -Reuters",2015-04-21 17:08:00-04:00,MYL,positive
879995.0,"Perrigo Announces Board Has Unanimously Rejected Bid from Mylan, Calls Deal Undervalued",2015-04-21 16:03:00-04:00,MYL,negative
879996.0,"Perrigo Board Expected to Reject Mylan $29B Bid as Soon as This Week, According to Source -Reuters",2015-04-21 13:47:00-04:00,MYL,negative
879997.0,Hearing Citi Has Said Teva's Bid for Mylan Should Not Exceed $90/Share,2015-04-21 12:42:00-04:00,MYL,neutral
879998.0,"BMO Capital Upgrades Mylan to Market Perform, Raises PT to $75.00",2015-04-21 12:08:00-04:00,MYL,neutral
879999.0,Benzinga's Volume Movers,2015-04-21 11:29:00-04:00,MYL,neutral
880000.0,Stocks Hitting 52-Week Highs,2015-04-21 11:08:00-04:00,MYL,neutral
880001.0,Mylan Shares Jump On $40 Billion Bid From Teva Pharmaceutical,2015-04-21 10:52:00-04:00,MYL,positive
880002.0,Morning Market Gainers,2015-04-21 09:45:00-04:00,MYL,neutral
880003.0,"UPDATE: Teva Says Proposal  to Acquire Mylan Contingent on Mylan Not Completing Proposed Acquisition of Perrigo, Another Company",2015-04-21 08:53:00-04:00,MYL,neutral
880004.0,"Teva Release Confirms Co. Has Proposed to Purchcase Mylan for $82/Share in Cash, Stock",2015-04-21 08:45:00-04:00,MYL,neutral
880005.0,Benzinga's Top #PreMarket Losers,2015-04-21 08:23:00-04:00,MYL,negative
880006.0,Benzinga's Top #PreMarket Gainers,2015-04-21 08:13:00-04:00,MYL,positive
880007.0,UPDATE: Mylan Shares Rise 10% Following Report of Potential Teva Bid; Perrigo Shares Fall 4%,2015-04-21 07:18:00-04:00,MYL,positive
880008.0,Teva Spokesperson Declines Comment on Rumored Bid for Mylan -Reuters,2015-04-21 06:42:00-04:00,MYL,neutral
880009.0,Mylan Shares Rise 12% Premarket on Rumored Bid from Teva; Perrigo Shares Fall 4%,2015-04-21 06:36:00-04:00,MYL,positive
880010.0,"Teva Preparing Bid for Mylan as Early as Tuesday, According to Sources -Bloomberg",2015-04-21 04:46:00-04:00,MYL,neutral
880011.0,Benzinga's Weekend M&A Chatter,2015-04-19 19:10:00-04:00,MYL,neutral
880012.0,Mylan: There's No Logic In The Teva Merger Rumor,2015-04-17 15:17:00-04:00,MYL,negative
880013.0,"Mylan Believes If An Actual Offer To Acquire Mylan Were To Materialize, The Board Would Carefully Consider The Option In Interest Of Stockholders, Company, And Stakeholders",2015-04-17 14:52:00-04:00,MYL,positive
880014.0,"Mylan Says That It Is Fully Commited To Stand Alone Strategy, Sees Much Overlap With Teva; Remains Committed On Proposal To Acquire Perrigo",2015-04-17 14:48:00-04:00,MYL,neutral
880015.0,Mylan Scores Final Win In Patent Challenge On Inhalation Drug,2015-04-17 14:27:00-04:00,MYL,positive
880016.0,Mylan Trading Resumed,2015-04-17 14:25:00-04:00,MYL,neutral
880017.0,Mylan Quotation To Resume At 2:19 P.M.,2015-04-17 14:22:00-04:00,MYL,neutral
880018.0,UPDATE: Perrigo Shares Spike Lower on DJ Report of Teva Bid for Mylan,2015-04-17 14:22:00-04:00,MYL,neutral
880019.0,Mylan Trading Halted On Volatility,2015-04-17 14:20:00-04:00,MYL,neutral
880020.0,"Teva Pharmaceutical Considering Bid for Mylan, According to Sources -DJ",2015-04-17 14:20:00-04:00,MYL,neutral
880021.0,Mylan's U.S. Patents On Perforomist Inhalation Solution Upheld By Federal Circuit; Mylan Share Price Rises On News,2015-04-17 12:57:00-04:00,MYL,positive
880022.0,Federal Circuit Upholds Mylan's U.S. Patents on Perforomist Inhalation Solution; Decision Prevents Approval of Teva ANDA,2015-04-17 12:55:00-04:00,MYL,positive
880023.0,Momenta Pharmaceuticals Spikes Up Following FDA News On Copaxone,2015-04-16 14:54:00-04:00,MYL,neutral
880024.0,Mylan Shares Spike Higher on Teva News,2015-04-16 12:31:00-04:00,MYL,positive
880025.0,"UPDATE: Mylan, Pfizer Settle On Viagra Patent Litigation; Up For Review By DOJ & FTC",2015-04-13 15:12:00-04:00,MYL,negative
880026.0,Mylan Settles Patent Litigation Related to Viagra,2015-04-13 15:10:00-04:00,MYL,negative
880027.0,Why The Mylan 'Love Triangle' Could Benefit Investors,2015-04-13 13:43:00-04:00,MYL,positive
880028.0,Antares IR Says No News Connected to Unusual Call Activity,2015-04-09 15:31:00-04:00,MYL,negative
880029.0,1 Challenge Bank Of America Sees For Mylan And Perrigo,2015-04-09 11:32:00-04:00,MYL,positive
880030.0,Hearing Renewed Takeover Chatter of Potential Pfizer Bid for Mylan,2015-04-09 09:44:00-04:00,MYL,neutral
880031.0,Citi Asks: Is A Mylan-Perrigo Merger Smart?,2015-04-09 09:36:00-04:00,MYL,positive
880032.0,And The Winner From The Mylan-Perrigo Merger Is... Teva?,2015-04-09 09:16:00-04:00,MYL,positive
880033.0,"Mylan Announcement under Irish Takeover Rules, Confirms Issued Share Capital of 489,503,828 Ordinary Shares",2015-04-09 08:50:00-04:00,MYL,positive
880034.0,Is Teva A Better Target For Mylan Than Perrigo? 2 Analysts Share Their Thoughts,2015-04-08 16:00:00-04:00,MYL,positive
880035.0,UPDATE: Perrigo Shareholders Would Recieve $205/Share In A Combination Of Cash & Mylan Stock For Each Perigo Stock; A 25% Premium To Perrigo's Closing Price Friday April 3rd.,2015-04-08 11:35:00-04:00,MYL,neutral
880036.0,UPDATE: Mylan Proposes to Acquire Perrigo for $205/Share,2015-04-08 11:30:00-04:00,MYL,neutral
880038.0,Mylan Proposes to Acquire Perrigo $205/Share,2015-04-08 11:29:00-04:00,MYL,neutral
880039.0,JPMorgan Says Mylan Has 3 Paths To Upside,2015-04-08 11:04:00-04:00,MYL,neutral
880040.0,Mylan Announces Launch of First Generic Version of Generess Fe,2015-04-07 07:34:00-04:00,MYL,neutral
880041.0,Mylan Prices 35M Share Offering @$53.85/Share,2015-03-31 19:53:00-04:00,MYL,positive
880042.0,Morning Market Losers,2015-03-30 09:49:00-04:00,MYL,negative
880043.0,Benzinga's Top #PreMarket Losers,2015-03-30 08:17:00-04:00,MYL,negative
880044.0,Mylan Announces Commencement of 35M Share Secondary Offering of Portion of Abbott's Ordinary Shares,2015-03-30 06:32:00-04:00,MYL,positive
880045.0,Is It Closing Time At The Biotech Bar?,2015-03-26 13:45:00-04:00,MYL,neutral
880046.0,Mylan Shares Spiking Again Following Wednesday Teva Bid Rumor,2015-03-12 10:50:00-04:00,MYL,positive
880047.0,"Benzinga's M&A Chatter for Wednesday March 11, 2015",2015-03-11 19:41:00-04:00,MYL,neutral
880048.0,Hearing BMO Believes Mylan Takeover Rumor is Baseless,2015-03-11 11:31:00-04:00,MYL,neutral
880049.0,Hearing Unconfirmed Market Chatter in Mylan,2015-03-11 09:45:00-04:00,MYL,negative
880050.0,Mylan Launches Generic Subutex Sublingual Tablets,2015-03-11 07:33:00-04:00,MYL,neutral
880051.0,Mylan Reports Launch of Generic Subutex Sublingual Tablets,2015-03-11 07:32:00-04:00,MYL,neutral
880052.0,Mylan Launches Generic Antabuse Tablets,2015-03-11 07:02:00-04:00,MYL,neutral
880053.0,Abbott Laboratories Reports 22.52% Stake in Mylan as of February 27; Units Acquired Mylan Shares in Consideration of Transfer of Assets to Mylan -13D,2015-03-07 06:21:00-05:00,MYL,positive
880054.0,Kindred Names Jon B. Rousseau Executive Vice President and President of RehabCare,2015-03-05 16:36:00-05:00,MYL,neutral
880055.0,UPDATE: Morgan Stanley Resumes Coverage On Mylan As Attractive Valuation Presents Opportunity,2015-03-05 10:24:00-05:00,MYL,positive
880056.0,"Morgan Stanley Assumes Mylan at Overweight, Announces $67.00 PT",2015-03-05 07:06:00-05:00,MYL,negative
880057.0,Mylan N.V. & Mylan Inc Commence Consent Solicitations For Mylan Notes,2015-03-03 08:57:00-05:00,MYL,positive
880058.0,"Mylan Sees FY15 Adj. EPS $4-$4.30 vs $4.20 Est., Sales $9.6B-$10.1B vs $9.82B Est.",2015-03-02 16:13:00-05:00,MYL,neutral
880059.0,"Mylan  Reports Q4 EPS $1.05 Vs Est $1.05, Sales $2.08B Vs Est $2.07B",2015-03-02 16:12:00-05:00,MYL,neutral
880060.0,"Earnings Scheduled For March 2, 2015",2015-03-02 04:44:00-05:00,MYL,neutral
880061.0,Mylan Files for Up to $1.67B Stock Shelf,2015-02-27 15:14:00-05:00,MYL,neutral
880062.0,"Option Alert: MYL March $60 Call 6,115 Traded vs 48 OI",2015-02-27 14:58:00-05:00,MYL,positive
880063.0,"Mylan Completes Acquisition Of Abbott's Foreign Developed Markets Specialty, Branded Generics Business",2015-02-27 12:31:00-05:00,MYL,neutral
880064.0,"Mylan Reports Signing of Exclusive Deal with Gilead Related to Distribution of Sovaldi, Harvoni in India",2015-02-23 07:10:00-05:00,MYL,positive
880065.0,"Mylan Signs Exclusive Agreement with Gilead Sciences to Distribute Sovaldi, Harvoni in India",2015-02-23 07:04:00-05:00,MYL,positive
880066.0,Paulson & Company's Q4 Moves: Healthcare And Beyond,2015-02-18 16:12:00-05:00,MYL,neutral
880067.0,Paulson & Co Increases Mylan Stake,2015-02-17 17:19:00-05:00,MYL,neutral
880068.0,Mylan Confirms First-to-File Patent Challenge Relating to NEXAVAR,2015-02-09 11:01:00-05:00,MYL,positive
880069.0,"Benzinga's M&A Chatter for Monday February 2, 2015",2015-02-02 19:07:00-05:00,MYL,neutral
880070.0,Benzinga's Volume Movers,2015-02-02 10:29:00-05:00,MYL,neutral
880071.0,"Theravance, Mylan Partner to Develop and Commercialize Novel LAMA Compound, TD-4208, for COPD",2015-02-02 07:12:00-05:00,MYL,positive
880072.0,US Stock Futures Rise Ahead Of Economic Data,2015-02-02 07:01:00-05:00,MYL,neutral
880073.0,Mylan to Acquire Famy Care Businesses for $750M,2015-02-02 06:45:00-05:00,MYL,positive
880074.0,Mylan Expands Hepatitis C Licensing Agreement with Gilead to Include Investigational Pan-Genotypic Agent,2015-01-26 10:59:00-05:00,MYL,positive
880075.0,"Cramer Weighs In On Transocean LTD, Mylan Inc And Honda Motor Co Ltd",2015-01-25 14:42:00-05:00,MYL,neutral
880076.0,Mylan Reports Launch of Generic of Glaxo's Epivir-HBV Tablets,2015-01-15 14:31:00-05:00,MYL,neutral
880077.0,"Mylan CEO States In Interview 'Plans To Expand Into Europe, South America; Sees Large Consolidation Deals In Drug Industry'",2015-01-09 14:56:00-05:00,MYL,positive
880078.0,Mylan Launches Generic Diovan® Tablets,2015-01-05 13:01:00-05:00,MYL,neutral
880079.0,South African National Dept of Health Selects Mylan as Leading Supplier for 2015/2018 Antiretroviral Tender,2014-12-31 06:02:00-05:00,MYL,neutral
880080.0,Top 4 Small-Cap Stocks In The Drugs-Generic Industry With The Lowest PEG Ratio,2014-12-18 04:31:00-05:00,MYL,negative
880081.0,Mylan Reports Launch of Generic Robaxin Injection,2014-12-11 07:31:00-05:00,MYL,neutral
880082.0,Mylan Launches First Generic Version Of Orapred ODT,2014-12-11 07:04:00-05:00,MYL,neutral
880083.0,Mylan Reports Launch 'One of First Available Generic Version of Celebrex Capsules,2014-12-10 07:35:00-05:00,MYL,neutral
880084.0,Mylan Receives Tentative FDA Approval For Pediatric Formulations Of Abacavir/Lamivudine Through Innovative Collaboration With ViiV Healthcare And Clinton Health Access Initiative,2014-12-04 10:01:00-05:00,MYL,positive
880085.0,Mylan Reports Deal with Gilead for Enhancement of Access to TAF-Based HIV Treatments in Developing Countires,2014-12-01 07:02:00-05:00,MYL,neutral
880086.0,CNBC's Stock Pops & Drops From November 26,2014-11-28 07:01:00-05:00,MYL,neutral
880087.0,Mylan Confirms First-to-File Patent Challenge Relating To BREVIBLOC,2014-11-25 07:34:00-05:00,MYL,positive
880088.0,Hearing Renewed Takeover Chatter in  Mylan,2014-11-19 09:51:00-05:00,MYL,neutral
880089.0,Mylan Signs Strategic Alliance Agreement With Walt Disney Parks and Resorts ,2014-11-07 08:10:00-05:00,MYL,positive
880090.0,Shares of Mylan Move Lower; May be in Response to Lannett Subpoena News,2014-11-06 11:28:00-05:00,MYL,neutral
880091.0,Mylan Launches Generic Loestrin 24 Fe ,2014-11-05 07:35:00-05:00,MYL,neutral
880092.0,Mylan Inc. Sees Q4 EPS $1.03-1.09 vs $1.00 Est,2014-10-30 16:46:00-04:00,MYL,neutral
880093.0,Mylan Inc. Sees FY2014 EPS $3.54-3.60 vs $3.50 Est,2014-10-30 16:06:00-04:00,MYL,neutral
880094.0,Mylan Inc. Reports Q3 EPS of $1.16 vs $1.14 Est; Revenue of $2.08B vs $2.06B Est,2014-10-30 16:06:00-04:00,MYL,neutral
880095.0,Mylan Launches Generic Viramune XR ,2014-10-30 12:52:00-04:00,MYL,neutral
880096.0,"Earnings Scheduled For October 30, 2014",2014-10-30 05:12:00-04:00,MYL,neutral
880097.0,Mylan Adjusts Pricing Terms Of Manufacturing Pacts With Abbot ,2014-10-22 07:24:00-04:00,MYL,neutral
880098.0,Mylan Reports Launch of Generic Combivir,2014-10-06 07:30:00-04:00,MYL,neutral
880099.0,Bank Of America Raises 2014 Outlook For Mylan Inc,2014-10-06 07:22:00-04:00,MYL,neutral
880100.0,Benzinga's Top #PreMarket Gainers,2014-10-03 08:44:00-04:00,MYL,positive
880101.0,Mylan Inc. Raises FY2014 EPS Guidance from $3.25-3.45 to $3.44-3.54,2014-10-03 07:04:00-04:00,MYL,neutral
880102.0,Mylan Inc. Raises Q3 EPS Guidance from $0.90-0.95 to $1.12-1.16 vs $0.94 Est,2014-10-03 07:01:00-04:00,MYL,neutral
880103.0,"Benzinga's M&A Chatter for Thursday October 2, 2014",2014-10-02 18:02:00-04:00,MYL,neutral
880104.0,Mylan Shares Off Highs Following Earlier Rumor of Bid from Teva,2014-10-02 10:37:00-04:00,MYL,positive
880105.0,Inversion Crackdown Leaves Several Deals In Limbo,2014-09-23 12:41:00-04:00,MYL,neutral
880106.0,Option Alert: Mylan Shares Move to High; Activity in Sep $50 Call; Currently $48.92,2014-09-18 11:43:00-04:00,MYL,positive
880107.0,"Mylan Reports Commencement of Phase III Trials for Generic Version of Advair Diskus, Insulin Analog to Lantus",2014-09-16 07:30:00-04:00,MYL,neutral
880108.0,US Stock Futures Down Ahead Of Industrial Production Report,2014-09-15 07:13:00-04:00,MYL,neutral
880109.0,Mylan In Pact With Gilead To Accelerate Access To Hepatitis C,2014-09-15 06:31:00-04:00,MYL,neutral
880110.0,"UPDATE: Gilead Says Licensees to Set Prices for Generic Version of Sovaldi, Will Pay Gilead a Royalty on Sales",2014-09-15 05:51:00-04:00,MYL,negative
880111.0,"Gilead Licenses Hep C Drug Sovaldi to 7 Companies Including Mylan, Ranbaxy",2014-09-15 05:48:00-04:00,MYL,neutral
880112.0,Mylan to Acquire U.S. Rights to Arixtra Injection From Aspen,2014-09-10 07:02:00-04:00,MYL,neutral
880113.0,Hearing Unconfirmed Market of Investor Stake in Mylan,2014-09-08 09:59:00-04:00,MYL,negative
880114.0, Court Grants Summary Judgment In Favor Of Mylan And FDA Related To Generic,2014-09-08 07:02:00-04:00,MYL,positive
880115.0,Mylan Launches Generic Boniva Injection ,2014-09-05 07:31:00-04:00,MYL,neutral
880116.0,UPDATE: NYSE Says No Report Filed Yet on Mylan; Shares Spiked to Low of $45.66 at 12:19 PM ET,2014-09-04 12:27:00-04:00,MYL,negative
880117.0,Eric Scott Hunsader @nanexllc Tweet: 'another fast news reading #HFT algo - in $MYL this time?',2014-09-04 12:21:00-04:00,MYL,neutral
880118.0,Mylan Spikes Lower,2014-09-04 12:20:00-04:00,MYL,negative
880119.0,Mylan Release Confirms ANDA for Three-Times-Per-Week Generic Copaxone Accepted,2014-08-28 11:22:00-04:00,MYL,positive
880120.0,Mylan Launches Generic Version of Klor-Con Extended-Release Tablets ,2014-08-22 07:34:00-04:00,MYL,neutral
880121.0,Mylan Reports Launch of Generic Precedex Injection,2014-08-19 11:42:00-04:00,MYL,neutral
880122.0,Mylan Announces Launch of Generic Xeloda,2014-08-11 07:30:00-04:00,MYL,neutral
880123.0,Benzinga's Top Downgrades,2014-08-08 09:04:00-04:00,MYL,positive
880124.0,US Stock Futures Edge Higher Ahead Of Productivity Data,2014-08-08 07:41:00-04:00,MYL,neutral
880125.0,RBC Capital Downgrades Mylan To Sector Perform,2014-08-08 07:10:00-04:00,MYL,neutral
880126.0,"RBC Capital Downgrades Mylan Inc. to Sector Perform, Lowers PT to $53.00",2014-08-08 06:58:00-04:00,MYL,negative
880127.0,"S&P 500 Falls To Two-Month Low, Dow Drifts Further Away From The 17,000 Mark",2014-08-07 16:41:00-04:00,MYL,negative
880128.0,US Stock Futures Rise; Jobless Claims Report In Focus,2014-08-07 07:44:00-04:00,MYL,neutral
880129.0,"UPDATE: Mylan Posts Lower Q2 Earnings, Narrows Full-Year Outlook",2014-08-07 07:17:00-04:00,MYL,negative
880130.0,Mylan Inc. Narrows FY2014 EPS Guidance from $3.25-3.60 to $3.25-3.45 vs $3.38 Est; Narrows FY2014 Sales Guidance from $7.80B-8.20B to $7.80B-8.0B vs $7.77B Est,2014-08-07 06:40:00-04:00,MYL,neutral
880131.0,Mylan Reports Q2 Adjusted EPS of $0.69 vs $0.70 Est; Revenue of $1.84B vs $1.88B Est,2014-08-07 06:31:00-04:00,MYL,neutral
880132.0,5 Drug Companies Profiting From Generics,2014-08-04 08:29:00-04:00,MYL,positive
880133.0,Citigroup Downgrades Mylan Inc. to Neutral,2014-07-25 07:28:00-04:00,MYL,neutral
880134.0,Mylan Wins Motion For Temporary Restraining Order Against Apotex For Authorized Generic Of Paxil CR,2014-07-23 07:08:00-04:00,MYL,positive
880135.0,Mylan Wins Motion To Enjoin GlaxoSmithKline From Providing Paroxetine CR Yo Apotex; Apotex Can No Longer Supply Authorized Generic Product,2014-07-17 07:02:00-04:00,MYL,positive
880136.0,UPDATE: Bank Of America Reiterates On Mylan Following Abbott Transaction,2014-07-15 08:49:00-04:00,MYL,neutral
880137.0,Dow Sets New Intraday High; Citigroup Impresses With Earnings,2014-07-14 16:44:00-04:00,MYL,positive
880138.0,Benzinga's Volume Movers,2014-07-14 10:20:00-04:00,MYL,neutral
880139.0,"Abbott CEO Says Wants to Sell Mylan Stake, Uncertain How Proceeds Would be Used; Interested in Acquiring Medical Optics Products -Reuters",2014-07-14 10:11:00-04:00,MYL,positive
880140.0,From Abbott Call to Discuss Mylan Deal: Will Sell Stake in 'Orderly' Manner,2014-07-14 10:09:00-04:00,MYL,neutral
880141.0,Morning Market Movers ,2014-07-14 09:38:00-04:00,MYL,neutral
880142.0,Benzinga's Top #PreMarket Gainers,2014-07-14 08:10:00-04:00,MYL,positive
880143.0,"8-K from Mylan Shows Co., Abbott Deal Includes $100M Termination Fee",2014-07-14 07:09:00-04:00,MYL,neutral
880144.0,Mylan to Acquire Abbott's Non-U.S. Developed Markets Specialty And Branded Generics Business In $5.3B All-Stock Transaction,2014-07-14 06:32:00-04:00,MYL,neutral
880145.0,Mylan to Acquire Abbott's Non-U.S. Developed Markets Specialty And Branded Generics Business In All-Stock Transaction ,2014-07-14 06:31:00-04:00,MYL,neutral
880146.0,Mylan Will Appeal EU Antitrust Fines Related to Generic Delay Deal - Bloomberg,2014-07-09 11:31:00-04:00,MYL,negative
880147.0,Mylan Reports Launch of Generic Micardis Tablets,2014-07-08 07:30:00-04:00,MYL,neutral
880148.0,Mylan Shares Move Higher as Co Reaffirms Q2 Guidance,2014-07-01 13:06:00-04:00,MYL,positive
880149.0,Shire Announces Vyvanse Patents Found to Be Infringed and Valid by US District Court,2014-06-25 05:42:00-04:00,MYL,neutral
880150.0,Mylan Announces Launch of Generic Actonel Tablets at 150mg Dose,2014-06-11 11:51:00-04:00,MYL,neutral
880151.0,Wells Fargo Initiates Coverage On The Pharmaceutical Space,2014-06-11 11:36:00-04:00,MYL,positive
880152.0,Wells Fargo Initiates Coverage on Mylan Inc. at Outperform,2014-06-11 06:47:00-04:00,MYL,positive
880153.0,Mylan Announces Launch of Generic Paraplatin,2014-06-09 07:32:00-04:00,MYL,neutral
880154.0,FDA Has Issued Approval for First Generic Versions of Celecoxib,2014-05-30 15:10:00-04:00,MYL,positive
880155.0,Mylan Issues Release Showing Belief Court Erred in Ruling Related to Generic Version of Celebrex,2014-05-30 12:46:00-04:00,MYL,neutral
880156.0,Mylan Reports Launch of Generic Malarone Tablets,2014-05-29 07:30:00-04:00,MYL,neutral
880157.0,Mylan Launches Generic Zyprexa Zydis Tablets ,2014-05-14 07:34:00-04:00,MYL,neutral
880158.0,Ian Estepan Tweet: '$TEVA just popped on $MYL saying there is a delay on capaxone on the conference call',2014-05-01 11:14:00-04:00,MYL,negative
880159.0,Mylan Inc. Reports Q1 EPS of $0.66 vs $0.64 Est; Revenue of $1.72B vs $1.78B Est,2014-05-01 07:00:00-04:00,MYL,neutral
880160.0,"Earnings Scheduled For May 1, 2014",2014-05-01 05:36:00-04:00,MYL,neutral
880161.0,Morning Market Losers ,2014-04-28 09:51:00-04:00,MYL,negative
880162.0,Meda Board of Directors Rejects Mylan Proposal; Terminates Discussions,2014-04-28 05:42:00-04:00,MYL,negative
880163.0,Benzinga's Weekend M&A Chatter,2014-04-27 20:21:00-04:00,MYL,neutral
880164.0,Mylan Files Suit Against FDA on Exclusivity Relating to Celecoxib ,2014-04-25 18:25:00-04:00,MYL,neutral
880165.0,"Mylan Raises Bid for Meda to 145 Kroner/Share, Shares Gain 3%",2014-04-25 14:34:00-04:00,MYL,positive
880166.0,UPDATE: Mylan Declines Comment on Report of Bid for Meda,2014-04-25 11:42:00-04:00,MYL,neutral
880167.0,Bloomberg Reporting Mylan Has Boosted Bid for Meda to Over 140 Kronor/Share,2014-04-25 11:35:00-04:00,MYL,positive
880168.0,UPDATE: FT (via Bloomberg) Says Mylan Has Made SEK145/Share Offer for Meda,2014-04-25 10:55:00-04:00,MYL,neutral
880169.0,Financial Times Reporting Mylan Makes a Bid for Meda,2014-04-25 10:46:00-04:00,MYL,neutral
880170.0,Mylan Shares Spike Higher; Hearing Chatter of New Meda Bid,2014-04-25 10:45:00-04:00,MYL,positive
880171.0,UPDATE: Mylan Launches First Generic ORTHO EVRA Patch,2014-04-16 16:14:00-04:00,MYL,neutral
880172.0,Mylan Launches First Generic ORTHO EVRA Patch,2014-04-16 16:14:00-04:00,MYL,neutral
880173.0,UPDATE: Mylan Will Be Able to Sell Generic Generess Fe (Pending Approval) Apr. 2015,2014-04-15 10:22:00-04:00,MYL,neutral
880174.0,Mylan Reports Settlement Deal for First-to-File Generess Fe,2014-04-15 10:20:00-04:00,MYL,neutral
880175.0,Mylan Launches Generic Lunesta Tablets ,2014-04-15 10:09:00-04:00,MYL,neutral
880176.0,"Actavis Reports Deal Related to Generess FE Patent Challenge, Will Grant Mylan License to MTK Generic Version",2014-04-15 08:03:00-04:00,MYL,positive
880177.0,Appeals Court Finds Roche's Boniva Patents on Osteoporosis Treatment Are Invalid - Bloomberg,2014-04-11 11:28:00-04:00,MYL,neutral
880178.0,"Mylan Says Judge Has Enforced Settlement Deal Between Mylan, Endo Related to Generic FROVA",2014-04-11 07:31:00-04:00,MYL,neutral
880179.0,"Citigroup Upgrades Mylan Inc. to Buy, Raises to $61.00",2014-04-07 09:39:00-04:00,MYL,neutral
880180.0,Benzinga's Weekend M&A Chatter,2014-04-06 21:15:00-04:00,MYL,neutral
880181.0,Meda Rejects Mylan's Takeover Proposal,2014-04-06 11:29:00-04:00,MYL,negative
880182.0,"Market Wrap For April 4: Dow Suffers Triple Digit Point Loss, Nasdaq Continues To Underperform",2014-04-04 16:44:00-04:00,MYL,negative
880183.0,"Mid-Afternoon Market Update: Markets Drop, Lead Lower by NASDAQ Momentum Names",2014-04-04 15:47:00-04:00,MYL,negative
880184.0,Mid-Day Market Update: NASDAQ Tumbles 1.8%; SYNNEX Shares Gain After Upbeat Results,2014-04-04 12:55:00-04:00,MYL,positive
880185.0,Mid-Morning Market Update: Markets Mixed; CarMax Results Miss Estimates,2014-04-04 10:14:00-04:00,MYL,negative
880186.0,"Meda Board Issues Statement Confirming Contact by Mylan, Rejection of Proposal",2014-04-04 09:13:00-04:00,MYL,negative
880187.0,"Meda Has Confirmed Approach by Mylan, Said Rejected the Offer - Bloomberg",2014-04-04 09:02:00-04:00,MYL,negative
880188.0,Citigroup Upgrades Mylan Inc. to Buy,2014-04-04 08:43:00-04:00,MYL,neutral
880189.0,Benzinga's Top #PreMarket Gainers,2014-04-04 08:14:00-04:00,MYL,positive
880190.0,UPDATE: Mylan Shares Rise 8% Premarket on Reports of Interest in Sweden's Meda,2014-04-04 07:14:00-04:00,MYL,positive
880191.0,Mylan Considering Takeover of Sweden's Meda -FT,2014-04-04 06:03:00-04:00,MYL,neutral
880192.0,UPDATE: Mylan Has Said the PTO is Refusing to Extend Copaxone Protection Past May,2014-04-03 14:30:00-04:00,MYL,negative
880193.0,US PTO Has Rejected Teva's '808 Patent Reissue Application on Copaxone,2014-04-03 14:29:00-04:00,MYL,negative
880194.0,"Mylan Offers Comments on Supreme Court Consideration of Standard of Review of Patent Claim Construction; Reaffirms Outlook, Sees Q1 Adj. EPS About Flat vs Q1'13",2014-03-31 15:16:00-04:00,MYL,positive
880195.0,"Mylan Wins Breach of Contract Litigation Against Glaxo, Receives $106.7M in Damages",2014-03-27 07:01:00-04:00,MYL,neutral
880196.0, District Court Upholds Mylan's US Patents on Perforomist Inhalation Solution,2014-03-24 13:28:00-04:00,MYL,positive
880197.0,District Court Upholds Mylan's US Patents of Perforomist,2014-03-24 13:28:00-04:00,MYL,neutral
880198.0,"US Stock Futures Up Ahead Of Jobless Claims, Retail Sales Data",2014-03-13 07:18:00-04:00,MYL,neutral
880199.0,Mylan Confirms Favorable Ruling in Generic Celebrex Patent Suit from Pfizer,2014-03-13 06:51:00-04:00,MYL,positive
880200.0,"Mylan Unveils Critical Care Segment in India, Launches Naloxone Hydrochloride Injection",2014-03-11 15:07:00-04:00,MYL,positive
880201.0,Morgan Stanley is Awaiting Approvals and M&A on Mylan in the Wake of P/E Re-Rating,2014-02-28 10:30:00-05:00,MYL,neutral
880202.0,"Needham Downgrades Mylan Inc. to Hold, Removes $40.00 PT",2014-02-28 07:56:00-05:00,MYL,neutral
880203.0,Market Wrap For February 27: Yellen Talks Pushes Markets Higher,2014-02-27 16:47:00-05:00,MYL,neutral
880204.0,From Mylan Call: Expecting Q1'14 EPS to Be About Equal to Q1'13,2014-02-27 10:37:00-05:00,MYL,neutral
880205.0,"From Mylan Call: Expecting FY14 Gross Margin 51-53%, R&D as a Percentage of Sales 7-8%",2014-02-27 10:32:00-05:00,MYL,negative
880206.0,Stocks Hitting 52-Week Highs,2014-02-27 10:10:00-05:00,MYL,neutral
880207.0,Mylan Inc. Sees FY2014 EPS $3.25-3.60 vs $3.38 Est; Sees Sales $7.80B-8.20B vs $7.70B Est,2014-02-27 07:04:00-05:00,MYL,neutral
880208.0,Mylan Inc. Reports Q4 EPS of $0.78 vs $0.75 Est; Revenue of $1.81B vs $1.81B Est,2014-02-27 07:01:00-05:00,MYL,neutral
880209.0,"Earnings Scheduled For February 27, 2014",2014-02-27 04:29:00-05:00,MYL,neutral
880210.0,Top 4 NASDAQ Stocks In The Drugs-Generic Industry With The Highest ROE,2014-02-21 04:35:00-05:00,MYL,positive
880211.0,Mylan Launches Hertraz in India ,2014-02-03 05:49:00-05:00,MYL,neutral
880212.0,Mylan Selected as Gilead's Exclusive Branded Medicines Business Partner for India ,2014-01-31 05:36:00-05:00,MYL,positive
880213.0,Mylan Announces Launch of Generic Version of Novo Nordisk's Prandin Tablets,2014-01-23 14:17:00-05:00,MYL,neutral
880214.0,Mylan Launches Generic Prandin Tablets ,2014-01-23 14:16:00-05:00,MYL,neutral
880215.0,Mylan Reports CE Mark for MyT4 PoC CD4 Diagnostic Test,2014-01-09 07:32:00-05:00,MYL,neutral
880216.0, Mylan Launches Generic Detrol LA Capsules,2014-01-07 14:32:00-05:00,MYL,neutral
880217.0,"RBC Capital Initiates Coverage on Mylan Inc. at Outperform, Announces $50.00 PT",2014-01-06 17:16:00-05:00,MYL,neutral
880218.0,Market Wrap For January 2: Markets Begin 2014 on Negative Note,2014-01-02 16:45:00-05:00,MYL,negative
880219.0,"FTC Okays Final Settlement Order for Mylan, Agila Deal",2013-12-18 12:15:00-05:00,MYL,positive
880220.0,Mylan Acquires Rights to Novel LAMA Respiratory Compound from Pfizer ,2013-12-18 09:43:00-05:00,MYL,positive
880221.0,Mylan Announces Acquisition Of Rights To Novel LAMA Respiratory Compound From Pfizer,2013-12-18 09:41:00-05:00,MYL,positive
880222.0,"UPDATE: Mylan Says In Settlement with Eisai, Valeant on Bexarotene",2013-12-17 14:33:00-05:00,MYL,neutral
880223.0,"Mylan Settlement for First-to-File Generic Version of TARGRETIN Includes No Later Than Jul. 9th, 2015 Release",2013-12-17 14:32:00-05:00,MYL,negative
880224.0,Mylan Announces Settlement Agreement for First-to-File Generic Version of TARGRETIN® ,2013-12-17 14:32:00-05:00,MYL,positive
880225.0,Top 4 Stocks In The Drugs-Generic Industry With The Highest Operating Margin,2013-12-16 04:26:00-05:00,MYL,positive
880226.0,Top 4 Stocks In The Drugs-Generic Industry With The Highest ROA,2013-12-13 04:12:00-05:00,MYL,positive
880227.0,"Teva, Mylan Settle Copaxone Patent Litigation in France, UK, Netherlands ",2013-11-25 08:58:00-05:00,MYL,negative
880228.0,"Teva, Mylan Settle Copaxone Patent Litigation in France, UK, Netherlands",2013-11-25 08:02:00-05:00,MYL,negative
880229.0,Mylan Announces Pricing of $2.0B of Senior Notes,2013-11-19 16:18:00-05:00,MYL,neutral
880230.0,Food Allergy Bill Offers Financial Incentives for States That Have Emergency Meds at Schools,2013-11-13 14:22:00-05:00,MYL,negative
880231.0,Mylan Launches Generic Version of Aciphex Tablets in US,2013-11-11 07:31:00-05:00,MYL,neutral
880232.0,Mylan Reports Launch of Generic Version of Eisai's Aciphex Tabs,2013-11-11 07:31:00-05:00,MYL,neutral
880233.0,"Stocks to Watch for November 07, 2013",2013-11-07 11:37:00-05:00,MYL,neutral
880234.0,"Earnings Scheduled For October 31, 2013",2013-10-31 05:03:00-04:00,MYL,neutral
880235.0,Benzinga Weekly Preview: FOMC Meeting Closely Watched,2013-10-25 16:18:00-04:00,MYL,neutral
880236.0,Benzinga's Top Initiations,2013-10-25 08:44:00-04:00,MYL,positive
880237.0,"Citigroup Initiates Coverage on Mylan Inc. at Neutral, Announces $42.00 PT",2013-10-25 07:35:00-04:00,MYL,neutral
880238.0,Mylan Faces Criticism from BMO After FDA Warning Letter to Agila,2013-10-18 16:10:00-04:00,MYL,negative
880239.0,"UPDATE: Morgan Stanley Downgrades Mylan on Binary Near-Term Stock Drivers, Robust Long-Term Growth Outlook",2013-10-14 10:03:00-04:00,MYL,positive
880240.0,"Morgan Stanley Downgrades Mylan Inc. to Equal-weight, Removes $41.00 PT",2013-10-14 06:33:00-04:00,MYL,neutral
880241.0,Top 4 Stocks In The Drugs-Generic Industry With The Highest Cash,2013-10-08 04:45:00-04:00,MYL,positive
880242.0,Stocks Hitting 52-Week Highs,2013-10-04 10:12:00-04:00,MYL,neutral
880243.0,"Mylan Launches First Generic VFEND for Oral Suspension, Wins 180 Days Marketing Exclusivity",2013-09-30 07:31:00-04:00,MYL,positive
880244.0,UPDATE: Mylan Confirms First-to-File Patent Challenge Related to Savella,2013-09-25 08:44:00-04:00,MYL,positive
880245.0,Mylan Confirms First-to-File Patent Challenge Related to Savella,2013-09-25 08:43:00-04:00,MYL,positive
880246.0,Teva Receives Favorable Court Decision in Mylan's Suit Related to Azilect,2013-09-23 08:26:00-04:00,MYL,positive
880247.0,"Mylan Supports Generic Drug Industry's Call on FDA to Uphold Consistent, Proven International Standard for Biosimilar Naming ",2013-09-23 07:30:00-04:00,MYL,positive
880248.0,UPDATE: Goldman Sachs Raises PT on Mylan on Increased Confidence in Key Revenue/Earnings Drivers,2013-09-12 10:51:00-04:00,MYL,positive
880249.0,"Goldman Sachs Maintains Buy on Mylan Inc., Raises PT to $46.00",2013-09-12 08:03:00-04:00,MYL,neutral
880250.0,"Bernstein Upgrades Mylan Inc. to Outperform, Raises PT to $44.00",2013-09-10 09:14:00-04:00,MYL,neutral
880251.0,Mylan Reports Recall of Birth Control Product ESME-28,2013-09-05 09:23:00-04:00,MYL,neutral
880252.0,"Form 8-K from Warner Chilcott Discloses Settlement with Mylan, Will Pay $12M in Total, Expecting $6M in Added Charges Not Already Made",2013-09-04 16:22:00-04:00,MYL,negative
880253.0,"Mylan Closes Transdermal Patch Plant Expansion in St. Albans, VT",2013-09-04 11:00:00-04:00,MYL,neutral
880254.0,Mylan Recalls Birth Control Product Freya-28 in Canada,2013-08-27 20:05:00-04:00,MYL,neutral
880255.0,"Mylan Loses Appeal To Sell Acne Drug Oracea, Court Says Lupin, Impax Also Infringed On Patent",2013-08-07 11:33:00-04:00,MYL,negative
880256.0,Buckingham Research Upgrades Mylan Inc. to Buy,2013-08-05 08:44:00-04:00,MYL,neutral
880257.0,UPDATE: UBS Investment Research Raises PT on Mylan Following Investor Day,2013-08-02 11:26:00-04:00,MYL,neutral
880258.0,"Cowen & Company Upgrades Mylan Inc. to Outperform, Raises PT to $45.00",2013-08-02 09:26:00-04:00,MYL,neutral
880259.0,"UBS Maintains Buy on Mylan Inc., Raises PT to $39.00",2013-08-02 09:08:00-04:00,MYL,neutral
880260.0,"Needham Downgrades Mylan Inc. to Buy, Raises PT to $40.00",2013-08-02 08:39:00-04:00,MYL,neutral
880261.0,UPDATE: Morgan Stanley Upgrades Mylan on Earnings and Multiple Call,2013-08-02 08:05:00-04:00,MYL,neutral
880262.0,"Morgan Stanley Upgrades Mylan Inc. to Overweight, Announces $41.00 PT",2013-08-02 06:29:00-04:00,MYL,negative
880263.0,"Mylan Reaffirms FY13 Outlook, Expecting FY14 Adj. EPS Growth 19%",2013-08-01 07:33:00-04:00,MYL,positive
880264.0,Mylan Inc. Reports Q2 EPS of $0.68 vs $0.67 Est; Revenue of $1.70B vs $1.73B Est,2013-08-01 07:32:00-04:00,MYL,neutral
880265.0,"Earnings Scheduled For August 1, 2013",2013-08-01 04:25:00-04:00,MYL,neutral
880266.0,"Form 8-K from Warner Chilcott Shows Co., Mylan Resolve Loestrin 24 FE Patent Litigation",2013-07-29 16:24:00-04:00,MYL,positive
880267.0,CAFC Confirms Mylan Invalidates Certain Teva Patent Claims on Copaxone,2013-07-26 11:19:00-04:00,MYL,positive
880268.0,Mylan Confirms First-to-File Patent Challenge Relating to BANZEL,2013-07-26 07:30:00-04:00,MYL,positive
880269.0,Top 4 Stocks In The Drugs-Generic Industry With The Lowest PEG Ratio,2013-07-26 04:17:00-04:00,MYL,negative
880270.0,Mylan Announces STALEVO® Settlement Agreement ,2013-07-25 08:24:00-04:00,MYL,positive
880271.0,Mylan Announces TARCEVA Settlement Agreement,2013-07-24 07:32:00-04:00,MYL,positive
880272.0,"Third Circuit Rules in Mylan's Favor Regarding Paroxetine Hydrochloride Extended-Release Tablets, Sending Mylan's Breach of Contract Claim Against GSK to Trial",2013-07-23 07:32:00-04:00,MYL,positive
880273.0,Teva Found on Summary Judgment to Infringe Mylan Patent for Perforomist® Inhalation Solution,2013-07-18 07:36:00-04:00,MYL,positive
880274.0,Court Finds in Favor of Mylan in Patent Infringement Suit Related to Certain Teva Copaxone® Patents ,2013-07-16 14:21:00-04:00,MYL,positive
880275.0,"Mylan Launches Generic Nor-Q.D.® Tablets, 0.35 mg (28-Day Cycle) ",2013-07-16 11:44:00-04:00,MYL,neutral
880276.0,Mylan Launches Generic Versions of Trilipix Caps,2013-07-15 09:51:00-04:00,MYL,neutral
880277.0,Mylan Confirms First-to-File Patent Challenge Relating to Vimpat(R) ,2013-07-15 07:31:00-04:00,MYL,positive
880278.0,Mylan Confirms First-to-File Patent Challenge for CANASA,2013-07-11 07:31:00-04:00,MYL,positive
880279.0,Mylan Launches Innovative Portfolio of Women's Care Products in India ,2013-06-27 07:31:00-04:00,MYL,positive
880280.0,Mylan Launches Generic Version of Viagra® in 11 European Countries,2013-06-26 11:07:00-04:00,MYL,neutral
880281.0,"Mylan Launches Generic Microner Tablets, 0.35mg",2013-06-26 07:30:00-04:00,MYL,neutral
880282.0,Mylan Names Roger Graham as Pres of Mylan Specialty,2013-06-24 07:32:00-04:00,MYL,neutral
880283.0,Mylan Looking to Raise Pact from $1.25B to $1.5B,2013-06-18 17:34:00-04:00,MYL,neutral
880284.0,"Mylan Announces Pricing of $1.15B in Senior Notes; Refinancing Revolving Credit Facility, Will Up From $1.25B to $1.5B",2013-06-18 16:20:00-04:00,MYL,positive
880285.0,"Jefferies Says Analysis on Elan Supports $19/Share Takeover Bid, Lifts Price Target to $19",2013-06-18 10:39:00-04:00,MYL,positive
880286.0,"Mylan Being Sued by Pfizer, Merck, Want Blockage of Proposed Copy of Azasite",2013-06-17 11:35:00-04:00,MYL,positive
880287.0,Mylan Files Automatic Mixed Securities Shelf,2013-06-13 17:22:00-04:00,MYL,positive
880288.0,"Mylan Chairman Says ""Sees Buying Back Stock In the Near Future""",2013-06-12 13:47:00-04:00,MYL,neutral
880289.0,Mylan Could Be Interested In Generic Assets Split from Pfizer,2013-06-12 13:33:00-04:00,MYL,positive
880290.0,Mylan at Goldman Sachs Healthcare Conference: Doesn't See Need to Shift to Brand-Name Therapies,2013-06-12 13:17:00-04:00,MYL,neutral
880291.0,"Mylan Chairman Says Company is Focused on Top-Line Growth, Won't Just Focus on Deals, Buybacks for Bottom Line",2013-06-12 13:16:00-04:00,MYL,positive
880292.0,UPDATE: JP Morgan Raises PT on Mylan as the Company Looks for Acquisitions ,2013-06-05 12:55:00-04:00,MYL,positive
880293.0,"JP Morgan Maintains Overweight on Mylan Inc., Raises PT to $38.00",2013-06-05 10:21:00-04:00,MYL,neutral
880294.0,Mylan's Specialty LP Announces Deal with Baseball Teams for Raising Awareness of Potentially Life-Threatening Allergies,2013-05-29 09:31:00-04:00,MYL,neutral
880295.0,"Appeals Court Says Teva Patent on Birth Control Pills is Invalid, Mylan, Lupin Win Ruling Related to Seasonique ",2013-05-21 11:15:00-04:00,MYL,positive
880296.0,"Bernstein Believes Mylan Could Offer $22/Share for Warner Chilcott, Calls Deal with Actavis More Likely",2013-05-21 10:52:00-04:00,MYL,neutral
880297.0,Federal Appellate Court Rules in Favor of Mylan in Patent Infringement Case,2013-05-21 07:33:00-04:00,MYL,negative
880298.0,Pharma M&A – Actavis to Acquire Warner Chilcott,2013-05-20 11:32:00-04:00,MYL,neutral
880299.0,Sanofi Wins Appeal to Revive Infringement Claim related to Allegra,2013-05-20 11:17:00-04:00,MYL,positive
880300.0,Mylan Launches Generic Tricor Tablets,2013-05-17 07:30:00-04:00,MYL,neutral
880301.0,Mylan Launches Generic Zomig Tablets,2013-05-15 11:41:00-04:00,MYL,neutral
880302.0,"Canaccord Analyst Saying New Mylan Deal Likely After Warner Chilcott, Actavis Reports",2013-05-15 09:51:00-04:00,MYL,neutral
880303.0,"Benzinga's M&A Chatter for Tuesday May 14, 2013",2013-05-14 18:01:00-04:00,MYL,neutral
880304.0,Mylan Spikes Higher,2013-05-14 14:45:00-04:00,MYL,neutral
880305.0,"Actavis Says they have Only Confirmed Talks with Warner Chilcott, 'This is the Extent of What We have Confirmed or Discussed Publicly'",2013-05-14 14:05:00-04:00,MYL,neutral
880306.0,"Mylan Refers to Report of Bid for Actavis as Speculation, Declines Comment",2013-05-14 13:58:00-04:00,MYL,neutral
880307.0,Bloomberg Reporting Actavis Said to Have Spurned $15B from Mylan,2013-05-14 13:22:00-04:00,MYL,neutral
880308.0,"BMO Capital Initiates Coverage on Mylan Inc. at Underperform, Announces $21.00 PT",2013-05-10 08:24:00-04:00,MYL,neutral
880309.0,"Mylan Inc. Reports Q1 EPS of $0.62, Inline; Revenue of $1.63B vs $1.69B Est",2013-05-02 16:37:00-04:00,MYL,neutral
880310.0,"US Stock Futures Up; GM Earnings, Economic Data In Focus",2013-05-02 05:51:00-04:00,MYL,neutral
880311.0,"Earnings Scheduled For May 2, 2013",2013-05-02 04:16:00-04:00,MYL,neutral
880312.0,"Court Says Merck Victory Upholding Vytorin Patents Will Stand, Says Mylan Can't Sell Copies of Vytorin, Zetia Before Apr. 2017",2013-04-11 11:21:00-04:00,MYL,neutral
880313.0,Downside in Valent Pharma Shares Likely Related to Mylan's Launch of Generic Zovirax; VRX Now Down 5+%,2013-04-03 15:27:00-04:00,MYL,positive
880314.0,Mylan Launches First Generic Version of Zovirax® Ointment,2013-04-03 15:02:00-04:00,MYL,neutral
880315.0,"Canaccord Genuity Maintains Hold on Mylan Inc., Lowers PT to $32.00",2013-04-02 06:13:00-04:00,MYL,negative
880316.0,"Bernstein Downgrades Mylan Inc. to Market Perform, Maintains $33.00 PT",2013-03-25 08:54:00-04:00,MYL,neutral
880317.0,Top 4 NASDAQ Stocks In The Drugs-Generic Industry With The Highest Cash,2013-03-21 06:54:00-04:00,MYL,positive
880318.0,Mylan Announces Launch of Generic Version of Xopenex System,2013-03-18 11:05:00-04:00,MYL,neutral
880319.0,Top 4 Stocks In The Drugs-Generic Industry With The Highest Profit Margin,2013-03-15 04:56:00-04:00,MYL,positive
880320.0,Mylan Reports Settlement Agreement Related to Fortamet,2013-03-13 15:15:00-04:00,MYL,positive
880321.0,"UPDATE: Canaccord Genuity Downgrades Mylan to Hold on Limited Upside, Lack of Catalysts",2013-03-11 07:56:00-04:00,MYL,negative
880322.0,Benzinga's Top Downgrades,2013-03-11 07:37:00-04:00,MYL,positive
880323.0,"Canaccord Genuity Downgrades Mylan Inc. to Hold, Maintains $33.00 PT",2013-03-11 06:25:00-04:00,MYL,neutral
880324.0,"UPDATE: Bank of America Reiterates Buy Rating, Raises PT on Mylan on Announced Agila Acquisition",2013-03-04 11:08:00-05:00,MYL,neutral
880325.0,"Bank of America Maintains Buy on Mylan Inc., Raises PO to $34.00",2013-03-04 08:16:00-05:00,MYL,negative
880326.0,Barron's Recap (3/2/12): Wealth Managers See Calmer Seas Ahead,2013-03-03 17:31:00-05:00,MYL,positive
880327.0,"Market Wrap for Thursday, February 28: Stocks close Little Changed",2013-02-28 16:30:00-05:00,MYL,neutral
880328.0,UPDATE: Goldman Sachs Raises PT to $33 on Mylan on Agila Specialties Purchase,2013-02-28 11:01:00-05:00,MYL,neutral
880329.0,"Mid-Morning Market Update: Markets Rise, Groupon Issues Downbeat Forecast",2013-02-28 10:23:00-05:00,MYL,neutral
880330.0,"Goldman Sachs Maintains Buy on Mylan Inc., Raises PT to $33.00",2013-02-28 08:29:00-05:00,MYL,neutral
880331.0,"Benzinga Market Primer: Thursday, February 28",2013-02-28 06:33:00-05:00,MYL,neutral
880332.0,Mylan to Buy Agila from Strides for $1.6B in Cash,2013-02-27 16:56:00-05:00,MYL,neutral
880333.0,Mylan Announces $500M Buyback Plan,2013-02-27 16:55:00-05:00,MYL,neutral
880334.0,Mylan Inc. Sees FY2013 EPS $2.75-2.95 vs $2.80 Est,2013-02-27 16:54:00-05:00,MYL,neutral
880335.0,Mylan Inc. Reports Q4 EPS of $0.65 vs $0.64 Est; Revenue of $1.72B vs $1.72B Est,2013-02-27 16:53:00-05:00,MYL,neutral
880336.0,"US Stock Futures Flat; Bernanke, Economic Data In Focus ",2013-02-27 06:24:00-05:00,MYL,neutral
880337.0,"Earnings Scheduled For February 27, 2013",2013-02-27 05:50:00-05:00,MYL,neutral
880338.0,"The Week Ahead: Earnings from JC Penney, Groupon, Salesforce",2013-02-22 17:16:00-05:00,MYL,neutral
880339.0,Mylan Loses Bid to Challenge AstraZeneca Patent on Seroquel XR,2013-02-14 12:06:00-05:00,MYL,negative
880340.0,Mylan Loses Appeals Court Bid to Invalidate Zetia Patents,2013-02-07 11:43:00-05:00,MYL,negative
880341.0,UPDATE: Morgan Stanley Downgrades Mylan to Equal-Weight Following Outperformance  ,2013-01-08 11:57:00-05:00,MYL,neutral
880342.0,"Morgan Stanley Downgrades Mylan Inc. to Equal-weight, Removes $27.00 PT",2013-01-08 07:37:00-05:00,MYL,neutral
880343.0,Top 4 NASDAQ Stocks In The Drugs-Generic Industry With The Highest Cash,2013-01-07 03:17:00-05:00,MYL,positive
880344.0,Mylan Unveils First Generic Maxalt MLT Tabs,2013-01-02 10:25:00-05:00,MYL,neutral
880345.0,"Mylan Pharma Wins Final FDA Approval for ANDA for Phenytoin Chewable Tablets, 50 mg",2012-12-28 10:56:00-05:00,MYL,positive
880346.0,"Mylan Announces Famy Care Received Final FDA Approval for ANDA for Levonorgestrel, Ethinyl Estradiol Tablets",2012-12-28 10:36:00-05:00,MYL,positive
880347.0,Mylan's Suit Against FDA Related to Generic Heart Drug Dismissed,2012-12-27 13:50:00-05:00,MYL,neutral
880348.0,Mylan Announces Settlement Related to Comtan,2012-12-20 08:56:00-05:00,MYL,neutral
880349.0,Mylan Launches Generic Version of Qualaquin Caps,2012-12-18 09:41:00-05:00,MYL,neutral
880350.0,"UPDATE: Bank of America Merrill Lynch Reiterates Buy Rating, Raises PT on Mylan",2012-12-17 10:56:00-05:00,MYL,neutral
880351.0,Mylan Announces Pricing of $750M in Senior Notes,2012-12-12 16:05:00-05:00,MYL,neutral
880352.0,Tuesday December 11st watchlist,2012-12-11 09:32:00-05:00,MYL,neutral
880353.0,Mylan Launches Generic Version of Atacand HCT,2012-12-05 08:44:00-05:00,MYL,neutral
880354.0,Mylan Launches Generic Detrol Tablets,2012-11-29 07:33:00-05:00,MYL,neutral
880355.0,Top 4 NASDAQ Stocks In The Drugs-Generic Industry With The Highest ROE,2012-11-29 03:19:00-05:00,MYL,positive
880356.0,"UPDATE: Canaccord Genuity Reiterates Buy Rating, Raises PT on Mylan",2012-11-28 10:51:00-05:00,MYL,neutral
880357.0,"Canaccord Genuity Reiterates Buy on Mylan Inc., Raises PT to $31.0",2012-11-28 09:26:00-05:00,MYL,neutral
880358.0,UPDATE: Bank of America Merrill Lynch Initiates Coverage on Mylan with Overweight Rating,2012-11-26 13:12:00-05:00,MYL,negative
880359.0,CORRECTION: Bank of America Initiates Coverage Mylan Bonds at Overweight,2012-11-26 10:11:00-05:00,MYL,negative
880360.0,Bank of America Initiates Coverage Mylan at Overweight,2012-11-26 08:13:00-05:00,MYL,negative
880361.0,Moody's Upgrades Mylan; Outlook Stable,2012-11-20 10:19:00-05:00,MYL,positive
880362.0,From Earlier: Leerink Swann Upgrades Mylan from Market Perform to Outperform,2012-11-16 10:25:00-05:00,MYL,neutral
880363.0,Stocks Hitting 52-Week Highs,2012-11-12 11:02:00-05:00,MYL,neutral
880364.0,Mylan Announces Settlement with Janssen Related to Ortho Tri-Cyclen Lo,2012-11-08 15:31:00-05:00,MYL,neutral
880365.0,Stocks Hitting 52-Week Highs,2012-11-01 10:18:00-04:00,MYL,neutral
880366.0,Benzinga's Top Upgrades,2012-10-26 07:26:00-04:00,MYL,positive
880367.0,UPDATE: Canaccord Genuity Upgrades Mylan to Buy,2012-10-26 07:13:00-04:00,MYL,neutral
880368.0,"Canaccord Upgrades Mylan from Hold to Buy, Raises PT from $25 to $30",2012-10-26 05:43:00-04:00,MYL,neutral
880369.0,Mylan Announces Settlement Agreement for its First-to-File Generic Version of Orapred ODT,2012-10-09 15:42:00-04:00,MYL,positive
880370.0,Mylan Launches Generic Avapro Tablets and Generic Avalide Tablets,2012-09-28 10:01:00-04:00,MYL,neutral
880371.0,Mylan Launches First Generic of Novartis' Diovan,2012-09-21 10:49:00-04:00,MYL,neutral
880372.0,Mylan Launches Generic Version of Antivert Tablets,2012-09-21 07:31:00-04:00,MYL,neutral
880373.0,Mylan Announces Settlement Agreement in Litigation Relating to Detrol LA ,2012-09-07 07:36:00-04:00,MYL,positive
880374.0,Mylan Selected as a Leading ARV Supplier to India's National AIDS Control Organization ,2012-09-04 07:32:00-04:00,MYL,neutral
880375.0,Pfizer and Mylan Partner for Generics Business in Japan,2012-08-22 17:00:00-04:00,MYL,neutral
880376.0,Mylan Launches Lithium Carbonate Extended-Release Tablets USP ,2012-08-10 07:30:00-04:00,MYL,neutral
880377.0,Mylan Launches Generic Version of Provigil® Tablets ,2012-08-10 07:04:00-04:00,MYL,neutral
880378.0,Mylan Specialty and Pfizer Announce Licensing Agreement for EpiPen® Injection 0.3/0.15mg in Japan,2012-08-07 17:29:00-04:00,MYL,positive
880379.0,Mylan Specialty and Pfizer Announce Licensing Agreement for EpiPen Injection 0.3/0.15mg in Japan,2012-08-07 16:02:00-04:00,MYL,positive
880380.0,Mylan Launches Generic Version of Singulair Tablets and Singulair Chewable Tablets ,2012-08-07 07:32:00-04:00,MYL,neutral
880381.0,Top 4 NASDAQ Stocks In The Drugs-Generic Industry With The Highest Revenue,2012-08-07 04:43:00-04:00,MYL,positive
880382.0,Mylan Signs Agreement with Gilead to Accelerate Access to Generic Single and Fixed-Dose Combination ARVs Containing Emtricitabine ,2012-08-02 10:21:00-04:00,MYL,positive
880383.0,Mylan Launches Generic Version of Sporanox® Capsules,2012-07-27 07:33:00-04:00,MYL,neutral
880384.0,UPDATE: Mylan Sees Unfavorable Currency Effect from $200M on Revenue,2012-07-26 10:52:00-04:00,MYL,neutral
880385.0,Mylan Guides Revenue at Low Range of $6.8-7.2B Forecast for 2012,2012-07-26 10:50:00-04:00,MYL,negative
880386.0,Mylan Reaffirms FY13 Forecast,2012-07-26 10:40:00-04:00,MYL,neutral
880387.0,Mylan Reports Q2 EPS $0.60 vs $0.55 Est; Revs $1.69B vs $1.66B Est,2012-07-26 08:16:00-04:00,MYL,neutral
880388.0,"Benzinga's Microcap Movers for Wednesday July 18, 2012",2012-07-18 22:00:00-04:00,MYL,neutral
880389.0,Somaxon Pharmaceuticals Announces Settlement of Silenor Patent Litigation With Mylan and PAR,2012-07-17 17:09:00-04:00,MYL,negative
880390.0,Mylan Announces Settlement Agreement in Litigation Relating to its Generic Silenor; Mylan Has Exclusive Rights to Sell Generic Silenor,2012-07-17 16:13:00-04:00,MYL,positive
880391.0,Consumer Prices Rose More than Expected in June,2012-07-17 10:21:00-04:00,MYL,neutral
880392.0,Producer Prices Unexpectedly Rose in June,2012-07-13 12:18:00-04:00,MYL,neutral
880393.0,Mylan Launches Generic Version of Lithobid Tablets ,2012-07-03 07:46:00-04:00,MYL,neutral
880394.0,Mylan Launches Generic Version of Clarinex® Allergy Medication ,2012-07-03 07:15:00-04:00,MYL,neutral
880395.0,Mylan Confirms First-to-File Patent Challenge Relating to Pristiq Tablets ,2012-06-28 07:32:00-04:00,MYL,positive
880396.0,Mylan Launches Thiamine Hydrochloride Injection ,2012-06-28 07:32:00-04:00,MYL,neutral
880397.0,"Teva Beats Momenta, Mylan in Copaxone Case",2012-06-25 16:43:00-04:00,MYL,neutral
880398.0,"Financial Breakfast: Morning News Summary for June 25, 2012",2012-06-25 07:29:00-04:00,MYL,neutral
880399.0,Mylan Comments on Copaxone Ruling; 2012 Earnings Guidance and 2013 Earnings Targets Remain Unchanged,2012-06-25 06:54:00-04:00,MYL,neutral
880400.0,Headline CPI Falls as Inflation Remains In Check,2012-06-14 13:06:00-04:00,MYL,neutral
880401.0,Producer Prices Drop More than Expected in May,2012-06-13 11:35:00-04:00,MYL,negative
880402.0,"Abbott Labs Settles Trilipix Case with Mylan, Watson and Lupin -Bloomberg",2012-06-12 16:08:00-04:00,MYL,neutral
880403.0,"Citi Comments on Provigil Ligitigation Settlement (MYL, TEVA, PRX)",2012-06-08 12:12:00-04:00,MYL,neutral
880404.0,"Citi Reiterates Mylan, Teva Pharmaceuticals Buy off Provigil Settlement",2012-06-08 12:05:00-04:00,MYL,neutral
880405.0,UPDATE: Bank of America Raises PO on Mylan to $27,2012-06-08 08:38:00-04:00,MYL,negative
880406.0,Mylan Settles Provigil(R) Litigation With Teva,2012-06-08 08:07:00-04:00,MYL,negative
880407.0,"Bank of America Maintains Mylan at Buy, Raises PO from $26 to $27",2012-06-08 06:59:00-04:00,MYL,negative
880408.0,Mylan Launches Generic Version of GSK's Epivir in the UK and Italy,2012-06-06 09:38:00-04:00,MYL,neutral
880409.0,Mylan Canada Receives Health Canada Approval for Generic Version of Tracleer® ,2012-06-06 07:32:00-04:00,MYL,positive
880410.0,Mylan Launches Generic Version of Lipitor,2012-05-29 13:15:00-04:00,MYL,neutral
880411.0,Mylan Announces Settlement Agreement in Litigation Relating to its Generic Xopenex,2012-05-29 08:01:00-04:00,MYL,positive
880412.0,Mylan Announces Settlement Agreement in Patent Infringement Litigation Relating to Sunovion's Brovana® Product ,2012-05-24 17:34:00-04:00,MYL,negative
880413.0,Mylan Launches Generic Version of Bonviva Film Coated Tablets in the UK and Italy ,2012-05-24 13:27:00-04:00,MYL,neutral
880414.0,Mylan Launches Generic Version of Viramune Tablets ,2012-05-23 11:43:00-04:00,MYL,neutral
880415.0,Mylan Launches Generic Version of Plavix Tablets ,2012-05-17 13:42:00-04:00,MYL,neutral
880416.0,"Paulson Increased Stakes in Hartford, Baxter, El Paso, MGM, Mylan",2012-05-15 17:25:00-04:00,MYL,positive
880417.0,Headline CPI in Line as Inflation Remains in Check,2012-05-15 08:56:00-04:00,MYL,neutral
880418.0,Mylan Launches Generic Lipitor in Five European Countries ,2012-05-11 07:30:00-04:00,MYL,neutral
880419.0,Mylan Increases 2012 Guidance Range to $2.45-2.55 vs $2.30-2.50; Announces $500M Share Repurchase Program ,2012-05-10 07:32:00-04:00,MYL,positive
880420.0,UPDATE: Mylan Launches First Generic Version of Doryx® 150 mg ,2012-04-30 14:23:00-04:00,MYL,neutral
880421.0,"From Earlier, Mylan Can Sell Generic Of Warner Chilcott's Doryx, Judge Rules",2012-04-30 14:11:00-04:00,MYL,neutral
880422.0,UPDATE: Teva Settles Nuvigil Litigation with Mylan   ,2012-04-30 08:24:00-04:00,MYL,negative
880423.0,Mylan Announces Settlement Agreement for its First-to-File Generic Version of Nuvigil,2012-04-30 08:05:00-04:00,MYL,positive
880424.0,"Earnings Recap for April 26, 2012",2012-04-26 09:50:00-04:00,MYL,neutral
880425.0,Mylan Says Q3 to Be Far Strongest of the Year,2012-04-26 09:04:00-04:00,MYL,positive
880426.0,Mylan Reports Q1 EPS $0.52 vs $0.51 Est; Revenues $1.59B vs $1.58B Est,2012-04-26 09:03:00-04:00,MYL,neutral
880427.0,Mylan and Pfizer Announce Epinephrine Auto-injector Settlement Agreement with Teva ,2012-04-26 07:46:00-04:00,MYL,positive
880428.0,Mylan Launches Generic Version of Zyprexa Tablets  ,2012-04-24 07:34:00-04:00,MYL,neutral
880429.0,Mylan Announces Expansion in Ireland; Expected To Generate More Than 500 Jobs By 2016,2012-04-18 07:16:00-04:00,MYL,neutral
880430.0,UPDATE: Supreme Court Sides With Generic Drug Makers In Legal Tactics Case,2012-04-17 10:49:00-04:00,MYL,positive
880431.0,Consumer Prices in March Rise as Expected,2012-04-13 08:59:00-04:00,MYL,neutral
880432.0,Mylan Launches First Generic Version of Lescol® Capsules ,2012-04-13 07:30:00-04:00,MYL,neutral
880433.0,"Benzinga's M&A Chatter for Thursday April 12, 2012",2012-04-12 18:19:00-04:00,MYL,neutral
880434.0,UPDATE: FDA Approves Mylan's Generic Fluvastatin,2012-04-12 14:42:00-04:00,MYL,positive
880435.0,"Hearing Chatter of Generic Approval for Mylan for Fluvastatin, Not Confirmed",2012-04-12 14:33:00-04:00,MYL,positive
880436.0,Hearing Chatter FDA Approves Mylan's Generic Fluvastatin ,2012-04-12 14:32:00-04:00,MYL,positive
880437.0,AstraZeneca Spokesperson Won't Comment on Earlier UBS Note Saying Mylan Could be a Takeover Target,2012-04-12 10:19:00-04:00,MYL,neutral
880438.0,Positive Rumors Circulate About Mylan,2012-04-12 09:37:00-04:00,MYL,positive
880439.0,Mylan Spiking Higher on Takeover Chatter; Currently at $22.19,2012-04-12 09:37:00-04:00,MYL,neutral
880440.0,"March PPI Ex-Food, Energy Rose More than Expected",2012-04-12 08:46:00-04:00,MYL,positive
880441.0,Mylan Sues FDA Seeking Ruling That Teva Holds No Exclusivity for Its Generic Version of Provigil,2012-04-05 12:42:00-04:00,MYL,negative
880442.0,Mylan Launches Generic Version of Mesnex Injection,2012-04-03 07:31:00-04:00,MYL,neutral
880443.0,Top 4 Mid-Cap Stocks In The Drugs-Generic Industry With The Highest EPS,2012-03-29 04:22:00-04:00,MYL,positive
880444.0,Mylan Launches Generic Version of Seroquel Tablets,2012-03-28 07:31:00-04:00,MYL,neutral
880445.0,"Mylan Launches Generic Version of Seroquel Tablets, 25 mg ",2012-03-28 07:30:00-04:00,MYL,neutral
880446.0,Mylan Gets Final Approval for Generic Version of Roche's Boniva,2012-03-20 07:30:00-04:00,MYL,positive
880447.0,"Headline CPI in Line, Core CPI Lower than Expected as Inflation Remains in Check",2012-03-16 10:06:00-04:00,MYL,negative
880448.0,Mylan Canada Receives OK for Generic Astra Zeneca's Cestor,2012-03-15 17:04:00-04:00,MYL,positive
880449.0,Mylan Gets Approval for Generic Viagra,2012-03-08 11:14:00-05:00,MYL,positive
880450.0,Mylan Continues to Pursue Damages and Injunction Against Sunovion's Brovana in Ongoing Litigation ,2012-03-02 14:40:00-05:00,MYL,negative
880451.0,Judge Invalidates 5 of 7 Mylan Patents in Case Against Sunovion -Bloomberg,2012-03-02 12:41:00-05:00,MYL,neutral
880452.0,Mylan Launches First Equivalent Product to Lexapro Tablets,2012-02-29 07:30:00-05:00,MYL,neutral
880453.0,Mylan Will Pay $57M to Settle Drug Overpricing Claim,2012-02-28 16:55:00-05:00,MYL,negative
880454.0,A Peek Into The Market Before The Trading Starts,2012-02-23 07:34:00-05:00,MYL,neutral
880455.0,"Financial Breakfast: Morning News Summary for February 23, 2012",2012-02-23 07:25:00-05:00,MYL,neutral
880456.0,Mylan Receives Tentative FDA Approval Through PEPFAR for Pediatric HIV/AIDS Therapy,2012-02-23 07:03:00-05:00,MYL,positive
880457.0,Mylan CEO: Believe we are the Only Global Player to Provide Global Scale on Generic Industry -CNBC,2012-02-22 14:48:00-05:00,MYL,neutral
880458.0,Mylan Targets 2012 EPS $2.30- $2.50 vs $2.41 Est,2012-02-21 16:31:00-05:00,MYL,neutral
880459.0,Earnings Roundup,2012-02-21 09:20:00-05:00,MYL,neutral
880460.0,Mylan Posts Jump In Q4 Profit,2012-02-21 07:57:00-05:00,MYL,positive
880461.0,"Financial Breakfast: Morning News Summary for February 21, 2012",2012-02-21 07:29:00-05:00,MYL,neutral
880462.0,Mylan Reports Q4 EPS $0.53 vs $0.50 Est; Revenues $1.53B vs $1.55B Est	 				,2012-02-21 07:01:00-05:00,MYL,neutral
880463.0,Mylan Resolves Defamation Litigation Against Pittsburgh Post-Gazette and Two of Its Reporters,2012-02-17 10:09:00-05:00,MYL,neutral
880464.0,Mylan and Pfizer Announce Epinephrine Auto-injector Settlement Agreement,2012-02-16 10:30:00-05:00,MYL,positive
880465.0,Hearing Goldman Sachs Upgrades Mylan from Neutral to Buy,2012-02-14 08:03:00-05:00,MYL,neutral
880466.0,"Mylan Receives Final FDA Approval for First Generic Version of Doryx Tablets, 150 mg  ",2012-02-09 07:31:00-05:00,MYL,positive
880467.0,Hearing Court Likely to Issue Decision in Favor of Mylan and Impax; Warner Chilcott Spikes Lower,2012-02-08 16:02:00-05:00,MYL,positive
880468.0,Top 4 NASDAQ Stocks In The Drugs-Generic Industry With The Highest Operating Margin,2012-02-06 04:07:00-05:00,MYL,positive
880469.0,Mylan Receives Tentative FDA Approval for Generic Version of Lipitor,2012-02-02 07:31:00-05:00,MYL,positive
880470.0,Mylan Confirms First-to-File Patent Challenge Relating to Actoplus Met® XR Tablets ,2012-01-09 07:32:00-05:00,MYL,positive
880471.0,ETF Showdown: Fun With Pharma,2011-12-30 16:10:00-05:00,MYL,positive
880472.0,End-of-Day Market Summary for December 27 2011,2011-12-27 16:20:00-05:00,MYL,neutral
880473.0,Mylan Launches First Generic Version of Teveten Tablets,2011-12-27 15:31:00-05:00,MYL,neutral
880474.0,A Peek Into The Market Before The Trading Starts,2011-12-27 07:48:00-05:00,MYL,neutral
880475.0,"Financial Breakfast: Morning News Summary for December 27, 2011",2011-12-27 07:26:00-05:00,MYL,neutral
880476.0,Mylan Receives Approval for First-to-File Generic Keppra XR Extended-Release Tablets ,2011-12-27 07:00:00-05:00,MYL,positive
880477.0, Notable Put Options Activity in Mylan ,2011-12-21 13:41:00-05:00,MYL,neutral
880478.0,Mylan Receives WHO Approval for Innovative 'Second-Line-in-a-Box' HIV/AIDS Treatment ,2011-12-20 07:02:00-05:00,MYL,positive
880479.0,Mylan Launches Generic Version of Toprol-XL Tablets,2011-12-16 14:53:00-05:00,MYL,neutral
880480.0,UPDATE: FDA Asking Mylan to Notify in Writing of Specific Steps Taken to Correct Violations Within 15 Day of Receipt of Letter -Reuter ,2011-12-13 09:39:00-05:00,MYL,negative
880481.0,Is Endo Pharmaceuticals Going to Seize Market Share? ,2011-12-12 15:41:00-05:00,MYL,positive
880482.0,Mylan Prelim Ban on Doryx Copy Vacated by Appeals Court; Mylan Wins Ruling That Overturns Ban on Generic Doryx,2011-12-12 11:05:00-05:00,MYL,negative
880483.0,Top 4 NASDAQ Stocks In The Drugs-Generic Industry With The Highest Cash,2011-12-09 04:19:00-05:00,MYL,positive
880484.0,"Financial Breakfast: Morning News Summary for December 2, 2011",2011-12-02 07:45:00-05:00,MYL,neutral
880485.0,A Peek Into The Market Before The Trading Starts,2011-12-02 07:42:00-05:00,MYL,neutral
880486.0,Mylan Launches Generic Version of Cyklokapron Injection,2011-12-02 07:00:00-05:00,MYL,neutral
880487.0,"Mylan Receives Tentative FDA Approval Through PEPFAR for First Heat-Stable, Fixed-Dose Combination of Atazanavir Sulfate and Ritonavir Tablets for HIV/AIDS",2011-12-01 13:44:00-05:00,MYL,positive
880488.0,Mylan Confirms First-to-File Patent Challenge Relating to Generess Fe ,2011-12-01 07:45:00-05:00,MYL,positive
880489.0,Mylan Launches Generic Version of Caduet® Tablets ,2011-12-01 07:31:00-05:00,MYL,neutral
880490.0,Mylan Receives Approval for Generic Version of Zinecard® for Injection ,2011-11-28 10:30:00-05:00,MYL,positive
880491.0,Canaccord Publishes Report on Specialty Pharmaceuticals ,2011-11-28 09:00:00-05:00,MYL,neutral
880492.0,FDA Says Mylan Inspection Found Significant Violations of Manufacturing Regulations -Reuters,2011-11-22 09:45:00-05:00,MYL,negative
880493.0,"Financial Breakfast: Morning News Summary for November 21, 2011",2011-11-21 07:34:00-05:00,MYL,neutral
880494.0,Mylan Announces Settlement Agreement for its First-to-File Generic Version of Vivelle-Dot,2011-11-21 07:03:00-05:00,MYL,positive
880495.0,"JP Morgan Reiterates Overweight, $28 PT on Mylan with Moderates Expectations ",2011-11-16 08:41:00-05:00,MYL,neutral
880496.0,Mylan Successfully Upsizes and Completes Refinancing of Credit Facility,2011-11-14 11:09:00-05:00,MYL,positive
880497.0,"Financial Breakfast: Morning News Summary for November 9, 2011",2011-11-09 07:48:00-05:00,MYL,neutral
880498.0,Mylan to Acquire Pfizer Respiratory Delivery Platform,2011-11-09 07:32:00-05:00,MYL,neutral
880499.0,Mylan Receives Approval for Generic Version of MS Contin Tablets ,2011-10-27 07:01:00-04:00,MYL,positive
880500.0,Mylan Inc's Profit Moves Up,2011-10-26 08:03:00-04:00,MYL,positive
880501.0,Mylan Announces Transition of CEO into Role of Executive Chairman;  Heather Bresch to Become CEO,2011-10-26 07:35:00-04:00,MYL,neutral
880502.0,Mylan Inc Reports Q3 EPS $0.55 vs $0.51 Est; Revenues $1.58B vs $1.54B Est			,2011-10-26 06:32:00-04:00,MYL,neutral
880503.0,Mylan Launches First Generic Version of Exelon Capsules in the U.K. ,2011-10-25 07:01:00-04:00,MYL,neutral
880504.0,"Mylan Laboratories Earnings Preview: Analysts Expect Higher EPS, Revenue",2011-10-21 16:07:00-04:00,MYL,neutral
880505.0,Mylan Announces Femcon Fe Settlement Agreement ,2011-10-19 07:03:00-04:00,MYL,positive
880506.0,Notable Put Options Activity in Mylan,2011-09-28 12:15:00-04:00,MYL,neutral
880507.0,"Hearing MYL, PRGO, IPXL Initiated at Hold by Canaccord",2011-09-28 06:11:00-04:00,MYL,neutral
880508.0,Mylan Announces XELODA Settlement and License Agreement ,2011-09-21 09:45:00-04:00,MYL,positive
880509.0,"Mylan's Matrix Receives Tentative FDA Approval Through PEPFAR for Novel ""Co-Packaged"" Version of HIV/AIDS Treatment ",2011-09-20 07:00:00-04:00,MYL,positive
880510.0,A Peek Into The Market Before The Trading Starts,2011-09-09 07:26:00-04:00,MYL,neutral
880511.0,"Mylan Receives Approval for Promethazine Hydrochloride Tablets, USP",2011-09-09 07:00:00-04:00,MYL,positive
880512.0,Whistleblower Lawsuit Accuses Par Pharmaceuticals of Nationwide Drug Switching Scheme,2011-09-06 16:00:00-04:00,MYL,negative
880513.0,Mylan Confirms First-to-File Patent Challenge Relating to FROVA Tablets  ,2011-08-17 07:51:00-04:00,MYL,positive
880514.0,Mad Money Lightning Round: Cramer Likes Southern Copper,2011-08-17 04:14:00-04:00,MYL,negative
880515.0,Endo Pharmaceuticals Sues Mylan Pharmaceuticals Over Frova Generic Drug,2011-08-16 16:17:00-04:00,MYL,neutral
880516.0,Options Brief: Mylan,2011-08-15 11:52:00-04:00,MYL,neutral
880517.0,Perrigo Earnings Preview,2011-08-15 09:55:00-04:00,MYL,neutral
880518.0,Calls Purchased on Mylan,2011-08-12 13:42:00-04:00,MYL,neutral
880519.0,A Peek Into The Market Before The Trading Starts,2011-08-12 07:43:00-04:00,MYL,neutral
880520.0,Mylan Launches Generic Version of Uroxatral® Tablets ,2011-08-12 07:00:00-04:00,MYL,neutral
880521.0,Options Brief: Mylan,2011-08-04 14:00:00-04:00,MYL,neutral
880522.0,Mylan Announces U.S. PTO Intends to Reissue Two Perforomist Patents to Dey Pharma ,2011-08-02 13:50:00-04:00,MYL,neutral
880523.0,Mylan Breaks Below 200-Day Moving Average at $22.37,2011-08-01 10:59:00-04:00,MYL,neutral
880524.0,Thursday's S&P Sector Recap,2011-07-28 17:50:00-04:00,MYL,neutral
880525.0,Mylan Sees 2013 EPS $2.75,2011-07-27 10:45:00-04:00,MYL,neutral
880526.0,Mylan Says It Is Well on Its Way to Achieve Year Goals,2011-07-27 10:38:00-04:00,MYL,positive
880527.0,Earnings Roundup ,2011-07-27 08:43:00-04:00,MYL,neutral
880528.0,Mylan Beats Second Quarter Expectations,2011-07-27 08:22:00-04:00,MYL,neutral
880529.0,UPDATE: Mylan Reports Stronger-Than-Expected Q2 Results,2011-07-27 07:30:00-04:00,MYL,neutral
880530.0,Mylan Reports Q2 EPS of $0.52 vs. $0.45 Est; Revenues $1.57B vs. $1.5B Est            ,2011-07-27 07:27:00-04:00,MYL,neutral
880531.0,"Earnings Preview: Mylan Laboratories EPS, Revenue Expected to Rise from Previous Quarter",2011-07-22 11:38:00-04:00,MYL,neutral
880532.0,Mylan Receives Voluntary License Rights to Gilead's HIV/AIDS Pipeline Products in Developing World,2011-07-12 07:03:00-04:00,MYL,neutral
880533.0,Wednesday's S&P 500 Sector Recap 6/29/11,2011-06-29 17:35:00-04:00,MYL,neutral
880534.0,Citi Maintains Buy on Mylan,2011-06-27 07:30:00-04:00,MYL,neutral
880535.0,J.P. Morgan Maintains Overweight Rating On Mylan,2011-06-24 08:25:00-04:00,MYL,negative
880536.0,Teva Pharmaceutical Down Slightly As Supreme Court Says Generics Can't Be Sued ,2011-06-23 13:02:00-04:00,MYL,positive
880537.0,Mylan Receives Approval for Generic Version of Aricept® Tablets ,2011-06-07 13:14:00-04:00,MYL,positive
880538.0,Mylan Receives Approval for Generic Version of Effexor XR® Capsules,2011-06-02 12:01:00-04:00,MYL,positive
880539.0,Mylan Launches Generic Version of Roxicodone Tablets,2011-05-25 08:19:00-04:00,MYL,neutral
880540.0,J.P. Morgan Reports on Mylan,2011-05-23 07:36:00-04:00,MYL,neutral
880541.0,Mylan Launches Generic Version of Depakote Sprinkle Capsules ,2011-05-23 07:02:00-04:00,MYL,neutral
880542.0,Cephalon Granted Temporary Restraining Order in AMRIX Patent Litigation ,2011-05-20 14:11:00-04:00,MYL,positive
880543.0,Top 4 Stocks In The Drugs-Generic Industry With The Highest ROE,2011-05-19 01:31:00-04:00,MYL,positive
880544.0,Mylan Launches First Generic Version of Xibrom Ophthalmic Solution ,2011-05-16 07:03:00-04:00,MYL,positive
880545.0,A Peek Into The Market Before The Trading Starts,2011-05-13 07:20:00-04:00,MYL,neutral
880546.0,Mylan Launches Generic Version of Risperdal M-Tab ,2011-05-13 07:02:00-04:00,MYL,neutral
880547.0,Options Brief: Mylan Inc. (MYL),2011-05-11 14:20:00-04:00,MYL,neutral
880548.0,Mylan Launches Generic Version of Percodan Tablets ,2011-05-05 07:33:00-04:00,MYL,neutral
880549.0,UPDATE: Morgan Stanley Downgrades Mylan To Equal-Weight From Overweight,2011-05-04 09:36:00-04:00,MYL,negative
880550.0,Mylan Reports EPS of $0.44 vs. $0.44 Estimate; Revenues $1.45B vs. $1.43B Estimate (MYL),2011-05-03 07:49:00-04:00,MYL,neutral
880551.0,"Mylan Laboratories Reports 8.7% Rise In Q1 Profit, Announces $350 million Buyback",2011-05-03 07:00:00-04:00,MYL,positive
880552.0,"Earnings Scheduled For May 3 (LM, MA, LVS, AVP, PFE, UNM, AMT, CBS, THC, CTSH, MCK, CLX, DUK, MRO, CMCSA, PCS, MYL, FWLT, TAP, ADM, EMR)",2011-05-03 00:43:00-04:00,MYL,neutral
880553.0,A Peek Into The Market Before The Trading Starts,2011-04-25 07:36:00-04:00,MYL,neutral
880554.0,Mylan Launches First Generic Version of Femara Tablets ,2011-04-25 07:30:00-04:00,MYL,neutral
880555.0,Mylan Launches Generic Version of Famvir® Tablets ,2011-04-20 07:32:00-04:00,MYL,neutral
880556.0,Mylan Launches Generic Famvir(R) Tablets (MYL),2011-04-20 07:31:00-04:00,MYL,neutral
880557.0,Options Brief: Mylan Inc. (MYL),2011-04-15 11:25:00-04:00,MYL,neutral
880558.0,JP Morgan Comments On Mylan Inc; Raises PT To $28,2011-04-11 08:32:00-04:00,MYL,positive
880559.0,Mylan Launches Generic Version of Sandostatin,2011-04-05 07:15:00-04:00,MYL,neutral
880560.0,Mylan Receives Approval for Generic Version of Xalatan Ophthalmic Solution ,2011-04-04 07:18:00-04:00,MYL,positive
880562.0,Options Brief: Mylan Inc. (MYL),2011-03-17 13:39:00-04:00,MYL,neutral
880563.0,Options Brief: Mylan Inc. (MYL),2011-03-16 11:05:00-04:00,MYL,neutral
880564.0,Standard & Poor's Upgrades Mylan,2011-03-10 14:19:00-05:00,MYL,neutral
880565.0,Goldman Sachs Maintains Buy on Mylan Inc. (MYL),2011-03-09 09:08:00-05:00,MYL,neutral
880566.0,Calls Purchased on Mylan Inc. (MYL),2011-03-07 10:41:00-05:00,MYL,neutral
880567.0,Mylan Confirms First-to-File Patent Challenge Relating to Vivelle-Dot,2011-03-01 11:45:00-05:00,MYL,positive
880568.0,Robert J. Cindrich and Heather Bresch Appointed to Mylan's Board ,2011-03-01 07:39:00-05:00,MYL,neutral
880569.0,Mylan Reports Q4 EPS od $0.45 vs. $0.45; Revenues $1.43B vs. $1.46B,2011-02-24 07:48:00-05:00,MYL,neutral
880570.0,"Top 4 NASDAQ Stocks In The Drugs-Generic Industry With The Highest Cash (MYL, SLXP, HITK, AKRX)",2011-02-17 03:11:00-05:00,MYL,positive
880571.0,Mylan Launches First Generic Version of Vfend Tablets ,2011-02-15 07:36:00-05:00,MYL,neutral
880572.0,Mylan Schedules Fourth Quarter 2010 Financial Results Conference Call ,2011-02-11 10:02:00-05:00,MYL,neutral
880573.0,Positive Phase IV Data on Nuvigil - Analyst Blog,2011-01-28 12:01:00-05:00,MYL,positive
880574.0,Positive Phase IV Data on Nuvigil - Analyst Blog,2011-01-28 11:30:00-05:00,MYL,positive
880575.0,Mylan Receives Approval for First-to-File Generic Sular,2011-01-28 08:02:00-05:00,MYL,positive
880576.0,Mylan's Subsidiary Obtains License for Promising HIV/AIDS Treatment ,2011-01-27 09:12:00-05:00,MYL,positive
880577.0,Mylan Announces Lipitor Settlement Agreement with Pfizer ,2011-01-25 08:32:00-05:00,MYL,positive
880578.0,Mylan Announces Caduet Settlement Agreement ,2011-01-25 08:27:00-05:00,MYL,positive
880579.0,Mylan's Matrix Receives Approval for Generic Protonix Delayed-release Tablets,2011-01-24 12:38:00-05:00,MYL,positive
880580.0,Mylan's Matrix Receives Tentative FDA Approval Under PEPFAR for Lamivudine and Zidovudine Tablets,2011-01-20 07:22:00-05:00,MYL,positive
880581.0,Calls Purchased on Mylan Inc. (MYL),2011-01-18 11:43:00-05:00,MYL,neutral
880582.0,A Peek Into The Market Before The Trading Starts,2011-01-18 07:45:00-05:00,MYL,neutral
880583.0,Mylan Receives Approval for Generic PrecoseTablets ,2011-01-18 07:30:00-05:00,MYL,positive
880584.0,No Trend Reversal Has Materialized Yet  01-10-2011,2011-01-10 18:28:00-05:00,MYL,negative
880585.0,Cephalon Drops Jet Lag Indication  - Analyst Blog,2010-12-29 10:33:00-05:00,MYL,negative
880586.0,Cephalon Drops Jet Lag Indication  - Analyst Blog,2010-12-29 10:00:00-05:00,MYL,negative
880587.0,"Mad Money Lightning Round OT: Cramer Likes TEVA (MYL, TEVA, RRD, ATT, VZ, D)",2010-12-20 19:26:00-05:00,MYL,negative
880588.0,A Peek Into The Market Before The Trading Starts,2010-12-17 07:56:00-05:00,MYL,neutral
880589.0,Mylan Confirms First-to-File Patent Challenge Relating to Orapred ODT,2010-12-17 07:33:00-05:00,MYL,positive
880590.0,Good Data on Teva's Laquinimod - Analyst Blog,2010-12-15 17:03:00-05:00,MYL,positive
880591.0,Good Data on Teva's Laquinimod - Analyst Blog,2010-12-15 16:42:00-05:00,MYL,positive
880592.0,"Stock Market News for Dec 15, 2010 - Market News",2010-12-15 09:33:00-05:00,MYL,neutral
880593.0,"Stock Market News for Dec 15, 2010 - Market News",2010-12-15 09:08:00-05:00,MYL,neutral
880594.0,Watson Inks Deal with Natco Pharma - Analyst Blog,2010-12-10 12:57:00-05:00,MYL,neutral
880595.0,Watson Inks Deal with Natco Pharma - Analyst Blog,2010-12-10 11:17:00-05:00,MYL,neutral
880596.0,Mylan Receives FDA Approval for Generic Version of Adalat,2010-12-10 07:32:00-05:00,MYL,positive
880597.0,Watson's Prochieve Achieves Target - Analyst Blog,2010-12-07 11:00:00-05:00,MYL,neutral
880598.0,Watson's Prochieve Achieves Target - Analyst Blog,2010-12-07 10:33:00-05:00,MYL,neutral
880599.0,Watson Launches New Pill - Analyst Blog,2010-12-02 09:00:00-05:00,MYL,neutral
880600.0,Watson Launches New Pill - Analyst Blog,2010-12-02 03:33:00-05:00,MYL,neutral
880601.0,Positive Data on Merck's Vytorin - Analyst Blog,2010-11-22 14:00:00-05:00,MYL,positive
880602.0,Positive Data on Merck's Vytorin - Analyst Blog,2010-11-22 08:33:00-05:00,MYL,positive
880603.0,Options Brief: Mylan Inc. (MYL),2010-11-19 11:53:00-05:00,MYL,neutral
880604.0,"Top 4 Stocks In The Drugs-Generic Industry With The Highest Cash (MYL, WPI, PRX, CPD)",2010-11-18 05:14:00-05:00,MYL,positive
880605.0,30-Yr Bond Yields Leading Move in Dollar  11-17-2010,2010-11-17 18:49:00-05:00,MYL,neutral
880606.0,Market Focused on Interest Rate Moves  11-16-2010,2010-11-16 18:52:00-05:00,MYL,positive
880607.0,Pharma & Biotech Industry Outlook - Nov. 2010 - Zacks Analyst Interviews,2010-11-09 17:03:00-05:00,MYL,neutral
880608.0,Pharma & Biotech Industry Outlook - Nov. 2010 - Industry Outlook,2010-11-09 17:03:00-05:00,MYL,neutral
880609.0,Pharma and Biotech Industry Outlook - Nov. 2010 - Industry Outlook,2010-11-09 17:03:00-05:00,MYL,neutral
880610.0,Mylan Falls Short on Revenue - Analyst Blog,2010-10-27 16:03:00-04:00,MYL,neutral
880611.0,"Mylan Beats on EPS, Misses on Sales  - Analyst Blog",2010-10-27 15:33:00-04:00,MYL,negative
880612.0,Buy Rating Reiterated On MYL,2010-10-27 06:52:00-04:00,MYL,neutral
880613.0,"Benzinga's After Hours Decliners (BWLD, PNRA, MYL, CIT, HUN)",2010-10-26 19:41:00-04:00,MYL,neutral
880614.0,"Mylan Reports Mixed Quarter, Shares Falling (MYL)",2010-10-26 16:40:00-04:00,MYL,positive
880615.0,Mylan Reports Adjusted Diluted EPS of $0.43,2010-10-26 16:37:00-04:00,MYL,neutral
880616.0,Citi Reiterates Buy On Mylan (MYL),2010-10-25 07:35:00-04:00,MYL,neutral
880617.0,Mylan Declares Quarterly Preferred Stock Dividend of $16.25,2010-10-19 13:47:00-04:00,MYL,neutral
880618.0,Mylan To Appeal Court Hearing In GSK Case,2010-10-19 09:58:00-04:00,MYL,neutral
880619.0,Mylan Sees Important Quarter Ahead As Core Business Remains Strong,2010-10-15 09:27:00-04:00,MYL,positive
880620.0,A Peek Into The Market Before The Trading Starts,2010-10-15 07:53:00-04:00,MYL,neutral
880621.0,Mylan Receives FDA Approvals for Generic Versions of Hyzaar® and Cozaar®  ,2010-10-15 07:18:00-04:00,MYL,neutral
880622.0,Mylan Launches Generic Version Of Wellbutrin,2010-10-06 07:18:00-04:00,MYL,neutral
880623.0,Goldman Adds Mylan To CL-Buy List,2010-09-23 08:27:00-04:00,MYL,neutral
880624.0,Citigroup Raises Estimates For Mylan,2010-09-10 08:13:00-04:00,MYL,neutral
880625.0,Mylan Acquires Bioniche Pharma - Analyst Blog,2010-09-08 14:03:00-04:00,MYL,neutral
880626.0,Goldman Sachs: Buy MYL Calls Ahead Of Earnings,2010-09-08 11:24:00-04:00,MYL,neutral
880627.0,Mylan Completes Acquisition of Bioniche Pharma (MYL)  ,2010-09-07 12:16:00-04:00,MYL,neutral
880628.0,New Dosages of Solodyn Approved - Analyst Blog,2010-08-31 14:06:00-04:00,MYL,positive
880629.0,"Goldman Sachs’ Specialty Pharma Playlist (MYL, AGN, PRGO)",2010-08-31 10:20:00-04:00,MYL,neutral
880630.0,Citi Has $23 Target On Mylan (MYL),2010-08-24 08:36:00-04:00,MYL,neutral
880631.0,Cephalon Sues Apotex  - Analyst Blog,2010-08-20 15:14:00-04:00,MYL,neutral
880632.0,FDA to Withdraw Shire Drug Approval  - Analyst Blog,2010-08-19 15:04:00-04:00,MYL,positive
880633.0,Eli Lilly Cuts Revenue Guidance  - Analyst Blog,2010-08-13 13:07:00-04:00,MYL,negative
880634.0,Teva Acquires Ratiopharm - Analyst Blog,2010-08-11 19:14:00-04:00,MYL,neutral
880635.0,Does Fed Have Anything Left to Stimulate Economy?  08-09-2010,2010-08-09 18:44:00-04:00,MYL,positive
880636.0,Market May Look to Challenge Upside Resistance  08-09-2010,2010-08-09 16:24:00-04:00,MYL,positive
880637.0,"Benzinga’s Top Upgrades (RYL, MYL, OHI, DE)",2010-08-09 07:37:00-04:00,MYL,positive
880638.0,Bernstein Ups MYL To Outperform,2010-08-09 06:56:00-04:00,MYL,neutral
880639.0,Mylan Labs' Profit Declines (MYL),2010-07-28 17:51:00-04:00,MYL,positive
880640.0,Mylan Declares Quarterly Preferred Stock Dividend,2010-07-19 07:55:00-04:00,MYL,neutral
880641.0,"Top Performing Industries For July 15 (NTY, CF, ARNA, MYL)",2010-07-15 14:51:00-04:00,MYL,positive
880642.0,Mylan to Buy Bioniche Pharma (MYL),2010-07-14 16:38:00-04:00,MYL,neutral
880643.0,"Top 4 Stocks In The Drugs-Generic Industry With The Highest ROE (HITK, PRX, WPI, MYL)",2010-07-12 06:30:00-04:00,MYL,positive
880644.0,"Top 4 Stocks In The Drugs-Generic Industry With The Highest EPS Estimates (WPI, HITK, PRX, MYL)",2010-07-12 06:26:00-04:00,MYL,positive
880645.0,Citi Rates Mylan (MYL) A High Risk Buy,2010-06-08 10:04:00-04:00,MYL,negative
880646.0,Citi Says Mylan (MYL) Shares Are A Buy,2010-05-28 11:29:00-04:00,MYL,positive
880647.0,"J.P. Morgan Endorses Teva And Hospira Stock (JOM, TEVA, HSP) ",2010-05-19 18:06:00-04:00,MYL,positive
880648.0,Bears Have Momentum  05-18-2010,2010-05-18 15:07:00-04:00,MYL,neutral
880649.0,Puts Action Heats Up on Mylan (MYL),2010-05-18 10:07:00-04:00,MYL,neutral
880650.0,Sustainability of Market Move  05-10-2010,2010-05-10 18:39:00-04:00,MYL,neutral
880651.0,"Top 5 NASDAQ Stocks In The Healthcare Sector With The Highest Sales (AMGN, TEVA, GILD, MYL, BIIB)",2010-05-06 07:13:00-04:00,MYL,positive
880652.0,Before Jumping Into A Single Health Care Stock Consider This ETF,2010-03-23 23:22:00-04:00,MYL,positive
880653.0,Investors Flock To Healthcare ETFs On Historic Reform,2010-03-22 16:13:00-04:00,MYL,neutral
880654.0,How Will Obama-Care Play Into The Markets And ETFs?,2010-03-21 21:50:00-04:00,MYL,positive
880655.0,"Fast Money Picks For March 19th (AA, MYL, TJX, UNG)",2010-03-18 20:35:00-04:00,MYL,neutral
880656.0,Thursday's Hot Stocks on Heavier Volume,2010-02-26 10:14:00-05:00,MYL,neutral
880657.0,"Top Performing Industries For February 25 (MYL, CNK, ESRX, GSS, MVG) ",2010-02-25 22:34:00-05:00,MYL,positive
880658.0,"Mylan Reports Strong Earnings, Stock Up (MYL)",2010-02-25 11:58:00-05:00,MYL,positive
880659.0,"Benzinga’s Top Pre-Market Gainers (BVF, PCS, MYL, ESRX, IPXL)",2010-02-25 08:57:00-05:00,MYL,positive
880660.0,Monday's Hot Stocks: Brush Up your Portfolio with Sirona Dental,2010-02-23 08:52:00-05:00,MYL,neutral
880661.0,"Best Deals For February 23, 2010 As Believed By Fast Money Final Trade (F, HMY, MYL, SKS, RSH, S)",2010-02-23 07:26:00-05:00,MYL,positive
880662.0,"Fast Money Picks For February 23rd (F, HMY, MYL, SKS) ",2010-02-22 18:46:00-05:00,MYL,neutral
880663.0,Generic Vs. Brand Name Drugs: Caylon Securities Conducts A Poll,2010-01-29 14:50:00-05:00,MYL,positive
880664.0,"Fast Money Picks For January 27th (MMM, AMGN, MYL) ",2010-01-26 18:19:00-05:00,MYL,neutral
880665.0,"UBS Adds OXY, MYL, CSX To Most Preferred List; Removes APA, TEVA",2010-01-26 13:11:00-05:00,MYL,neutral
880666.0,"Benzinga’s News Roundup (BA, MYL, MSFT, VLY, ORI, RDN, GNW, PMI)",2009-12-22 15:29:00-05:00,MYL,neutral
880667.0,New Additions To The Nasdaq 100 Index,2009-12-14 00:56:00-05:00,MYL,neutral
880668.0,"New 52-Week High Stocks (MDT, ADI, DLTR, DTV, MYL)",2009-11-24 12:09:00-05:00,MYL,neutral
880669.0,"NASDAQ Most Traded, November 23",2009-11-23 18:46:00-05:00,MYL,neutral
880670.0,"Fast Money Picks For November 23rd (KR, WMT, BAC, MYL)",2009-11-21 09:04:00-05:00,MYL,neutral
880671.0,Mylan (MYL) Resolves Suit With DOJ,2009-10-19 11:21:00-04:00,MYL,positive
